“We are treating cannabis-infused beverages exactly like we’re treating alcohol.”
By Liam Niemeyer, Kentucky Lantern
The Kentucky Senate advanced a bill Friday that would <a href="https://www.marijuanamoment.net/kentucky-senate-panel-votes-to-ban-sale-of-hemp-derived-beverages-on-a-temporary-basis/" target="_blank" rel="noopener">regulate intoxicating hemp-derived beverages</a> but without banning their sales as first proposed.
The bill’s sponsor, Sen. Julie Raque Adams, R-Louisville, amended Senate Bill 202 after Republicans and Democrats alike expressed skepticism about the ban when the measure was approved by a committee earlier this week.
Adams’s floor amendment removed the temporary sales ban and would instead impose a cap of 5 milligrams of tetrahydrocannabinol, or THC, on cannabis-derived drinks. The bill adds regulation of the intoxicating beverages to state laws that regulate alcoholic beverages, giving the Kentucky Department of Alcoholic Beverage Control the authority to oversee their distribution and sale.
Raque Adams said her floor amendment provided a “really solid starting point to put guardrails around this product so it doesn’t get in the hands of our children, guardrails for public health and guardrails for safety while maintaining the small business interests that we have seen across the commonwealth.”
“We are treating cannabis-infused beverages exactly like we’re treating alcohol,” Adams said.
As canned hemp-derived beverages containing THC have been gaining popularity across the country and popping up in convenience stores, state governments have increasingly sought to regulate them.
SB 202 passed the Senate by a vote of 29-6 with the minority of Democrats opposing the legislation, arguing that, while they agreed with regulating the beverages, the legislation was rushed and that senators and the public were not given enough time to understand the changes.
Sen. David Yates, D-Louisville, said he worried about trying to digest large changes to the <a href="https://apps.legislature.ky.gov/record/25rs/sb202.html" target="_blank" rel="noopener">bill</a>, noting some hemp-derived beverages have mixtures of various cannabinoids. Sen. Karen Berg, D-Louisville, questioned the 5 milligram THC limit because she didn’t know how the THC in the beverages is absorbed compared to gummies or cannabis flower.
“I think when we’re dealing with something that is regulating an industry that is currently legal, we have to be able to hear from that industry to make sure that we’re getting these regulations correct and that there aren’t any unintended consequences,” said. Sen. Cassie Chambers Armstrong, D-Louisville.
She said Adams’ bill “might be the perfect place for us to land” for regulation but that she did not have the information to know for sure.
Raque Adams used a “shell” bill as a vehicle for addressing hemp-derived beverages after the deadline for filing bills had passed. The original SB 202 made minor technical changes in the law before Raque Adams replaced its contents with her bill.
<a href="https://kentuckylantern.com/2025/03/07/ky-senate-votes-to-regulate-intoxicating-hemp-beverages-but-drops-sales-ban/" target="_blank" rel="noopener">This story was first published by Kentucky Lantern.</a>
<blockquote class="wp-embedded-content" data-secret="jBxgUTLrx8"><a href="https://www.marijuanamoment.net/kentucky-governor-personally-awards-states-first-medical-marijuana-cards-and-pushes-congress-to-end-gun-ban-for-patients/">Kentucky Governor Personally Awards State’s First Medical Marijuana Cards And Pushes Congress To End Gun Ban For Patients</a></blockquote>

Photo courtesy of Brendan Cleak.
The post <a href="https://www.marijuanamoment.net/kentucky-senate-passes-hemp-drinks-bill-with-amendment-regulating-instead-of-banning-them/">Kentucky Senate Passes Hemp Drinks Bill With Amendment Regulating, Instead Of Banning, Them</a> appeared first on <a href="https://www.marijuanamoment.net/">Marijuana Moment</a>.

“We are treating cannabis-infused beverages exactly like we’re treating alcohol.” By Liam Niemeyer, Kentucky Lantern The Kentucky Senate advanced a bill Friday that would regulate intoxicating hemp-derived beverages but without banning their sales as first proposed. The bill’s sponsor, Sen. Julie Raque Adams, R-Louisville, amended Senate Bill 202 after Republicans and Democrats alike expressed skepticism […]
The post <a href="https://www.marijuanamoment.net/kentucky-senate-passes-hemp-drinks-bill-with-amendment-regulating-instead-of-banning-them/">Kentucky Senate Passes Hemp Drinks Bill With Amendment Regulating, Instead Of Banning, Them</a> appeared first on <a href="https://www.marijuanamoment.net/">Marijuana Moment</a>.

Marijuana Moment

Kentucky Senate Passes Hemp Drinks Bill With Amendment Regulating, Instead Of Banning, Them

“It’s a consumer protection bill that is not intended to impact processors that are already testing and labeling their products appropriately.”
By Maya Homan, Georgia Recorder
Three bills <a href="https://www.marijuanamoment.net/georgia-lawmakers-weigh-broader-access-to-medical-marijuana-potentially-expanding-limited-low-thc-program/" target="_blank" rel="noopener">changing the way Georgia regulates hemp and medical cannabis</a> have cleared the Senate ahead of Thursday’s Crossover Day deadline. The votes on the bills are some of the only ones this session that didn’t fall cleanly along party lines, with Senate Republicans divided over expanding medical access to cannabis and members of both parties split over new regulations on recreational hemp products.
Medical cannabis
<a href="https://www.legis.ga.gov/legislation/70559" target="_blank" rel="noopener">Senate Bill 220</a>, also known as the “Putting Georgia’s Patients First Act,” passed in a contentious 39–17 vote after more than an hour of debate in the Senate. Like its counterpart in the other chamber, <a href="https://www.legis.ga.gov/legislation/69832" target="_blank" rel="noopener">House Bill 227</a>, the bill replaces the term “low-THC oil” with “medical cannabis” in Georgia code, removes requirements that certain medical diagnoses like cancer or Parkinson’s disease be “severe or end stage” and adds lupus to the list of qualifying health conditions.
Unlike the House version, SB 220 removes an existing prohibition against vaping cannabis oil and raises the percentage of THC that medical cannabis products may contain from 5 percent to 50 percent.
The bill was amended on the floor to include a provision allowing caregivers to pick up medical cannabis from pharmacies. Three other amendments aimed at reducing the amount of THC allowed in medical cannabis, removing the provision that allows for vaping, and removing PTSD and intractable pain from the list of approved diagnoses failed during a series of floor votes.
Hemp bills
Two bills aimed at strengthening hemp regulations in Georgia passed the Senate in decisive votes on Crossover Day, seeking to limit recreational use of marijuana as the chamber simultaneously eased restrictions for medical use.
Marietta Republican Sen. Kay Kirkpatrick’s <a href="https://www.legis.ga.gov/legislation/69550" target="_blank" rel="noopener">SB 33</a> subjects chemical compounds like delta-8 THC, delta-10 THC, hexahydrocannabinol (HHC) and other cannabinoids to testing and labeling regulations that were added last year under <a href="https://www.legis.ga.gov/legislation/67002" target="_blank" rel="noopener">SB 494</a>. It passed in a 50–6 vote.
In her speech from the well, Kirkpatrick said her bill is aimed at cutting down on unregulated hemp products from China and other countries.
“This bill is not a ban,” Kirkpatrick said. “It’s a consumer protection bill that is not intended to impact processors that are already testing and labeling their products appropriately. It’s intended to make sure that consumers buying these products are clear on what they’re buying.”
<a href="https://www.legis.ga.gov/legislation/69550" target="_blank" rel="noopener">Senate Bill 254</a>, sponsored by Athens Republican Bill Cowsert, seeks to impose new limits on THC-infused products after the Georgia Department of Agriculture raised the maximum amount of THC that can be included in a single beverage from 5 mg to 10 mg.
Cowsert urged lawmakers to codify the original 5 mg serving size restrictions on THC-infused beverages, calling the higher-dose beverages a “loaded gun” and arguing that one 10 mg serving of THC was equivalent to four glasses of wine.
“Most states are limiting greatly the amount of THC that can be included in a beverage, or in a tincture, or any kind of lotions, or in gummies,” he said. “And the reason is to protect consumers—protect the public—from the psychoactive components of THC.”
Like SB 33, the bill includes new restrictions on cannabinoid variants like delta-8 THC and delta-10 THC. It was ultimately amended on the floor by a narrow 29–27 vote to ban all THC-infused beverages, and passed the Senate in a 42–14 vote.
<a href="https://georgiarecorder.com/briefs/georgia-senators-ok-bills-to-limit-thc-content-in-beverages-expand-access-to-medical-cannabis/">This story was first published by Georgia Recorder.</a>
<blockquote class="wp-embedded-content" data-secret="2oUbj7NZpZ"><a href="https://www.marijuanamoment.net/ohio-gop-lawmaker-files-bill-to-revise-voter-approved-marijuana-law-with-less-sweeping-changes-than-senate-passed-measure/">Ohio GOP Lawmaker Files Bill To Revise Voter-Approved Marijuana Law With Less Sweeping Changes Than Senate-Passed Measure</a></blockquote>

Photo courtesy of Mike Latimer.
The post <a href="https://www.marijuanamoment.net/georgia-senate-passes-bills-to-expand-medical-marijuana-access-and-limit-thc-in-hemp-beverages/">Georgia Senate Passes Bills To Expand Medical Marijuana Access And Limit THC In Hemp Beverages</a> appeared first on <a href="https://www.marijuanamoment.net/">Marijuana Moment</a>.

“It’s a consumer protection bill that is not intended to impact processors that are already testing and labeling their products appropriately.” By Maya Homan, Georgia Recorder Three bills changing the way Georgia regulates hemp and medical cannabis have cleared the Senate ahead of Thursday’s Crossover Day deadline. The votes on the bills are some of […]
The post <a href="https://www.marijuanamoment.net/georgia-senate-passes-bills-to-expand-medical-marijuana-access-and-limit-thc-in-hemp-beverages/">Georgia Senate Passes Bills To Expand Medical Marijuana Access And Limit THC In Hemp Beverages</a> appeared first on <a href="https://www.marijuanamoment.net/">Marijuana Moment</a>.

Georgia Senate Passes Bills To Expand Medical Marijuana Access And Limit THC In Hemp Beverages

StratCann’s weekly round-up of cannabis industry news for the week ending March 8, 2025.
The post <a href="https://stratcann.com/news/week-in-weed-march-8-2025/">Week in Weed – March 8, 2025</a> appeared first on <a href="https://stratcann.com/">StratCann</a>.

StratCann

Week in Weed – March 8, 2025

The beginning of March kicks of the start of <a href="http://womenshistorymonth.gov/" target="_blank" rel="noreferrer noopener">Women’s History Month</a>. It began as a national, annual celebration in 1981. Today, many organizations are paying tribute, including the Library of Congress, the National Endowment for the Humanities and the Smithsonian Institution—to name a few. This is a time to honor and celebrate the women throughout history who’ve made an impact on our culture.



From science to technology to history and art, countless women have contributed to the progression of humanity—often unrecognized. But, what about trailblazers in the cannabis industry?



As more women emerge as CEOs, investment partners and leaders in business, the industry will look to the dynamic, innovative and professionally daring women shaping the market’s future. Check out these articles below for some of our favorites concerning women and cannabis.



<figure class="wp-block-image size-full"><a href="https://cannabisnow.com/wp-content/uploads/2023/10/Gen-Z-Women.jpg"><img fetchpriority="high" decoding="async" width="1000" height="600" src="https://cannabisnow.com/wp-content/uploads/2023/10/Gen-Z-Women.jpg" alt="Gen Z Women and Cannabis" class="wp-image-66905" srcset="https://cannabisnow.com/wp-content/uploads/2023/10/Gen-Z-Women.jpg 1000w, https://cannabisnow.com/wp-content/uploads/2023/10/Gen-Z-Women-300x180.jpg 300w, https://cannabisnow.com/wp-content/uploads/2023/10/Gen-Z-Women-768x461.jpg 768w, https://cannabisnow.com/wp-content/uploads/2023/10/Gen-Z-Women-400x240.jpg 400w" sizes="(max-width: 1000px) 100vw, 1000px"></a></figure><h4 class="wp-block-heading"><a href="https://cannabisnow.com/gen-z-women-and-cannabis-a-love-story/">Gen Z Women and Cannabis: A Love Story</a></h4>



Gen Z women are coming of age in a time where cannabis is much more normalized and the “reefer madness” scare tactics don’t really work. Additionally, women currently make up approximately one-third of buyers in the industry.



<figure class="wp-block-image size-full"><a href="https://cannabisnow.com/wp-content/uploads/2023/09/Women-and-weed.jpg"><img decoding="async" width="1000" height="600" src="https://cannabisnow.com/wp-content/uploads/2023/09/Women-and-weed.jpg" alt="" class="wp-image-66713" srcset="https://cannabisnow.com/wp-content/uploads/2023/09/Women-and-weed.jpg 1000w, https://cannabisnow.com/wp-content/uploads/2023/09/Women-and-weed-300x180.jpg 300w, https://cannabisnow.com/wp-content/uploads/2023/09/Women-and-weed-768x461.jpg 768w, https://cannabisnow.com/wp-content/uploads/2023/09/Women-and-weed-400x240.jpg 400w" sizes="(max-width: 1000px) 100vw, 1000px"></a></figure><h4 class="wp-block-heading"><a href="https://cannabisnow.com/women-and-weed/">Women &amp; Weed: A Story as Old as Time</a></h4>



While smoking is generally considered in popular parlance to be a masculine activity, especially smoking intoxicants, that’s not the whole reason women have been historically sidelined in cannabis.



<figure class="wp-block-image size-full"><a href="https://cannabisnow.com/wp-content/uploads/2023/08/Brett-Heyman-Women-of-Influence.jpg"><img decoding="async" width="1000" height="600" src="https://cannabisnow.com/wp-content/uploads/2023/08/Brett-Heyman-Women-of-Influence.jpg" alt="Brett Heyman" class="wp-image-66332" srcset="https://cannabisnow.com/wp-content/uploads/2023/08/Brett-Heyman-Women-of-Influence.jpg 1000w, https://cannabisnow.com/wp-content/uploads/2023/08/Brett-Heyman-Women-of-Influence-300x180.jpg 300w, https://cannabisnow.com/wp-content/uploads/2023/08/Brett-Heyman-Women-of-Influence-768x461.jpg 768w, https://cannabisnow.com/wp-content/uploads/2023/08/Brett-Heyman-Women-of-Influence-400x240.jpg 400w" sizes="(max-width: 1000px) 100vw, 1000px"></a><figcaption class="wp-element-caption">Brett Hayman, founder of cannabis accessory brand Edie Parker.</figcaption></figure><h4 class="wp-block-heading"><a href="https://cannabisnow.com/tag/women-of-influence/">Women of Influence</a></h4>



A few issues back, we presented an entire edition of our print magazine dedicated to the extraordinary women in and around our industry. This “Women Of Influence” issue featured a remarkable roster of leaders, artists and entrepreneurs, led by Vanderbilt University scientist, author and fierce cannabis advocate, Dr. Annabelle Manalo-Morgan, who credits the plant with nothing less than saving her son’s life.



<figure class="wp-block-image size-large"><a href="https://cannabisnow.com/wp-content/uploads/2016/05/Cannabis-Weed-Addictive-Women@2x.jpg"><img loading="lazy" decoding="async" width="1024" height="661" src="https://cannabisnow.com/wp-content/uploads/2016/05/Cannabis-Weed-Addictive-Women@2x-1024x661.jpg" alt="" class="wp-image-20233" srcset="https://cannabisnow.com/wp-content/uploads/2016/05/Cannabis-Weed-Addictive-Women@2x-1024x661.jpg 1024w, https://cannabisnow.com/wp-content/uploads/2016/05/Cannabis-Weed-Addictive-Women@2x-300x194.jpg 300w, https://cannabisnow.com/wp-content/uploads/2016/05/Cannabis-Weed-Addictive-Women@2x-768x495.jpg 768w, https://cannabisnow.com/wp-content/uploads/2016/05/Cannabis-Weed-Addictive-Women@2x-620x400.jpg 620w, https://cannabisnow.com/wp-content/uploads/2016/05/Cannabis-Weed-Addictive-Women@2x-85x54.jpg 85w, https://cannabisnow.com/wp-content/uploads/2016/05/Cannabis-Weed-Addictive-Women@2x.jpg 1240w" sizes="auto, (max-width: 1024px) 100vw, 1024px"></a></figure><a href="https://cannabisnow.com/study-marijuana-addictive-women/">Study: Is Marijuana More Addictive for Women? </a> Research conducted by Women’s Health Research at Yale (WHRY) is set to examine whether women are more likely to become addicted to marijuana than their male counterparts.



<figure class="wp-block-image size-full"><a href="https://cannabisnow.com/wp-content/uploads/2018/09/tokin-women.jpeg"><img loading="lazy" decoding="async" width="1000" height="600" src="https://cannabisnow.com/wp-content/uploads/2018/09/tokin-women.jpeg" alt="Tokin Women Cannabis Now" class="wp-image-37712" srcset="https://cannabisnow.com/wp-content/uploads/2018/09/tokin-women.jpeg 1000w, https://cannabisnow.com/wp-content/uploads/2018/09/tokin-women-300x180.jpeg 300w, https://cannabisnow.com/wp-content/uploads/2018/09/tokin-women-768x461.jpeg 768w, https://cannabisnow.com/wp-content/uploads/2018/09/tokin-women-400x240.jpeg 400w" sizes="auto, (max-width: 1000px) 100vw, 1000px"></a></figure><h4 class="wp-block-heading"><a href="https://cannabisnow.com/celebrate-international-womens-day-tokin-women/">Celebrate International Women’s Day with These Tokin’ Women</a></h4>



Celebrate the day by learning more about these prominent women who are also cannabis consumers. To honor International Women’s Day, here is a list of 15 books referenced in “<a href="https://squareup.com/market/california-norml/tokin-women-a-year-herstory" target="_blank" rel="noreferrer noopener">Tokin’ Women: A 4000-Year Herstory</a>.” 




The post <a href="https://cannabisnow.com/celebrate-the-women-of-cannabis-this-month/">Celebrate the Women of Cannabis This Month</a> appeared first on <a href="https://cannabisnow.com/">Cannabis Now</a>.

It's March, and that means it's Women's Month. We've curated some of our top stories recognizing cannabis industry boss babes to celebrate. 
The post <a href="https://cannabisnow.com/celebrate-the-women-of-cannabis-this-month/">Celebrate the Women of Cannabis This Month</a> appeared first on <a href="https://cannabisnow.com/">Cannabis Now</a>.

Cannabis Now

Celebrate the Women of Cannabis This Month

True North Cannabis Co’s court-appointed monitor is seeking offers for the three businesses or assets as part of a court-supervised sale and investment solicitation process...
The post <a href="https://stratcann.com/financials/true-north-cannabis-enters-sisp-process-monitor-seeks-buyers/">True North Cannabis enters SISP process, monitor seeks buyers</a> appeared first on <a href="https://stratcann.com/">StratCann</a>.

True North Cannabis enters SISP process, monitor seeks buyers

Getting high in the morning is not like it was back in the day. Now, you might be thinking, “Wait, it isn’t?” while pondering your long-lost youth and the cannabis consumption habits that feisty little whippersnapper once maintained to get through the day.



If your regimen was anything like ours, then you enjoyed the kind of enthusiastic <a href="https://cannabisnow.com/work-hard-play-hard-the-trick-to-staying-high-all-day-long/">wake and bake ritual</a> that had everyone at your place of employment looking at you funny when you first started.



You may have even worn your <a href="https://cannabisnow.com/how-to-deal-with-cannabis-induced-panic-attacks/">paranoia</a> on your sleeve, prompting people to ask too many questions. Remember, back when you used to have to feed kitchen managers a line of BS about having allergies if they mentioned anything about you looking stoned? Even if you knew they smoked weed too, you really couldn’t reveal your secret. “No, I don’t do that,” you would tell them. “It’s the change of seasons… ragweed or something.”



More like a bag of weed.



But you were consistent in your acts of stoned servitude. You showed up to your shift each day completely blazed out of your mind, eyes squinty and redder than hell’s carpet. So, by the end of the first month, the higher-ups were just like, “You know what, maybe that kid really does have allergies,” and it was never mentioned again. They were just happy someone showed every day and did the work no one else wanted to do.



That was the grinding life of the canna-head way back when. Maybe it still is for some. It’s what needed to be done for us to keep our heads on straight while also making sure there was plenty of money in our pockets to pay the bills and afford more herb. Let’s face it, weed’s never been cheap!



But times have changed.



These days, you have a full-time job, maybe even a career — one that requires more attention to detail than when you were just washing dishes for a living. And let’s not forget about those kids. Kids need things, like fully functional parents to get them off to school, talk to teachers, and perhaps even help rally the troops before, during and after all of their extracurricular activities. This life we’re talking about right here, one that is commonly referred to by the millennial generation as “adulting,” is balls to the wall, Jack! It is not a life that can be easily conquered by those who linger in the ranks of the perpetually wasted. Therefore, getting too ripped on weed first thing in the morning is not the smartest approach to keeping the family unit on track to achieving its potential.



But you don’t have to stop smoking pot before starting your day. It would be ridiculous to suggest that grown-ups should renounce the coveted morning wake and bake ritual. Even though we have better jobs now, they still suck a big one sometimes. But it is not beyond the scope of reason that some regular users may need to change up their strategy a little to get through the day without getting fired or catching a surprise visit from CPS.



Some folks can make this adjustment easier than others. So for those of you who clicked this link looking for some heavy guidance on this very real, very serious issue, don’t worry about a thing. We’ve got you… for the most part.



Okay, so you cannot just open your eyes first thing in the morning and start doing bong rips right out of the gate. You’re not Seth Rogen. And, we can’t even believe we have to say this, but put that dab rig down. Heck no, man, you need a little finesse to fit into the big boy or girl panties you’re going to need as soon as those kids climb out of bed and start asking for breakfast.



Ever try pouring milk after <a href="https://cannabisnow.com/cold-start-dabs/">dabs</a>?



Meanwhile, you, yourself, must get ready for work, as the same sh*t different day routine still means clocking in at a business at a particular time of morning and being prepared to go-go-go once the boss starts barking orders. So, as soon as the alarm goes off, hit the snooze button and reach for the nicely packed bowl or vape pen on the nightstand. But take no more than two modest hits off that bad boy before putting on some pants and moving to the kitchen. This dose should provide you with enough of a head change to ensure the kiddos get the eggs, cereal or whatever their growing bodies need before it’s time for them to get dressed for school. Then lo and behold, you’ll get them fed without the oldest calling 911 because he’s convinced that you’re having a stroke.



While the kids finish getting ready, now is the perfect opportunity for you jump back into the bedroom for a refresher hit — no more than that, though. Otherwise you could end up mumbling about conspiracy theories during that early morning meeting with Principal Pritchett. You won’t have to worry about running concessions at Thursday’s basketball game once you spill out something like, “So, do you really think we landed on the moon, or is Alex Jones onto something?”



Start looking for a new school district now!



For all intents and purposes, let’s assume you have a job that does not nail employees to the wall with random drug tests, nor do they care if you all smoke weed on your own time, as long as you show up on time and kick ass. If you are one of those people where a pop whiz quiz is always lurching around the corner, like a factory worker or a federal employee, perhaps this article is not for you. <a href="https://cannabisnow.com/pass-a-drug-test-employers-are-still-testing-people-for-marijuana/">Try this one on for size.</a>



Okay, so where were we? That’s right, grind time. Now that the kids are safe in school and you’re en route to your place of employment, it’s totally acceptable to squeeze in another hit or two before you enter the parking lot.



If you are confused at this juncture, seeing as smoking more weed means you’d have to do it behind the wheel and you’re thinking, Jeez, I don’t know about this, Cannabis Now, isn’t that a little dangerous? Well, probably. But we’re all adults here, or at least we’re supposed to be, so don’t be self-righteous about it. We’re only trying to help. But let’s get real, if you weren’t getting high, you’d probably still be texting and stuffing an Egg McBig Mac down your throat at 70 mph. So, what’s the difference? At least you can still pay attention to the road with a smoking device in your hand. Or do we need to write a tutorial on that, too?



Listen, nobody is telling you that you have to take another hit before you get to work, just that it is (kind of) acceptable to do so. Pull over if need be. Just watch out for cops!



Maybe you’d feel more comfortable saving that pre-shift hit for when you are sitting in the parking lot, and that’s fine too. It is also not against the rules to skip it and wait until lunch to take your buzz up a notch. Depending on the potency of the strain, that might not be a bad idea.



Also, if it’s your first day, week or even month on the job, you might want to take it easy. But if this is a position you’ve been holding down for a while now, get to the headspace that you need to be in. Just remember to use those eye drops. There is no need going into work all red-eyed and obvious, unless you just feel like waxing nostalgic by explaining to your supervisor how your allergies are acting up.



That’s up to you… because our work is done.




The post <a href="https://cannabisnow.com/the-grown-ups-morning-marijuana-strategy/">The Grown-Up’s Morning Marijuana Strategy</a> appeared first on <a href="https://cannabisnow.com/">Cannabis Now</a>.

Just FYI: This article is for entertainment purposes only. There’s no single trick to getting high sans consequences in the morning. If you were hoping to follow our advice to the letter, you need more help than you thought.
The post <a href="https://cannabisnow.com/the-grown-ups-morning-marijuana-strategy/">The Grown-Up’s Morning Marijuana Strategy</a> appeared first on <a href="https://cannabisnow.com/">Cannabis Now</a>.

The Grown-Up’s Morning Marijuana Strategy

Changes to Ohio’s voter-approved adult-use cannabis law proposed in a bill introduced this week by House Republicans are less extreme than those passed by the state Senate.
<a href="https://mjbizdaily.com/ohio-house-republicans-introduce-adult-use-cannabis-bill/">Ohio House Republicans’ cannabis measure a ‘slap in face,’ NORML says</a> is a post from: <a href="https://mjbizdaily.com/">MJBizDaily: Financial, Legal &amp; Cannabusiness news for cannabis entrepreneurs</a>

MJBizDaily

Ohio House Republicans’ cannabis measure a ‘slap in face,’ NORML says

Ayr Wellness has signed a letter of intent to sell its four marijuana stores in Illinois because the company doesn’t have the scale to compete over the long term.
<a href="https://mjbizdaily.com/ayr-wellness-is-selling-4-marijuana-stores-in-illinois/">Ayr Wellness is selling 4 marijuana stores in Illinois</a> is a post from: <a href="https://mjbizdaily.com/">MJBizDaily: Financial, Legal &amp; Cannabusiness news for cannabis entrepreneurs</a>

Ayr Wellness is selling 4 marijuana stores in Illinois

A House committee in New Hampshire has advanced a bill that would decriminalize use and possession of psilocybin.
Members of the House Criminal Justice and Public Safety voted unanimously, 16–0, to pass the bill, HB 528, from Rep. Kevin Verville (R).
Prior to moving the bill forward, the committee first adopted an amendment to temper the proposed reform. As originally introduced, it would have completely removed all penalties around obtaining, purchasing, transporting, possessing or using psilocybin, effectively legalizing it on a noncommercial basis.
The amended version of the legislation imposes penalties, but they’re significantly lower than the state’s current felony-level prohibition.
Under the new amendment, a first psilocybin offense would be a violation, subject to a fine of $100 or less. Second and third offenses would be class B misdemeanors, carrying fines of up to $500 and $1,000, respectively, but also with no risk of jail time.
Fourth and subsequent offenses would still be classified as felonies.
Notably, language of the proposal does not include any specific limit to the amount of psilocybin a person could possess.
The committee’s chair, Rep. Terry Roy (R), said that while he opposes full legalization of psilocybin, he believes the drug has medical value and ought not be punished as a felony.
“I’d like to see it done through proper scientific channels, through university studies and the [Department of Veterans Affairs],” Roy explained. “But having said that, I support this bill lowering it from a felony. We don’t need more intoxicated people, but we also don’t need more felons.”

Action on the bill follows a committee hearing last month at which a member of the panel, Rep. Kathleen Paquette (R), <a href="https://www.marijuanamoment.net/new-hampshire-gop-lawmaker-asks-colleagues-to-legalize-psilocybin-because-it-can-treat-headache-disorder-she-suffers-from/">discussed her lifelong struggle with intractable pain from cluster headaches—a condition the psychedelic is known to treat</a>.
“I suffer from a chronic, excruciating pain condition called trigeminal cephalalgia, also known as cluster headache. They’re called cluster headaches because they tend to cycle and come in clusters,” she told colleagues at that meeting. “When I’m in cycle, I have unbearable attacks of burning, piercing, stabbing pain behind my eye, the pain is so violently severe that I cry, I rock, I pace and I usually end up rolling around on the floor, clutching my head and sobbing. My nose runs, my eye swells and it’s not unusual for me to be vomiting.”
Psilocybin is “believed to help people like me by potentially interrupting and preventing headache cycles,” she continued. “It is thought to reduce inflammation in the brain, alter pain perception and reset the neural pathways that interrupts these painful cycles.”
At the most recent committee hearing on Friday, Rep. David Meuse (D) referenced Paquette’s disclosure.
“We actually heard some pretty compelling testimony from one of our colleagues,” he said, “and I think that really, really helped.”
“I think where I’m at on this is: This particular change to the bill allows it to be treated more like cannabis from a penalty perspective, and less like fentanyl, which I think is a good thing given the therapeutic benefits,” Meuse said of the amended version of HB 528. “It also gives us time to weigh and measure what the potential therapeutic value of this is, to wait for studies to come out before we make any additional decisions on what we’re doing.”
Rep. Alissandra Murray (D), meanwhile, said that testimony at the panel’s last hearing made clear that “not only is this not really a dangerous drug, but it also has medicinal benefits that people are unable to take advantage of currently because of its classification under the Controlled Drug Act.”
“While entirely removing it might be too big a step for this legislature to take right now,” Murray continued, “I think this is a good compromise to start with. And hopefully people will be able to treat their conditions if they need to and not face a felony for doing so.”
Despite the unanimous vote to advance the measure, Vice Chair Rep. Jennifer Rhodes (R) said she was hesitant to endorse the proposal too broadly.
“I just have to say for the record that all this conversation about this being medicine, that’s almost make me want to say ‘no,'” Rhodes said. “I am not a doctor. I don’t know that any of us in here are…If we’re doing this because we’re taking away the penalty, that’s one thing, but doing it because we’re trying to say that we’re making it be medicine, that’s the part that I’m not OK with.”
At the hearing last month, one committee member asked sponsor Verville why he chose to focus the <a href="https://gc.nh.gov/bill_status/billinfo.aspx?id=92&amp;inflect=2" target="_blank" rel="noopener">bill</a> on only psilocybin rather than put forward legislation to more broadly legalize the therapeutic use of multiple psychedelics, as the lawmaker has done in the past.
Verville said at the time that he’s “smart enough to know” that pushing for broader reform “is a big bite, and I get a lot of feedback from people that were sympathetic but didn’t vote in favor, and and so what I’ve what I’ve done this year is I’ve rolled this back to only be psilocybin.”
“I dream of a day when we have medical psychedelics available. I dream of that day,” he said. “There are demonstrated medical benefits with depression, post-traumatic stress syndrome—interestingly enough, addiction. So psychedelics can be used to cure addiction to a very high rate.”
This bill, however, is “a discussion” and the beginning of a “debate that we really need to start having in an honest, forthright manner.”
Reached on Friday, Verville told Marijuana Moment he’s “very pleased and very proud” of the committee for “passing this common sense legislation to stop making felons out of users of psilocybin.”
HB 528 next proceeds to the House floor, where it’s been put on the consent calendar.
Separately, the House Criminal Justice and Public Safety Committee <a href="https://www.marijuanamoment.net/new-hampshire-lawmakers-move-forward-with-plan-to-legalize-simple-possession-of-marijuana/">gave its approval to two cannabis-related bills earlier this week</a>.
One—HB 198, from Rep. Jared Sullivan (D)—would take a simple, unregulated approach to marijuana legalization. If approved, that measure would allow adults 21 and older to possess up to two ounces of marijuana flower, 10 grams of concentrate and up to 2,000 milligrams of THC in other cannabis products.
Retail sales of marijuana products, along with home cultivation, would remain illegal under the plan. Consuming marijuana on public land would also be prohibited.
Another bill—HB 190, from Rep. Heath Howard (D)—would increase the possession limit of medical marijuana by patients and caregivers, raising it to four ounces from the current two. Existing 10-day patient purchase limits would also increase from two ounces up to four.
And late last month, the full House of Representatives both <a href="https://www.marijuanamoment.net/new-hampshire-house-passes-republican-led-bill-to-legalize-marijuana/" rel="noopener" data-google-interstitial="false">passed a simple bill to legalize marijuana for adults</a> and also approved measures that would <a href="https://www.marijuanamoment.net/new-hampshire-house-passes-bills-to-late-patients-to-grow-medical-marijuana-at-home-and-annul-past-cannabis-convictions/">annul certain criminal records around cannabis and allow medical marijuana patients to grow the plant at home</a>.
The legalization measure, also from Verville, would remove state penalties around cannabis-related conduct for adults 21 and older, but it would not establish a licensed commercial market or a broader regulatory scheme.
— 
Marijuana Moment is <a href="https://www.marijuanamoment.net/bills/" target="_blank" rel="noopener">tracking hundreds of cannabis, psychedelics and drug policy bills</a> in state legislatures and Congress this year. <a href="https://www.patreon.com/marijuanamoment" target="_blank" rel="noopener">Patreon supporters</a> pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. <a href="https://www.marijuanamoment.net/bills/" target="_blank" rel="noopener"><img loading="lazy" decoding="async" class="alignnone wp-image-9128 size-medium" src="https://www.marijuanamoment.net/wp-content/uploads/2018/12/MM_Bill_Tracker_V5_blank.jpg" alt="" width="300" height="300"></a> Learn more about our <a href="https://www.marijuanamoment.net/bills/" target="_blank" rel="noopener">marijuana bill tracker</a> and become a <a href="https://www.patreon.com/marijuanamoment/" target="_blank" rel="noopener">supporter on Patreon</a> to get access. 
—
The proposal includes no limits on marijuana possession or cultivation. And despite its lack of a regulatory structure for a commercial industry, it would carve out marijuana from the state’s laws against illicit drug sales. State-registered patients or caregivers could, however, have their registration ID cards revoked for selling marijuana no people outside the medical system.
Minors would continue to be barred from using marijuana under the bill. People under 21 would be guilty of a violation if found possessing or using the substance, and anyone under 18 would be referred to a screening for substance use disorders. Adults who use marijuana in a public place would also be guilty of a violation.
It’s widely believed that New Hampshire Gov. Kelly Ayotte (R) would stand in the way of any adult-use legalization bill that were to make it to her desk this session, however. A former U.S. senator and state attorney general, Ayotte <a href="https://www.marijuanamoment.net/new-hampshire-candidates-for-governor-differ-sharply-on-marijuana-legalization-in-latest-debate/" rel="noopener" data-google-interstitial="false">said repeatedly on the campaign trail last year that she would oppose efforts at adult-use legalization</a>.
New Hampshire lawmakers nearly passed legislation last session that would have legalized and regulated marijuana for adults—a proposal that then-Gov. Chris Sununu (R) had indicated he’d support. But infighting over how the market would be set up ultimately scuttled that proposal. House Democrats <a href="https://www.marijuanamoment.net/new-hampshire-senate-approves-marijuana-legalization-bill-with-final-house-vote-expected-later-today/" data-google-interstitial="false">narrowly voted to table it at the last minute</a>, taking issue with the proposal’s state-controlled franchise model, which would have given the state unprecedented sway over retail stores and consumer prices.
A poll from last June found that <a href="https://www.marijuanamoment.net/new-hampshire-residents-support-marijuana-legalization-bill-that-lawmakers-killed-last-week-poll-shows/" rel="noopener" data-google-interstitial="false">almost two thirds (65 percent) of New Hampshire residents supported legalizing marijuana</a>. Nearly that same share of residents (61 percent) said at the time that they also supported last session’s failed legalization bill, HB 1633.
Read the full amendment to HB 528 below:

<blockquote class="wp-embedded-content" data-secret="Jr96NW5Siy"><a href="https://www.marijuanamoment.net/legalizing-marijuana-was-justin-trudeaus-greatest-accomplishment-poll-of-canadians-finds/">Legalizing Marijuana Was Justin Trudeau’s Greatest Accomplishment, Poll Of Canadians Finds</a></blockquote>

The post <a href="https://www.marijuanamoment.net/new-hampshire-lawmakers-unanimously-approve-psilocybin-decriminalization-bill/">New Hampshire Lawmakers Unanimously Approve Psilocybin Decriminalization Bill</a> appeared first on <a href="https://www.marijuanamoment.net/">Marijuana Moment</a>.

A House committee in New Hampshire has advanced a bill that would decriminalize use and possession of psilocybin. Members of the House Criminal Justice and Public Safety voted unanimously, 16–0, to pass the bill, HB 528, from Rep. Kevin Verville (R). Prior to moving the bill forward, the committee first adopted an amendment to temper […]
The post <a href="https://www.marijuanamoment.net/new-hampshire-lawmakers-unanimously-approve-psilocybin-decriminalization-bill/">New Hampshire Lawmakers Unanimously Approve Psilocybin Decriminalization Bill</a> appeared first on <a href="https://www.marijuanamoment.net/">Marijuana Moment</a>.

New Hampshire Lawmakers Unanimously Approve Psilocybin Decriminalization Bill

New polling data shows that Canadians rank cannabis legalization as Justin Trudeau’s top accomplishment in his nearly ten years in office.
The post <a href="https://stratcann.com/news/canadians-list-cannabis-legalization-as-trudeaus-crowning-success/">Canadians list cannabis legalization as Trudeau’s crowning success</a> appeared first on <a href="https://stratcann.com/">StratCann</a>.

Canadians list cannabis legalization as Trudeau’s crowning success

State senators in Kentucky and Georgia advanced bills this week that would enact steeper restrictions on hemp products.
<a href="https://mjbizdaily.com/bills-that-would-add-more-hemp-product-limits-advance-in-kentucky-and-georgia/">Bills that would add more hemp-product limits advance in Kentucky and Georgia</a> is a post from: <a href="https://mjbizdaily.com/">MJBizDaily: Financial, Legal &amp; Cannabusiness news for cannabis entrepreneurs</a>

Bills that would add more hemp-product limits advance in Kentucky and Georgia

Health Canada has released a new consultation document looking at the potential regulatory path for CBD to be regulated as a natural health product.
The post <a href="https://stratcann.com/news/health-canada-seeks-more-feedback-on-cbd-as-a-natural-health-product-and-cbd-for-pets/">Health Canada seeks more feedback on CBD as a natural health product, and CBD for pets</a> appeared first on <a href="https://stratcann.com/">StratCann</a>.

Health Canada seeks more feedback on CBD as a natural health product, and CBD for pets

Cannabis sales increased from 2023 while alcohol sales declined somewhat, according to the newest figures shared by Statistics Canada.
The post <a href="https://stratcann.com/news/canadians-consuming-less-alcohol-more-cannabis/">Canadians are consuming less alcohol and more cannabis</a> appeared first on <a href="https://stratcann.com/">StratCann</a>.

Canadians are consuming less alcohol and more cannabis

Florida Republican lawmakers are working to impose significant restrictions on the ability to put initiatives on the ballot—a plan that could impair efforts to let voters decide on marijuana legalization next year.
Gov. Ron DeSantis (R)—who <a href="https://www.marijuanamoment.net/florida-voters-reject-marijuana-legalization-ballot-measure-endorsed-by-trump-and-opposed-by-desantis/">strongly advocated against a 2024 legalization proposal</a> that ultimately failed to achieve a steep 60 percent vote threshold—pitched the idea to lawmakers, calling for changes to the petition gathering process that threaten to further complicate citizen-led reform efforts for a range of issues.
On Thursday, legislators took up that call, with the House Government Operations Subcommittee advancing a bill from Rep. Jenna Persons-Mulicka (R) that would, among other things, require petitioners to post a $1 million bond before commencing signature gathering, prohibit the use of out-of-state petitioners and narrow the window in which signatures must be handed over to election officials, among other changes.
“The process has been taken over by out of state fraudsters looking to make a quick buck and by special interests’ intent on buying their way into our Constitution,” Persons-Mulicka argued at the hearing. “The bill seeks to root out the problem and provide assurances that only those with a stake in our Constitution can change it to that end.”
Opponents say the legislation, which is now headed to the full House State Affairs Committee, would have a chilling effect on citizen-led ballot efforts, making it even more cost-prohibitive and leaving campaigns with greater liabilities as it concerns signature gathering.
For marijuana reform stakeholders and advocates, the proposal amounts to government overreach. DeSantis and other key Republicans have made their skepticism clear about having voters decide on constitutional amendments in the first place, and the last several legalization ballot initiatives were challenged by state officials.
Last year’s marijuana proposal did receive a strong majority of the vote, but Florida’s 60 percent requirement for constitutional amendments ultimately made the latest push unsuccessful. That’s despite tens of millions of dollars coming into the Smart &amp; Safe Florida campaign, including from major cannabis companies—primarily the multi-state operator Trulieve.
To add more restrictions on the petitioning process—which under Persons-Mulicka’s bill would also include increased fines for election law violations and a system allowing voters to retract their signatures from petition forms—could make Smart &amp; Safe’s 2026 legalization push all the more challenging.
Asked by Marijuana Moment about the potential impact of the bill on the campaign, a Smart &amp; Safe Florida spokesperson declined to comment.
Similar legislation sponsored by Sen. Blaise Ingoglia (R) has also been filed in the Senate.
While the House bill’s sponsor didn’t explicitly say that the proposal is responsive to any particular issue, arguments about the need to change the process were frequently heard in the run-up to last year’s election in Florida, when both marijuana and abortion rights were on the ballot.
Under the new <a href="https://www.flsenate.gov/Session/Bill/2025/1205/" target="_blank" rel="noopener">bill</a>, signatures collected before enactment would not be subjected to the revised restrictions. Smart &amp; Safe Florida has so far <a href="https://dos.elections.myflorida.com/initiatives/initdetail.asp?account=83475&amp;seqnum=3" target="_blank" rel="noopener">submitted</a> just over 7,100 valid signatures of the 891,523 needed to make the 2026 ballot with its latest version of the legalization initiative, according to the Florida Division of Elections.
The <a href="https://www.marijuanamoment.net/florida-campaign-files-new-marijuana-legalization-initiative-for-2026-ballot-after-reform-failed-in-last-election/">campaign’s 2026 iteration includes several changes</a> that seem responsive to issues raised by critics about the 2024 version, which was endorsed by President Donald Trump on the campaign trail.
For example, there’s new clarifying language prohibiting the sale of marijuana products that are marketed in a way that might be appealing to children.
It further explicitly states that nothing in the measure would “prohibit the legislature from providing for the home growing of marijuana by adults for their personal use and the reasonable regulation thereof.” That clarification may assuage concerns from certain advocates who criticized the lack of a home grow option in the original proposal.
The initiative would also make it so medical marijuana operators that have been licensed as of January 1, 2025 would be able to start providing for adult-use sales starting on the effective date.
Another nuance in the new proposal concerns licensure for businesses that want to enter the space in the future. Some worried that the prior version could effectively create a monopoly benefitting the existing medical marijuana operators alone because it simply said the legislature wasn’t prohibited from allowing additional licenses, without a mandate to actually take up that issue.
Last month, a survey from the University of North Florida found that, despite last year’s ballot proposal failing,<a href="https://www.marijuanamoment.net/bipartisan-florida-voters-overwhelmingly-back-marijuana-legalization-as-campaign-pushes-2026-reform-measure-poll-finds/"> there’s overwhelming bipartisan voter support for the reform</a>. It showed that 67 percent of Florida voters now back legalization, including 82 percent of Democrats, 66 percent of independents and 55 percent of Republicans.
The results conflict with another recent poll from the Florida Chamber of Commerce, a proactive opponent of legalization, that found majority support for the reform among likely voter (53 percent) <a href="https://www.marijuanamoment.net/marijuana-legalization-has-majority-support-in-florida-but-not-enough-to-be-enacted-new-poll-from-opposition-group-finds/" rel="noopener" data-google-interstitial="false">but not enough to be enacted under the 60 percent requirement</a>.
Meanwhile, the governor said in January that <a href="https://www.marijuanamoment.net/new-florida-marijuana-initiative-faces-big-time-trouble-in-supreme-court-desantis-says-predicting-itll-be-blocked-from-2026-ballot/" target="_blank" rel="noopener" data-google-interstitial="false">the latest version of the legalization initiative is in “big time trouble”</a> with the state Supreme Court, predicting it will be blocked from going before voters next year.
“There’s a lot of different perspectives on on marijuana,” DeSantis said. “It should not be in our Constitution. If you feel strongly about it, you have elections for the legislature. Go back candidates that you believe will be able to deliver what your vision is on that.”
“But when you put these things in the Constitution—and I think, I mean, the way they wrote, there’s all kinds of things going on in here. I think it’s going to have big time trouble getting through the Florida Supreme Court,” he said.
Last year, the governor accurately predicted that <a href="https://www.marijuanamoment.net/desantis-says-marijuana-legalization-will-be-on-florida-ballot-following-court-review/" target="_blank" rel="noopener" data-google-interstitial="false">the 2024 cannabis measure from the campaign would survive a legal challenge</a> from the state attorney general. It’s not entirely clear why he feels this version would face a different outcome.
— 
Marijuana Moment is <a href="https://www.marijuanamoment.net/bills/" target="_blank" rel="noopener">tracking hundreds of cannabis, psychedelics and drug policy bills</a> in state legislatures and Congress this year. <a href="https://www.patreon.com/marijuanamoment" target="_blank" rel="noopener">Patreon supporters</a> pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. <a href="https://www.marijuanamoment.net/bills/" target="_blank" rel="noopener"><img loading="lazy" decoding="async" class="alignnone wp-image-9128 size-medium" src="https://www.marijuanamoment.net/wp-content/uploads/2018/12/MM_Bill_Tracker_V5_blank.jpg" alt="" width="300" height="300"></a> Learn more about our <a href="https://www.marijuanamoment.net/bills/" target="_blank" rel="noopener">marijuana bill tracker</a> and become a <a href="https://www.patreon.com/marijuanamoment/" target="_blank" rel="noopener">supporter on Patreon</a> to get access. 
—
Separately, a Florida GOP senator claimed recently that <a href="https://www.marijuanamoment.net/trump-was-tricked-into-endorsing-florida-marijuana-legalization-initiative-gop-senator-says/" target="_blank" rel="noopener" data-google-interstitial="false">the legalization campaign “tricked” Trump into supporting the 2024 measure</a> by misleading him and the general public about key provisions.
Ahead of the election, Trump said in September that he felt <a href="https://www.marijuanamoment.net/trump-says-florida-marijuana-legalization-ballot-measure-will-be-very-good-for-the-state-adding-that-medical-use-is-absolutely-amazing-for-patients/" target="_blank" rel="noopener" data-google-interstitial="false">Amendment 3 was “going to be very good” for the state</a>.
Before making the comments, <a href="https://www.marijuanamoment.net/trump-met-with-top-marijuana-company-ceo-and-florida-gop-senator-before-supporting-legalization-measure/" target="_blank" rel="noopener" data-google-interstitial="false">Trump met with the CEO of Trulieve, Kim Rivers</a>, as well as with a GOP state senator who is in favor of the reform.
While Trump endorsed the Florida cannabis initiative—as well as federal rescheduling and industry banking access—he has since been silent on cannabis issues. And his cabinet choices have mixed records on marijuana policy.
<blockquote class="wp-embedded-content" data-secret="WzZ1iSjXkw"><a href="https://www.marijuanamoment.net/ohio-gop-lawmaker-files-bill-to-revise-voter-approved-marijuana-law-with-less-sweeping-changes-than-senate-passed-measure/">Ohio GOP Lawmaker Files Bill To Revise Voter-Approved Marijuana Law With Less Sweeping Changes Than Senate-Passed Measure</a></blockquote>

Photo courtesy of Chris Wallis // Side Pocket Images.
The post <a href="https://www.marijuanamoment.net/florida-lawmakers-approve-bill-making-it-harder-to-put-initiatives-on-ballot-as-marijuana-legalization-campaign-pursues-2026-effort/">Florida Lawmakers Approve Bill Making It Harder To Put Initiatives On Ballot As Marijuana Legalization Campaign Pursues 2026 Effort</a> appeared first on <a href="https://www.marijuanamoment.net/">Marijuana Moment</a>.

Florida Republican lawmakers are working to impose significant restrictions on the ability to put initiatives on the ballot—a plan that could impair efforts to let voters decide on marijuana legalization next year. Gov. Ron DeSantis (R)—who strongly advocated against a 2024 legalization proposal that ultimately failed to achieve a steep 60 percent vote threshold—pitched the […]
The post <a href="https://www.marijuanamoment.net/florida-lawmakers-approve-bill-making-it-harder-to-put-initiatives-on-ballot-as-marijuana-legalization-campaign-pursues-2026-effort/">Florida Lawmakers Approve Bill Making It Harder To Put Initiatives On Ballot As Marijuana Legalization Campaign Pursues 2026 Effort</a> appeared first on <a href="https://www.marijuanamoment.net/">Marijuana Moment</a>.

Florida Lawmakers Approve Bill Making It Harder To Put Initiatives On Ballot As Marijuana Legalization Campaign Pursues 2026 Effort

As Canadian Prime Minister Justin Trudeau prepares to leave office, Canadians are giving him an exit review—and he’s evidently earned the highest marks for his role in legalizing marijuana nationwide.
A survey of Canadian adults from the non-profit Angus Reid Institute found that, among the prime minister’s policy achievements, cannabis reform was the most popular, with 52 percent describing it as a success of the administration. Just 24 percent called it a failure.
Out of 10 policy items that respondents were asked about, legalization was the only one with majority support.
Going down the list, 47 percent gave Trudeau credit for his handling of the COVID-19 pandemic, 46 percent supported his expansion of social services, 45 percent said he effectively navigated the Ukraine-Russia war and 39 percent backed his ban on assault-style firearms, for example.
<div class="wp-caption alignnone">
<img loading="lazy" decoding="async" aria-describedby="caption-attachment-116145" class="wp-image-116145 size-large" src="https://www.marijuanamoment.net/wp-content/uploads/2025/03/32ddf140-7f0a-44ce-8094-e1a35541d5bb-e1741366407946-1024x468.jpeg" alt="" width="740" height="338" srcset="https://www.marijuanamoment.net/wp-content/uploads/2025/03/32ddf140-7f0a-44ce-8094-e1a35541d5bb-e1741366407946-1024x468.jpeg 1024w, https://www.marijuanamoment.net/wp-content/uploads/2025/03/32ddf140-7f0a-44ce-8094-e1a35541d5bb-e1741366407946-300x137.jpeg 300w, https://www.marijuanamoment.net/wp-content/uploads/2025/03/32ddf140-7f0a-44ce-8094-e1a35541d5bb-e1741366407946-768x351.jpeg 768w, https://www.marijuanamoment.net/wp-content/uploads/2025/03/32ddf140-7f0a-44ce-8094-e1a35541d5bb-e1741366407946.jpeg 1274w" sizes="auto, (max-width: 740px) 100vw, 740px">Via Angus Reid Institute.
</div>
Marijuana legalization also proved more popular than the prime minister’s efforts to promote gender equality (38 percent), impose a federal carbon tax (19 percent), complete an oil pipeline (17 percent), respond to inflation (14 percent) and address immigration policy (10 percent).
The <a href="https://angusreid.org/trudeau-legacy-covid-19-inflation-marijuana-snc-lavalin-we-charity/" target="_blank" rel="noopener">survey</a> involved interviews with 1,850 Canadian adults from March 4-6, with a +/- 2 percentage point margin of error.
Canada <a href="https://www.marijuanamoment.net/heres-when-canadas-legal-marijuana-sales-will-begin/">legalized marijuana for adult-use at the federal level</a> in 2018, with the vocal support of Trudeau, who campaigned on the issue.
While the implementation of the cannabis program didn’t come without its hitches, studies and surveys have indicated that it’s been generally successful, achieving many of the goals advocates argued it would such as <a href="https://www.marijuanamoment.net/canadas-marijuana-legalization-law-effectively-shifts-people-away-from-illicit-market-while-youth-use-remains-steady-government-report-shows/" target="_blank" rel="noopener">giving Canadian adults a safer and regulated alternative to the illicit market</a>, without driving youth consumption as prohibitionists claimed it would.
According to a government report released in December, <a href="https://www.marijuanamoment.net/canadas-marijuana-legalization-law-effectively-shifts-people-away-from-illicit-market-while-youth-use-remains-steady-government-report-shows/" target="_blank" rel="noopener">the vast majority of Canadian consumers now say they obtain cannabis legally</a>, with only 3 percent of respondents reporting purchasing from illicit sources.
Observers have also been <a href="https://www.marijuanamoment.net/how-canadas-medical-marijuana-system-changed-after-the-country-legalized-recreational-cannabis/" target="_blank" rel="noopener">watching how broader adult-use legalization impacts medical marijuana in Canada</a>, noting, for example, patient enrollment rates declining after legalization was enacted but before retailers opened for business.
A study earlier this year, meanwhile, found <a href="https://www.marijuanamoment.net/marijuana-study-comparing-u-s-and-canada-finds-broad-legalization-support-and-similar-use-rates-despite-differing-national-policies/" target="_blank" rel="noopener">similar marijuana use rates and support for legalization in both the U.S. and Canada</a> despite the countries’ different national approaches to regulating the drug.
Another report out of Canada this year found marijuana legalization was <a href="https://www.marijuanamoment.net/marijuana-legalization-linked-to-decline-in-beer-sales-indicating-substitution-effect-canadian-study-finds/" target="_blank" rel="noopener">“associated with a decline in beer sales,” suggesting a substitution effect</a> where consumers shift from one product to the other.
A separate study last year found that the <a href="https://www.marijuanamoment.net/high-school-students-say-marijuana-is-harder-to-access-following-legalization-for-adults-canadian-study-shows/" target="_blank" rel="noopener">proportion of high-school students who said marijuana was easy to obtain has fallen</a> in recent years.
<blockquote class="wp-embedded-content" data-secret="xPSuo3Qlrl"><a href="https://www.marijuanamoment.net/psychedelics-have-promising-medical-applications-congressional-watchdog-agency-says-but-research-challenges-remain/">Psychedelics Have ‘Promising Medical Applications,’ Congressional Watchdog Agency Says, But Research Challenges Remain</a></blockquote>

The post <a href="https://www.marijuanamoment.net/legalizing-marijuana-was-justin-trudeaus-greatest-accomplishment-poll-of-canadians-finds/">Legalizing Marijuana Was Justin Trudeau’s Greatest Accomplishment, Poll Of Canadians Finds</a> appeared first on <a href="https://www.marijuanamoment.net/">Marijuana Moment</a>.

As Canadian Prime Minister Justin Trudeau prepares to leave office, Canadians are giving him an exit review—and he’s evidently earned the highest marks for his role in legalizing marijuana nationwide. A survey of Canadian adults from the non-profit Angus Reid Institute found that, among the prime minister’s policy achievements, cannabis reform was the most popular, […]
The post <a href="https://www.marijuanamoment.net/legalizing-marijuana-was-justin-trudeaus-greatest-accomplishment-poll-of-canadians-finds/">Legalizing Marijuana Was Justin Trudeau’s Greatest Accomplishment, Poll Of Canadians Finds</a> appeared first on <a href="https://www.marijuanamoment.net/">Marijuana Moment</a>.

Legalizing Marijuana Was Justin Trudeau’s Greatest Accomplishment, Poll Of Canadians Finds

<figure><img width="300" height="141" src="https://projectcbd.org/wp-content/uploads/2025/03/hempswindle-intoxicating-300x141.jpg" class="attachment-medium size-medium wp-post-image" alt="" decoding="async" srcset="https://projectcbd.org/wp-content/uploads/2025/03/hempswindle-intoxicating-300x141.jpg 300w, https://projectcbd.org/wp-content/uploads/2025/03/hempswindle-intoxicating-1024x480.jpg 1024w, https://projectcbd.org/wp-content/uploads/2025/03/hempswindle-intoxicating-768x360.jpg 768w, https://projectcbd.org/wp-content/uploads/2025/03/hempswindle-intoxicating-1536x720.jpg 1536w, https://projectcbd.org/wp-content/uploads/2025/03/hempswindle-intoxicating-1200x563.jpg 1200w, https://projectcbd.org/wp-content/uploads/2025/03/hempswindle-intoxicating-1568x735.jpg 1568w, https://projectcbd.org/wp-content/uploads/2025/03/hempswindle-intoxicating-400x188.jpg 400w, https://projectcbd.org/wp-content/uploads/2025/03/hempswindle-intoxicating.jpg 1800w" sizes="(max-width: 34.9rem) calc(100vw - 2rem), (max-width: 53rem) calc(8 * (100vw / 12)), (min-width: 53rem) calc(6 * (100vw / 12)), 100vw"></figure>California lab tests expose massive fraud, illegal products &amp; the cannabis equivalent of ultra-processed junk food
The post <a rel="nofollow" href="https://projectcbd.org/hemp/intoxicating-hemp-swindle/">Intoxicating Hemp Swindle</a> appeared first on <a rel="nofollow" href="https://projectcbd.org/">Project CBD</a>.

Hemp – Project CBD

Intoxicating Hemp Swindle

A newly published journal article says the cannabis component CBD could be an effective way to avoid oral infections when incorporated into the primary material used in dentures.
Published last month in the journal Molecules, the government-funded research says bonding CBD to dentures demonstrates “potential for antibiotic-free denture coatings, reducing dental biofilms and plaque formation, and improving oral health outcomes.”
To study the properties of CBD in dentures, researchers incorporated the cannabinoid into a type of plastic known as poly(methyl methacrylate) (PMMA), which the paper explains is “the primary material for dentures due to its favorable physical and aesthetic qualities.” Researchers then tested antimicrobial activity against three types of bacteria: Staphylococcus aureus, Escherichia coli and Streptococcus agalactiae.
Results showed that the CBD denture coatings had “significant bactericidal effects” against so-called Gram-positive bacteria. In terms of Gram-negative bacteria—which are typically more resistant to antibiotics—the CBD coating was ineffective against free-floating, so-called “planktonic” Gram-negative bacteria but effectively eliminated communities of bacteria known as biofilms.
“Biofilm studies revealed a 99% reduction in biofilm growth for both Gram-positive and Gram-negative bacteria on CBD-infused PMMA compared to standard PMMA,” the report says. “The CBD disrupted bacterial cell ways, causing lysis,” or the breakdown of the cell itself.
“In summary,” authors wrote, “biofilm studies showed PMMA/CBD coatings were effective in eradicating all the pathogens on their surface.”
<blockquote>“This study showed that CBD can be incorporated into materials, enabling antibiotic-free dentures for preventing dental biofilms and reducing dental plaques.”</blockquote>
In some cases, the differences between CBD-infused plastic and normal PMMA were striking. For example, growth of the bacteria S. agalactiae on untreated PMMA “was significantly 10,000 times greater” compared to the CBD-treated sample.
“The addition of CBD in the coatings provided a 99% reduction in S. aureus and E. coli biofilms, and a 99.99% reduction in S. agalactiae biofilms,” the report says.
The paper appeared in a special issue of Molecules dedicated to the antibacterial applications of so-called “intelligent polymer materials,” and was federally funded by the Natural Sciences and Engineering Research Council of Canada.
“This investigation presents a pioneering approach for the development of antibiotic-free coatings, offering an alternative to conventional methods,” wrote the five-author research team, from Western University in Ontario, Canada.
One area in need of further study is how to craft coatings that can release antibiofilm agents in a controlled, sustained manner, authors noted. “This sustained release will maintain effective concentrations of the CBD over an extended period, maximizing their ability to disrupt biofilms and eliminate bacteria within them,” they said.
In the study, researchers found a “burst release” of CBD for the first 12 hours followed by “a steady release into the surrounding environment in vitro afterward.”
Future research should also examine why the CBD coating was ineffective against planktonic bacteria but successfully eradicated biofilms of the same bacteria.
“Further investigations on the gene expressions involved in biofilm maintenance, development, and maturation of factors associated with exopolysaccharide (EPS) synthesis and CBD could be studied to better understand its antibiofilm mechanisms,” the <a href="https://www.mdpi.com/1420-3049/30/4/943" target="_blank" rel="noopener">paper</a> says. “Other scopes of research could be CBD and its effect on the biosynthesis of fimbriae, surface proteins, virulence factor genes, and other bacterial structures involved in adherence to surfaces.”
The new findings come as a separate study found that CBD could offer a <a href="https://www.marijuanamoment.net/cbd-could-effectively-treat-common-vaginal-infections-study-concludes/">promising treatment for a common type of vaginal infection</a>.
That report similarly focused on biofilms, specifically of the bacterium Gardnerella vaginalis, which is found naturally in the vagina but can also cause vaginosis when out of balance with other microbes. In laboratory tests, CBD demonstrated antibacterial and antioxidant effects that weakened G. vaginalis and eliminated biofilms.
“Our study shows that CBD exhibits antibacterial and antibiofilm activities against G. vaginalis clinical isolates,” that paper said, “and is thus a potential drug for the treatment of vaginosis caused by this bacterium.”
Another recent paper, published in the journal Pharmaceuticals, found that CBD could be <a href="https://www.marijuanamoment.net/cbd-could-be-a-useful-addition-to-sunscreen-hair-care-and-wound-healing-products-study-finds/">a useful addition to certain skin products given its anti-aging and antioxidant properties</a> as well as evidence that it may speed the healing of wounds.
“Overall, we suggest that CBD exhibits many potential characteristics that can be used to develop topical cosmeceutical products, such as sun protection products, hair care products, or wound healing products,” the study said, noting that low concentrations of the cannabinoid were also not toxic to cells during short-term treatment.
A report published last autumn by university researchers in India and Thailand found that <a href="https://www.marijuanamoment.net/cannabis-oil-can-help-heal-skin-wounds-by-creating-a-more-conducive-environment-for-tissue-regeneration-review-finds/" target="_blank" rel="noopener" data-google-interstitial="false">cannabis oil containing CBD may also help promote the healing of skin wounds</a>, writing that it offers “promising benefits” despite a need to better optimize product formulations.
That study looked specifically at how cannabis oil can reduce so-called “reactive oxygen species” (ROS) during the healing of wounds. Those chemicals “play a crucial role in would development by causing cell and tissue damage,” it explained.
“Increased ROS levels can hinder wound healing by exacerbating inflammation and cellular damage,” said the paper, published in the journal Pharmaceutics. “CBD’s antioxidant properties mitigate these effects, fostering a more conducive environment for tissue regeneration.”
Another paper, published last July in the Journal of the American Academy of Dermatology, found that <a href="https://www.marijuanamoment.net/cbd-lotion-tied-to-reduced-skin-damage-from-uv-rays-new-study-finds/" target="_blank" rel="noopener" data-google-interstitial="false">applying CBD-infused lotion to the skin appeared to be tied to a lower risk of damage from exposure to ultraviolet (UV) rays</a>. Researchers at George Washington University, Northwestern University, the University of Miami and the Center for Clinical and Cosmetic Research wrote that 21 percent of those who used the CBD cream had less damage than the control group that received a placebo. Another 47 percent had comparable damage, and 11 percent showed better results after taking the placebo versus the cannabis lotion.
The possible benefits aren’t limited to human applications.
A separate study, published in the journal Frontiers in Veterinary Science last year, concluded that cannabis <a href="https://www.marijuanamoment.net/cannabis-may-be-viable-alternative-treatment-for-dogs-with-common-skin-disease-case-study-shows/" target="_blank" rel="noopener" data-google-interstitial="false">appears to be a “viable alternative” treatment option for dogs suffering from a common skin disease</a>—especially if they experience adverse side effects from conventional steroid therapies
That study detailed the efficacy of full-spectrum CBD oil on a dog with the autoimmune disease discoid lupus erythematosus (DLE). The condition, which causes hair loss and redness that could progress to lesions, is typically treated with corticosteroids and other medications that can put a strain on a dog’s liver.
A veterinarian prescribed a full-spectrum oil with a 2:1 THC:CBD ratio, which was administered orally—at first, one drop per day for three days and gradually increasing it “until the optimal dose for symptom control was identified.”
“Within a few weeks, the dog exhibited significant improvement in dermatological signs, accompanied by a concurrent improvement in liver function,” the study said. “Interestingly, the owner reported an improvement in the dog’s behavior shortly after discontinuing prednisolone and within the first day of receiving the cannabis oil.”
Another analysis, published this earlier year, found that more than <a href="https://www.marijuanamoment.net/more-than-1-in-10-americans-used-cbd-within-the-past-month-new-analysis-of-federal-data-shows/">1 in 10 Americans reported consuming the non-psychoactive cannabis component within the past month</a>, with prevalence significantly higher among people who also used marijuana itself.
<blockquote class="wp-embedded-content" data-secret="hf8bSoYqhN"><a href="https://www.marijuanamoment.net/7-in-10-marijuana-consumers-plan-to-spend-more-or-the-same-amount-on-cannabis-in-2025-poll-finds/">7 In 10 Marijuana Consumers Plan To Spend More Or The Same Amount On Cannabis In 2025, Poll Finds</a></blockquote>

Photo courtesy of <a href="https://unsplash.com/photos/b2haCjfk_cM" target="_blank" rel="noopener">Kimzy Nanney</a>.
The post <a href="https://www.marijuanamoment.net/coating-dentures-with-cbd-can-help-prevent-oral-infections-government-funded-study-shows/">Coating Dentures With CBD Can Help Prevent Oral Infections, Government-Funded Study Shows</a> appeared first on <a href="https://www.marijuanamoment.net/">Marijuana Moment</a>.

A newly published journal article says the cannabis component CBD could be an effective way to avoid oral infections when incorporated into the primary material used in dentures. Published last month in the journal Molecules, the government-funded research says bonding CBD to dentures demonstrates “potential for antibiotic-free denture coatings, reducing dental biofilms and plaque formation, […]
The post <a href="https://www.marijuanamoment.net/coating-dentures-with-cbd-can-help-prevent-oral-infections-government-funded-study-shows/">Coating Dentures With CBD Can Help Prevent Oral Infections, Government-Funded Study Shows</a> appeared first on <a href="https://www.marijuanamoment.net/">Marijuana Moment</a>.

Coating Dentures With CBD Can Help Prevent Oral Infections, Government-Funded Study Shows

A federal agency has published a short report on the medical use of psychedelics, finding that their ability to “change a person’s perceptions and sense of self” can make for “promising medical applications.”
The paper, from the Government Accountability Office (GAO), says there’s a need for further research, but it also notes that because psychedelics such as LSD, MDMA and psilocybin remain Schedule I controlled substances, securing permission to carry out that research can be a challenge.
“To conduct research on these drugs, scientists need to follow several steps,” the report from GAO, which is often referred to as Congress’s “watchdog,” states in a section about ongoing challenges. “These include obtaining permission from the U.S. Drug Enforcement Administration, finding clinical grade drugs to test, and identifying appropriate spaces in which to test and store these drugs.”
“Difficulties associated with conducting large, blind trials of psychedelics have limited researchers’ ability to determine the safety and effectiveness of these drugs,” GAO continues, “which is required for them to gain approval from the Food and Drug Administration (FDA). FDA approval is generally required before prescription drugs can be marketed for sale in the U.S.”
Despite the obstacles, the paper acknowledges that hundreds of clinical trials have investigated psychedelics as a potential treatment for post-traumatic stress disorder (PTSD) and depression.
“Between 2015 and early 2025, over 340 trials on psychedelics began or were completed,” it says. “For example, one study found that psilocybin reduced depression symptoms more than escitalopram, an SSRI.”
<blockquote class="twitter-tweet" data-width="550" data-dnt="true">
Science &amp; Tech Spotlight: Medical Use of Psychedelics <a href="https://t.co/xD6DHLwNcT">https://t.co/xD6DHLwNcT</a>
— U.S. GAO (@USGAO) <a href="https://twitter.com/USGAO/status/1897658438806618533?ref_src=twsrc%5Etfw">March 6, 2025</a>
</blockquote>

Other opportunities identified by GAO include mental health and pain management.
“Research has shown that psychedelics, such as psilocybin and MDMA, decrease fear and anxiety, with the potential to positively affect behavior in combination with therapy,” the report says, adding that psychedelics also “appear to show promise for patients with certain headache disorders and cancer pain,” apparently by reducing inflammation and altering pain perception through interactions with the brain’s serotonin receptors.
The agency also noted the relatively minor risks associated with psychedelics compared to many other pharmaceutical treatments:
“Psychedelics may have non-life-threatening side effects, such as headaches or vomiting. In some cases, the use of these drugs can lead to safety risks due to impairment, or illicit psychedelics may be contaminated with dangerous substances such as fentanyl. While some research suggests that the use of psychedelics does not typically lead to physical addiction, the adverse effects of these drugs have not been fully studied.”
Beyond policy-related obstacles to research, the GAO report also points to methodological challenges. For example, in a typical blinded trial, participants aren’t supposed to know whether they received the experimental compound or a placebo. “Because of the distinct effects of psychedelics on recipients,” the new paper says, “it is difficult to prevent trial participants from knowing whether they received the treatment.”
<div class="wp-caption alignnone">
<img loading="lazy" decoding="async" aria-describedby="caption-attachment-116105" class="wp-image-116105 size-large" src="https://www.marijuanamoment.net/wp-content/uploads/2025/03/rId17_image4-1-1024x764.png" alt="" width="740" height="552" srcset="https://www.marijuanamoment.net/wp-content/uploads/2025/03/rId17_image4-1-1024x764.png 1024w, https://www.marijuanamoment.net/wp-content/uploads/2025/03/rId17_image4-1-300x224.png 300w, https://www.marijuanamoment.net/wp-content/uploads/2025/03/rId17_image4-1-768x573.png 768w, https://www.marijuanamoment.net/wp-content/uploads/2025/03/rId17_image4-1.png 1300w" sizes="auto, (max-width: 740px) 100vw, 740px">Government Accountability Office
</div>
“This may complicate efforts to design such trials and interpret their findings. Clinical trials have tried to work around this by using an active placebo, such as a low dose of a psychedelic,” authors wrote. “Alternatively, researchers might compare the treatment with a more typical one, such as an SSRI.”
As the GAO <a href="https://www.gao.gov/products/gao-25-108021" target="_blank" rel="noopener">report</a> notes, the past decade has seen a flurry of new study into psychedelics.
Late last year, for example, researchers for the first time ever <a href="https://www.marijuanamoment.net/first-patient-dosed-in-historic-study-on-whether-lsd-effectively-treats-anxiety/">administered LSD to patients in a Phase 3 clinical trial</a> into whether the psychedelic can be used to effectively treat generalized anxiety disorder (GAD).
The study is eventually expected to enroll about 200 people in the U.S. and will compare the effects of a proprietary LSD product to a placebo.
In March of last year, the <a href="https://www.marijuanamoment.net/lsd-like-drug-wins-fda-breakthrough-therapy-status-for-treatment-of-generalized-anxiety-disorder/" rel="noopener" data-google-interstitial="false">Food and Drug Administration (FDA) granted the LSD product “breakthrough therapy” status</a> as a treatment for GAD.
Last summer, meanwhile, a scientific review into MDMA found that five out of six studies looking at the substances’ potential to treat for post-traumatic stress disorder (PTSD) <a href="https://www.marijuanamoment.net/results-on-mdma-therapy-for-ptsd-are-encouraging-but-its-not-yet-ready-for-widespread-adoption-study-says/">“provide evidence for the apparent safety and efficacy” of the therapy</a>.
Authors called the findings “encouraging” but said more robust research is needed before MDMA-assisted therapy sees widespread adoption over currently available forms of treatment.
That review came on the heels of an FDA advisory panel rejecting an application to authorize MDMA-assisted therapy. A group of bipartisan lawmakers and veterans advocates, however, almost immediately pushed back on that decision.
“What we’re asking for the FDA to recognize is the science,” said Rep. Morgan Luttrell (R-TX), who in a June op-ed for Marijuana Moment criticized the FDA Psychopharmacologic Drugs Advisory Committee <a href="https://www.marijuanamoment.net/gop-congressman-who-used-psychedelics-for-mental-health-slams-fda-panels-mdma-rejection-op-ed/" target="_blank" rel="noopener" data-google-interstitial="false">for recommending against against MDMA-assisted therapy</a>.
Psilocybin has also been the subject of considerable research, including as a mental health aid and a treatment for substance use disorders.
Earlier this year, for example, a study on <a href="https://www.marijuanamoment.net/psilocybin-assisted-therapy-is-effecting-in-treating-methamphetamine-addiction-new-study-says/">the use of psilocybin-assisted therapy to treat methamphetamine use disorder</a> found that the treatment “was feasible to implement in an outpatient setting, did not appear to generate safety concerns, and demonstrated signals of effectiveness warranting further investigation.”
That report, which was not peer reviewed, was published by The Lancet as a preprint in January. It found that among a small group of people in a stimulant treatment program, “Methamphetamine craving decreased while quality of life, depression, anxiety, and stress improved from baseline to day 28 and 90 follow-up.”
The National Institutes of Health last year announced that it <a href="https://www.marijuanamoment.net/feds-fund-research-on-how-psychedelics-can-treat-meth-addiction-with-new-2-4-million-grant/" target="_blank" rel="noopener" data-google-interstitial="false">would put $2.4 million toward funding studies on the use of psychedelics to treat methamphetamine use disorders</a>—funding that came as federal health officials noted sharp increases in deaths from methamphetamine and other psychostimulants in recent years, with fatal overdoses involving the substances rising nearly fivefold between 2015 and 2022.
In 2023, meanwhile, the National Institute on Drug Abuse (NIDA) announced a <a href="https://www.marijuanamoment.net/federal-agency-announces-1-5-million-in-funding-for-research-on-psychedelics-to-treat-drug-addiction/" target="_blank" rel="noopener" data-google-interstitial="false">$1.5 million funding round to further study psychedelics and addiction</a>.
Psilocybin has already been given federal breakthrough therapy status for the treatment of certain types of depression.
Last year the National Center for Complementary and Integrative Health (NCCIH), which is part of the National Institutes of Health, also <a href="https://www.marijuanamoment.net/federal-health-agency-acknowledges-psilocybins-therapeutic-potential-and-touts-forthcoming-psychedelic-research/">published an informational web page about psilocybin</a>, acknowledging the substance as a possible treatment for alcohol use disorder, anxiety and depression.
The page, “Psilocybin for Mental Health and Addiction: What You Need To Know,” also highlighted psilocybin research being funded by the federal government into the drug’s effects on pain, migraines, psychiatric disorders and various other conditions.
Findings of another recent study suggests that the use of full-spectrum psychedelic mushroom extract <a href="https://www.marijuanamoment.net/study-finds-natural-psychedelic-mushrooms-produce-enhanced-effects-compared-to-synthesized-psilocybin-suggesting-entourage-effect/" rel="noopener" data-google-interstitial="false">has a more powerful effect than chemically synthesized psilocybin alone</a>, which could have implications for psychedelic-assisted therapy. The findings imply that the experience of entheogenic mushrooms may involve a so-called “entourage effect” <a href="https://www.marijuanamoment.net/new-study-shows-how-marijuana-compounds-like-cannabinoids-terpenes-and-flavonoids-interact-for-medical-benefits/" rel="noopener" data-google-interstitial="false">similar to what’s observed with cannabis and its many components.</a>
A separate study recently published by the American Medical Associatio (AMA) found that <a href="https://www.marijuanamoment.net/use-of-psilocybin-for-mental-health-treatment-not-associated-with-risk-of-paranoia-american-medical-association-study-finds/" rel="noopener" data-google-interstitial="false">single-dose psilocybin use was “not associated with risk of paranoia,”</a> while other adverse effects such as headaches are generally “tolerable and resolved within 48 hours.”
That study, published in JAMA Psychiatry, involved a meta-analysis of double-blind clinical trials where psilocybin was used to treat anxiety and depression from 1966 to last year.
AMA published another recent study that similarly contradicted commonly held beliefs about the potential risks of psychedelics use, finding the substances <a href="https://www.marijuanamoment.net/psychedelic-use-linked-to-lower-rates-of-psychotic-symptoms-in-adolescents-study-published-by-american-medical-association-finds/" rel="noopener" data-google-interstitial="false">“may be associated with lower rates of psychotic symptoms among adolescents.”</a>
Also, results of a clinical trial published by AMA in late 2023 <a href="https://www.marijuanamoment.net/psilocybins-efficacy-and-safety-for-bipolar-ii-depression-demonstrated-by-american-medical-association-study/" rel="noopener" data-google-interstitial="false">“suggest efficacy and safety” of psilocybin-assisted psychotherapy</a> for treatment of bipolar II disorder, a mental health condition often associated with debilitating and difficult-to-treat depressive episodes.
The association also published research earlier that year finding that people with major depression experienced <a href="https://www.marijuanamoment.net/psilocybin-associated-with-significantly-reduced-symptoms-of-major-depression-after-one-dose-american-medical-association-study-finds/" rel="noopener" data-google-interstitial="false">“clinically significant sustained reduction” in their symptoms</a> after just one dose of psilocybin.
<blockquote class="wp-embedded-content" data-secret="IKfatteTCT"><a href="https://www.marijuanamoment.net/medical-marijuana-is-a-safe-and-effective-treatment-for-pain-and-sleep-issues-in-older-people-study-shows/">Medical Marijuana Is A ‘Safe And Effective Treatment’ For Pain And Sleep Issues In Older People, Study Shows</a></blockquote>

Photo courtesy of <a href="https://en.wikipedia.org/wiki/List_of_psilocybin_mushroom_species#/media/File:Psilocybe.tampanensis.two.jpg" target="_blank" rel="noopener">Wikimedia/Workman</a>.
The post <a href="https://www.marijuanamoment.net/psychedelics-have-promising-medical-applications-congressional-watchdog-agency-says-but-research-challenges-remain/">Psychedelics Have ‘Promising Medical Applications,’ Congressional Watchdog Agency Says, But Research Challenges Remain</a> appeared first on <a href="https://www.marijuanamoment.net/">Marijuana Moment</a>.

A federal agency has published a short report on the medical use of psychedelics, finding that their ability to “change a person’s perceptions and sense of self” can make for “promising medical applications.” The paper, from the Government Accountability Office (GAO), says there’s a need for further research, but it also notes that because psychedelics […]
The post <a href="https://www.marijuanamoment.net/psychedelics-have-promising-medical-applications-congressional-watchdog-agency-says-but-research-challenges-remain/">Psychedelics Have ‘Promising Medical Applications,’ Congressional Watchdog Agency Says, But Research Challenges Remain</a> appeared first on <a href="https://www.marijuanamoment.net/">Marijuana Moment</a>.

Psychedelics Have ‘Promising Medical Applications,’ Congressional Watchdog Agency Says, But Research Challenges Remain

“We are simply placing a moratorium on their sale until such time as we can establish robust regulations that protect Kentucky consumers.”
By Liam Niemeyer, Kentucky Lantern
Kentucky lawmakers advanced a “shell” bill Wednesday evening to ban the sale of hemp-derived beverages in the state until summer of 2026, a move supporters say will allow time to understand how intoxicating versions of the beverages are impacting consumers.
But those involved in the hemp industry decried the proposed moratorium on the sale of hemp-derived beverages as hampering, or even crippling, small businesses trying to market, distribute or sell the canned beverages that are gaining popularity across the country and popping up in places including convenience stores.
Senate Bill 202 sponsor Sen. Julie Raque Adams (R-Louisville) said the goal of her bill is to better understand and regulate intoxicating hemp-derived beverages similar to how the state regulates other intoxicating beverages such as beer or liquor.
She spoke to lawmakers alongside Rep. Matthew Koch (R- Paris) with a line of cans on a desk featuring various flavors and amounts of infused non-intoxicating cannabidiol, known as CBD, and other cannabinoids, which can include intoxicating tetrahydrocannabinol, or THC.
“We are simply placing a moratorium on their sale until such time as we can establish robust regulations that protect Kentucky consumers and, most importantly, Kentucky children,” Adams said. “We have a real, I think, consumer protection issue going on right now. We need to make sure that Kentucky gets this right.”
Legislative concerns about regulating hemp-derived beverages sprang into public view on the 22nd day of this year’s 30-day session. The deadline for filing bills in the Senate was February 18.
SB 202 originally made minor technical corrections in Kentucky law but was rewritten Wednesday through a substitute bill adopted by the Kentucky Senate’s Licensing and Occupations Committee.
The practice of rewriting seemingly unimportant bills, known as “shell bills,” with little notice in order to make significant changes to state law has been criticized by the Kentucky League of Women Voters, along with other legislative maneuvers that the League says exclude the public from participation in the legislative process. Lawmakers have argued “shell” bills allow them more time to work on legislation and advance it beyond the deadline to file bills each legislative session.
What would Senate Bill 202 currently do?
Under SB 202, the ban on the sale of hemp-derived beverages would begin immediately upon the legislation becoming law and continue until July 1, 2026. The bill also directs the Cabinet for Health and Family Services to create regulations specifically for beverages containing non-intoxicating cannabidiol, known as CBD, and other cannabinoids, which can include intoxicating THC.
Additionally, <a href="https://apps.legislature.ky.gov/record/25rs/sb202.html" target="_blank" rel="noopener">SB 202</a> would direct the University of Kentucky Cannabis Center to study the testing, manufacture, distribution, sales and effects on consumers of such beverages and present a report to the Legislative Research Commission by January 1, 2026.
Adams said given the “chatter” the bill has created among the state’s hemp industry, the version of SB 202 is likely just a “starting place” with the end goal of finding appropriate regulations for a nascent industry. She said she ultimately wants to engage stakeholders on how it should be regulated.
SB 202 advanced from the Senate Licensing and Occupations Committee with seven Republicans voting in favor, two Republicans voting against and the two Democrats on the committee voting to pass on the legislation. Both Republicans and Democrats on the committee were concerned about the impacts a moratorium could have on businesses in the state, though some Republicans voted to advance the bill with the understanding it would be changed.
“By having a total prohibition in July of 2026, we’re punishing the good players as well,” said Sen. Stephen Meredith (R-Leitchfield) who voted to advance the bill. “It’ll shut down their revenue stream and, probably, they won’t exist.”
Various people representing the hemp products industry strongly opposed the current version of the legislation implementing a moratorium, though those who testified to lawmakers disagreed over how the beverages should be regulated—whether there should be a cap on the amount of milligrams of intoxicating THC in each beverage and what that cap should be.
Jim Higdon, the co-founder of the Kentucky company Cornbread Hemp, which makes various hemp-derived balms, gummies and oils, told lawmakers the moratorium would put his growing company “at risk” by undercutting a THC-infused beverage product launch the company has planned for April.
“I don’t understand how a moratorium is different from a ban,” Hidgon said. “If, as a small business, we are forced into a moratorium, it will kill our growth. And as a small business that’s growing and being successful—successful in Kentucky—we would like to help the General Assembly to continue to grow and employ Kentuckians.”
Higdon said his company has spent a little more than $1.2 million to launch the planned beverage, featuring fruity flavors and about five milligrams of THC in each can. He told the Lantern that canceling the product launch would take a toll on his staffing, hemp farmers and more.
Sen. Jimmy Higdon (R-Lebanon) the father of the Cornbread Hemp co-founder, voted against the bill advancing out of committee. The Republican said the bill was detrimental to small business and that such beverages were already regulated by the state.
Where hemp-derived beverages go from here
The rise of hemp-derived beverages and other products proliferating across Kentucky began with federal lawmakers legalizing the cultivation of hemp in the 2018 Farm Bill. That federal legislation also removed the prohibition of the production of intoxicating delta-8 THC, a hemp-derived version of the THC found in marijuana that can give a user a similar “high.”
But the legality of hemp-derived delta-8 THC products in Kentucky wasn’t immediate, and the initial focus of Kentucky hemp production homed in on the extraction of non-intoxicating CBD products.
​​The Kentucky Hemp Association sued the state in 2021 after a series of police raids of delta-8 THC products, arguing delta-8 THC was made legal under a past federal farm bill. A Boone County Circuit Court judge sided with the association in 2022 to legalize the products in the state.
In 2023, Kentucky lawmakers passed a bill into law directing the Cabinet for Health and Family Services to regulate delta-8 THC products. The cabinet subsequently created a series of regulations overseeing the sale of such products including restricting sales to people 21 years old or older.
The creation of intoxicating hemp-derived beverages with delta-8 THC have followed since with state legislatures taking a harder look at the regulation of such beverages.
Higdon, the hemp products company co-founder, told lawmakers he’d prefer SB 202 to be amended to have a cap on the amount of milligrams of THC in each beverage. But Dee Taylor, the president of the Kentucky Hemp Association and an owner of a Louisville hemp business, cautioned against having such a cap.
Taylor said her husband deals with seizures and needs a higher amount of THC in such beverages, and anecdotally she’s had alcoholics come into her business who use the beverages instead of drinking alcohol.
Hidgon said the hemp industry includes people from various backgrounds, describing the industry as “an island of misfit toys.” Because of that, it’s “difficult to find consensus” on how to regulate the beverages.
The thing industry stakeholders agree on: A moratorium isn’t the way forward.
“States are robustly regulating this sector, and lots of states are coming up with lots of different answers,” Hidgon said. “A moratorium is prohibition.”
<a href="https://kentuckylantern.com/2025/03/05/kentucky-lawmakers-advance-shell-bill-to-ban-sale-of-hemp-derived-beverages-until-next-year/" target="_blank" rel="noopener">This story was first published by Kentucky Lantern.</a>
<blockquote class="wp-embedded-content" data-secret="9JT6zGwsip"><a href="https://www.marijuanamoment.net/kentucky-governor-personally-awards-states-first-medical-marijuana-cards-and-pushes-congress-to-end-gun-ban-for-patients/">Kentucky Governor Personally Awards State’s First Medical Marijuana Cards And Pushes Congress To End Gun Ban For Patients</a></blockquote>

Photo courtesy of <a href="https://pixabay.com/en/cannabis-hemp-intoxicant-drugs-2773112/" target="_blank" rel="noopener">Pixabay</a>.
The post <a href="https://www.marijuanamoment.net/kentucky-senate-panel-votes-to-ban-sale-of-hemp-derived-beverages-on-a-temporary-basis/">Kentucky Senate Panel Votes To Ban Sale Of Hemp-Derived Beverages On A Temporary Basis</a> appeared first on <a href="https://www.marijuanamoment.net/">Marijuana Moment</a>.

“We are simply placing a moratorium on their sale until such time as we can establish robust regulations that protect Kentucky consumers.” By Liam Niemeyer, Kentucky Lantern Kentucky lawmakers advanced a “shell” bill Wednesday evening to ban the sale of hemp-derived beverages in the state until summer of 2026, a move supporters say will allow […]
The post <a href="https://www.marijuanamoment.net/kentucky-senate-panel-votes-to-ban-sale-of-hemp-derived-beverages-on-a-temporary-basis/">Kentucky Senate Panel Votes To Ban Sale Of Hemp-Derived Beverages On A Temporary Basis</a> appeared first on <a href="https://www.marijuanamoment.net/">Marijuana Moment</a>.

Kentucky Senate Panel Votes To Ban Sale Of Hemp-Derived Beverages On A Temporary Basis

In an industry where certifications are a benchmark to identifying qualified producers and manufacturers, Control Union Canada has established itself as a leading body to...
The post <a href="https://stratcann.com/profiles/control-union-canada-cannabis-compliance/">Certifying Trust: Control Union Canada’s role in cannabis compliance</a> appeared first on <a href="https://stratcann.com/">StratCann</a>.

Certifying Trust: Control Union Canada’s role in cannabis compliance

Oprah Winfrey is highlighting the cultural “shift” around psychedelics, expressing enthusiasm about the therapeutic potential of substances like psilocybin.
In an episode of The Oprah Podcast that was released on Tuesday, Winfrey spoke with author Michael Pollan, who’s helped bring plant-based medicine into the mainstream, about the state of science and policy around psychedelics.
Winfrey credited Pollan for being “part of the shift I’ve seen,” including an increase in media coverage and personal stories about “people who have engaged with the experience of psychedelics.”
“I think something is happening in the culture,” the media mogul, who has previously peddled controversial myths about psychedelics, such as the idea that MDMA causes abscesses in the brain.
Pollan said that “what’s happened since 2018, I never would have imagined how many studies are going on, how much research is being done and how many people are seeking psychedelic therapy.”
<blockquote class="instagram-media" data-instgrm-captioned data-instgrm-permalink="https://www.instagram.com/reel/DGyJKlDpGUP/?utm_source=ig_embed&amp;utm_campaign=loading" data-instgrm-version="14">
<div> <a href="https://www.instagram.com/reel/DGyJKlDpGUP/?utm_source=ig_embed&amp;utm_campaign=loading" target="_blank"> 
<div>
<div></div>
<div>
<div></div>
<div></div>
</div>
</div>
<div></div>
<div><svg width="50px" height="50px" viewbox="0 0 60 60" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink"><g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"><g transform="translate(-511.000000, -20.000000)" fill="#000000"><g><path d="M556.869,30.41 C554.814,30.41 553.148,32.076 553.148,34.131 C553.148,36.186 554.814,37.852 556.869,37.852 C558.924,37.852 560.59,36.186 560.59,34.131 C560.59,32.076 558.924,30.41 556.869,30.41 M541,60.657 C535.114,60.657 530.342,55.887 530.342,50 C530.342,44.114 535.114,39.342 541,39.342 C546.887,39.342 551.658,44.114 551.658,50 C551.658,55.887 546.887,60.657 541,60.657 M541,33.886 C532.1,33.886 524.886,41.1 524.886,50 C524.886,58.899 532.1,66.113 541,66.113 C549.9,66.113 557.115,58.899 557.115,50 C557.115,41.1 549.9,33.886 541,33.886 M565.378,62.101 C565.244,65.022 564.756,66.606 564.346,67.663 C563.803,69.06 563.154,70.057 562.106,71.106 C561.058,72.155 560.06,72.803 558.662,73.347 C557.607,73.757 556.021,74.244 553.102,74.378 C549.944,74.521 548.997,74.552 541,74.552 C533.003,74.552 532.056,74.521 528.898,74.378 C525.979,74.244 524.393,73.757 523.338,73.347 C521.94,72.803 520.942,72.155 519.894,71.106 C518.846,70.057 518.197,69.06 517.654,67.663 C517.244,66.606 516.755,65.022 516.623,62.101 C516.479,58.943 516.448,57.996 516.448,50 C516.448,42.003 516.479,41.056 516.623,37.899 C516.755,34.978 517.244,33.391 517.654,32.338 C518.197,30.938 518.846,29.942 519.894,28.894 C520.942,27.846 521.94,27.196 523.338,26.654 C524.393,26.244 525.979,25.756 528.898,25.623 C532.057,25.479 533.004,25.448 541,25.448 C548.997,25.448 549.943,25.479 553.102,25.623 C556.021,25.756 557.607,26.244 558.662,26.654 C560.06,27.196 561.058,27.846 562.106,28.894 C563.154,29.942 563.803,30.938 564.346,32.338 C564.756,33.391 565.244,34.978 565.378,37.899 C565.522,41.056 565.552,42.003 565.552,50 C565.552,57.996 565.522,58.943 565.378,62.101 M570.82,37.631 C570.674,34.438 570.167,32.258 569.425,30.349 C568.659,28.377 567.633,26.702 565.965,25.035 C564.297,23.368 562.623,22.342 560.652,21.575 C558.743,20.834 556.562,20.326 553.369,20.18 C550.169,20.033 549.148,20 541,20 C532.853,20 531.831,20.033 528.631,20.18 C525.438,20.326 523.257,20.834 521.349,21.575 C519.376,22.342 517.703,23.368 516.035,25.035 C514.368,26.702 513.342,28.377 512.574,30.349 C511.834,32.258 511.326,34.438 511.181,37.631 C511.035,40.831 511,41.851 511,50 C511,58.147 511.035,59.17 511.181,62.369 C511.326,65.562 511.834,67.743 512.574,69.651 C513.342,71.625 514.368,73.296 516.035,74.965 C517.703,76.634 519.376,77.658 521.349,78.425 C523.257,79.167 525.438,79.673 528.631,79.82 C531.831,79.965 532.853,80.001 541,80.001 C549.148,80.001 550.169,79.965 553.369,79.82 C556.562,79.673 558.743,79.167 560.652,78.425 C562.623,77.658 564.297,76.634 565.965,74.965 C567.633,73.296 568.659,71.625 569.425,69.651 C570.167,67.743 570.674,65.562 570.82,62.369 C570.966,59.17 571,58.147 571,50 C571,41.851 570.966,40.831 570.82,37.631"></path></g></g></g></svg></div>
<div>
<div>View this post on Instagram</div>
</div>
<div></div>
<div>
<div>
<div></div>
<div></div>
<div></div>
</div>
<div>
<div></div>
<div></div>
</div>
<div>
<div></div>
<div></div>
<div></div>
</div>
</div>
<div>
<div></div>
<div></div>
</div>
</a>
<a href="https://www.instagram.com/reel/DGyJKlDpGUP/?utm_source=ig_embed&amp;utm_campaign=loading" target="_blank">A post shared by Oprah (@oprah)</a>
</div>
</blockquote>

Winfrey said that while she’s intrigued by the experiences of others who’ve taken psychedelics, she personally “would be afraid of having a psychotic break” and “losing my mind” and “not getting it back.”
But she did concede that there may be something to the effects of plant medicine on consciousness.
“I’m not conscious enough to know, but I know that there is a oneness—there’s a connection with all of nature. I just don’t know what it is,” she said, adding that, in nature, “the plants aren’t speaking to me, but I know that there is life there. I know that there is something going on that is deeper than what we can see.”

She also equated the psychedelic experience with meditation, saying “it sounds like psychedelics is a higher level of the deepest of the meditations.”
“You’re elevating, enhancing and opening your consciousness to experience life and yourself differently. That’s what I think,” Winfrey said.
However, after Pollan explained the complexities of standardizing psychedelic-assisted therapy as a policy matter, given the restrictive requirements to get federal approval to bring drugs to market, Winfrey said “that’s why I don’t think we’re here yet.”
“We’re certainly not here yet because, like everything, once people start using it, it’s just like the anti-obesity drugs,” she said. “Then people create their own pharmacies for making the anti-obesity drugs, and people are doing it on the side, and it’s not authorized and stuff. I think it’s dangerous for people to have these kind of explorations without a guide.”
While Winfrey hasn’t personally experimented with psychedelics, she has previously disclosed that she’s smoked marijuana, and in 1995 while taping an episode of the famed Oprah Winfrey Show that centered on drug recovery, she <a href="https://www.washingtonpost.com/archive/politics/1995/01/13/oprah-winfrey-admits-drug-use/22391376-4674-463c-b4a0-efc6239ff9fb/" target="_blank" rel="noopener">talked</a> about smoking crack cocaine in her youth.
Last year, she also <a href="https://www.youtube.com/watch?v=YZJ8bz_KkFw&amp;amp;t=777s" target="_blank" rel="noopener">spoke</a> with neuroscientist Roland Griffiths about the therapeutic benefits of psychedelics, commenting on the efficacy of certain entheogenic substances in the treatment of depression, for example.
<blockquote class="wp-embedded-content" data-secret="26Tm9s7DbE"><a href="https://www.marijuanamoment.net/woody-harrelson-wishes-he-could-invite-bob-marley-to-his-marijuana-dispensary-but-fears-the-reggae-legend-would-out-smoke-him/">Woody Harrelson Wishes He Could Invite Bob Marley To His Marijuana Dispensary—But Fears The Reggae Legend Would Out-Smoke Him</a></blockquote>

The post <a href="https://www.marijuanamoment.net/oprah-highlights-cultural-shift-around-psychedelics-but-worries-about-losing-my-mind-if-she-experimented/">Oprah Highlights Cultural ‘Shift’ Around Psychedelics—But Worries About ‘Losing My Mind’ If She Experimented</a> appeared first on <a href="https://www.marijuanamoment.net/">Marijuana Moment</a>.

Oprah Winfrey is highlighting the cultural “shift” around psychedelics, expressing enthusiasm about the therapeutic potential of substances like psilocybin. In an episode of The Oprah Podcast that was released on Tuesday, Winfrey spoke with author Michael Pollan, who’s helped bring plant-based medicine into the mainstream, about the state of science and policy around psychedelics. Winfrey […]
The post <a href="https://www.marijuanamoment.net/oprah-highlights-cultural-shift-around-psychedelics-but-worries-about-losing-my-mind-if-she-experimented/">Oprah Highlights Cultural ‘Shift’ Around Psychedelics—But Worries About ‘Losing My Mind’ If She Experimented</a> appeared first on <a href="https://www.marijuanamoment.net/">Marijuana Moment</a>.

Oprah Highlights Cultural ‘Shift’ Around Psychedelics—But Worries About ‘Losing My Mind’ If She Experimented

The best cannabis brands find ways to connect, knowing their audience will choose brands that help them feel good about themselves, their communities and decisions.
<a href="https://mjbizdaily.com/building-cannabis-brands-that-reach-across-markets/">Building cannabis brands that reach across markets</a> is a post from: <a href="https://mjbizdaily.com/">MJBizDaily: Financial, Legal &amp; Cannabusiness news for cannabis entrepreneurs</a>

Building cannabis brands that reach across markets

NC medical marijuana chances; NM psilocybin; US Embassy’s psychedelics warning; Study: Medical cannabis for cancer; NORML: push back on reform attacks
<a href="https://www.marijuanamoment.net/newsletter/" target="_blank" rel="noopener noreferrer">Subscribe</a> to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.
<div class="mc4wp-form-fields">Get our daily newsletter.

	<label>Email address: </label>
	


	
</div>
<label>Leave this field empty if you're human: </label><div class="mc4wp-response"></div>

Your support makes Marijuana Moment possible…
Your good deed for the day: donate to an independent publisher like Marijuana Moment and ensure that as many voters as possible have access to the most in-depth cannabis reporting out there. Support our work at <a href="https://www.patreon.com/marijuanamoment">https://www.patreon.com/marijuanamoment </a>/ TOP THINGS TO KNOW <a href="https://www.marijuanamoment.net/ohio-gop-lawmaker-files-bill-to-revise-voter-approved-marijuana-law-with-less-sweeping-changes-than-senate-passed-measure/">The chair of the Ohio House Finance Committee filed a bill to alter the state’s voter-approved marijuana legalization law</a>—but not as drastically as Senate-passed legislation would. <a href="https://www.marijuanamoment.net/north-carolina-house-speaker-says-republican-lawmakers-could-be-more-open-to-medical-marijuana-legalization-this-year/">North Carolina’s new Republican House speaker said his chamber’s members could be more open to accepting a medical cannabis legalization bill</a> sent over from the Senate this session than they have been in past years. <a href="https://www.marijuanamoment.net/another-new-mexico-senate-committee-approves-bill-to-legalize-psilocybin-therapy/">The New Mexico Senate Judiciary Committee approved a bill to create a therapeutic psilocybin program by legalizing the active ingredient in psychedelic mushrooms</a> for use in a supervised medical setting. <a href="https://www.marijuanamoment.net/u-s-embassy-warns-americans-not-to-use-traditional-psychedelics-in-peru-including-ayahuasca/">The U.S. Embassy in Peru is warning traveling Americans against using the psychedelic ayahuasca</a>—saying it is “dangerous” and can cause “severe illness, including mental health episodes.” <a href="https://www.marijuanamoment.net/medical-marijuana-provides-significant-improvements-in-cancer-symptoms-study-shows/">A new study found that medical marijuana provides “significant improvements in cancer-related symptoms” but that “high out-of-pocket costs for cannabis may be especially burdensome</a> among those already financially struggling, raising questions about affordability of and equitable access to this therapy.” <a href="https://www.marijuanamoment.net/marijuana-consumers-are-under-attack-in-multiple-states-and-its-time-to-fight-back-op-ed/">NORML Deputy Director Paul Armentano argues in a new Marijuana Moment op-ed that “lawmakers from both parties are placing cannabis consumers in their crosshairs”</a> with new bills to roll back legalization or enact huge tax hikes, and that it’s time to fight back. <a href="https://www.marijuanamoment.net/idaho-lawmakers-approve-measure-to-block-voters-from-being-able-to-legalize-marijuana/">The Idaho House of Representatives passed a resolution in support of a proposed constitutional amendment that would block voters from being able to legalize marijuana at the ballot</a> by making it so only the legislature could end prohibition. <a href="https://www.marijuanamoment.net/committee-in-tennessee-signs-off-on-proposal-to-tighten-restrictions-on-hemp-industry/">The Tennessee House Judiciary Committee approved a bill to tighten restrictions on intoxicating hemp products</a>, including by removing them from convenience and grocery stores. / FEDERAL <a href="https://x.com/DEAHQ/status/1895126809412284771">The Drug Enforcement Administration Museum</a> posted a video about material seized from a cross-border drug smuggling tunnel that it has in its collection. A <a href="https://x.com/RachelYehuda/status/1895873036009754836">Department of Veterans Affairs</a> official tweeted about a psychedelics chapter she co-wrote for a new book on the neurobiology of mental illness. / STATES <a href="https://www.houstonchronicle.com/politics/texas/article/greg-abbott-thc-ban-texas-20206632.php">Texas</a> Gov. Greg Abott (R) dodged a question about whether he supports Lt. Gov. Dan Partrick’s (R) push to ban consumable hemp products with any amount of THC. A <a href="https://chadronradio.com/senator-ben-hansen-responds-in-support-for-regulated-access-to-medical-cannabis/">Nebraska</a> senator authored an op-ed about the need to upload the will of voters who approved medical cannabis legalization ballot initiatives. <a href="https://www.wabi.tv/2025/03/04/legislators-speak-bills-calling-testing-medical-cannabis-limiting-youth-usage/">Maine</a> lawmakers spoke in support of their legislation to require testing of medical cannabis products and set THC caps. <a href="https://www.kxnet.com/news/top-stories/bill-seeks-to-allow-edible-marijuana-for-medical-purposes/">North Dakota</a> lawmakers discussed their legislation to allow medical cannabis edibles. <a href="https://hhs.iowa.gov/media/15551/download?inline">Iowa</a> regulators posted guidance for law enforcement about consumable hemp products. <a href="https://www.cdtfa.ca.gov/news/25-02.htm">California</a> generated $219 million in cannabis revenue in the fourth quarter of 2024. <a href="https://headynj.com/breaking/seef-wholesale-cannabis-tax-town-hall-held-as-gov-murphy-proposes-increase/">New Jersey</a> regulators hosted a town hall meeting to receive input on how to allocate cannabis equity funding. <a href="https://agi.alabama.gov/hemp/2025/03/discover-hemp-join-our-orientation-meetings-march-11th-18th-20th/">Alabama</a> regulators will host several hemp program orientation sessions this month. — 
Marijuana Moment is <a href="https://www.marijuanamoment.net/bills/" target="_blank" rel="noopener">tracking hundreds of cannabis, psychedelics and drug policy bills</a> in state legislatures and Congress this year. <a href="https://www.patreon.com/marijuanamoment" target="_blank" rel="noopener">Patreon supporters</a> pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. <a href="https://www.marijuanamoment.net/bills/" target="_blank" rel="noopener"><img loading="lazy" decoding="async" class="alignnone wp-image-9128 size-medium" src="https://www.marijuanamoment.net/wp-content/uploads/2018/12/MM_Bill_Tracker_V5_blank.jpg" alt="" width="300" height="300"></a> Learn more about our <a href="https://www.marijuanamoment.net/bills/" target="_blank" rel="noopener">marijuana bill tracker</a> and become a <a href="https://www.patreon.com/marijuanamoment/" target="_blank" rel="noopener">supporter on Patreon</a> to get access. 
—
/ LOCAL <a href="https://cannabis.lacity.gov/articles/2024-annual-report">Los Angeles, California</a> regulators published an annual report on the city’s cannabis program. / INTERNATIONAL A <a href="https://rp-online.de/politik/deutschland/sondierungen-wie-geht-es-mit-dem-cannabis-gesetz-weiter_aid-124567679">German</a> Social Democratic Party official said the party would push to maintain the country’s marijuana law if it enters into a governing agreement with a conservative party that wants to repeal it. / SCIENCE &amp; HEALTH A study’s findings “support the potential of CBD in alleviating the underlying pathology and symptoms associated with” <a href="https://journals.sagepub.com/doi/10.1177/25424823241284464">Alzheimer’s disease</a>. A study of mice found that “CBD alleviates oxidative stress in stress-induced <a href="https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1567210/abstract">liver injury</a>, enhances mitochondrial morphology, and reduces liver damage.” / BUSINESS <a href="https://www.globenewswire.com/news-release/2025/03/06/3038060/0/en/AYR-Wellness-Reports-Fourth-Quarter-and-Full-Year-2024-Results.html">AYR Wellness Inc.</a> reported quarterly net revenue of $114 million and a net loss of $164.2 million. / CULTURE <a href="https://www.youtube.com/watch?v=f_fM6v64-NQ&amp;t=31m6s">Bill Murray and Joe Rogan</a> spoke about the passage of the Controlled Substances Act during the Nixon administration.
Make sure to <a href="https://www.marijuanamoment.net/newsletter/">subscribe</a> to get Marijuana Moment’s daily dispatch in your inbox.
<div class="mc4wp-form-fields">Get our daily newsletter.

	<label>Email address: </label>
	


	
</div>
<label>Leave this field empty if you're human: </label><div class="mc4wp-response"></div>

The post <a href="https://www.marijuanamoment.net/another-ohio-push-to-alter-cannabis-law-approved-by-voters-newsletter-march-7-2025/">Another Ohio push to alter cannabis law approved by voters (Newsletter: March 7, 2025)</a> appeared first on <a href="https://www.marijuanamoment.net/">Marijuana Moment</a>.

NC medical marijuana chances; NM psilocybin; US Embassy’s psychedelics warning; Study: Medical cannabis for cancer; NORML: push back on reform attacks Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Your support makes Marijuana Moment possible… Your […]
The post <a href="https://www.marijuanamoment.net/another-ohio-push-to-alter-cannabis-law-approved-by-voters-newsletter-march-7-2025/">Another Ohio push to alter cannabis law approved by voters (Newsletter: March 7, 2025)</a> appeared first on <a href="https://www.marijuanamoment.net/">Marijuana Moment</a>.

Another Ohio push to alter cannabis law approved by voters (Newsletter: March 7, 2025)

The <a href="https://www.bag.admin.ch/bag/fr/home/gesund-leben/sucht-und-gesundheit/cannabis/pilotprojekte/ergebnisse-pilotversuche.html">preliminary findings from Switzerland’s seven active pilot trials</a>, involving around three per cent of the country’s active cannabis consumers, have been published by a local university.
Just days after <a href="https://businessofcannabis.com/switzerland-could-become-europes-first-fully-fledged-adult-use-market-by-2026/">Switzerland announced it was positioning itself to become the first European country to launch a full commercial adult-use cannabis market</a>, an analysis of its pioneering adult-use pilot trials has provided some early insights into the impact its ambitious plans could have on Swiss society.
With the seven different pilots all exploring unique ways of selling and dispensing cannabis, these pilot projects are inextricably linked to its wider cannabis reform project, and the pilots will help provide an evidence-based framework for similar projects across the globe moving forward. While the trials are still in their nascent stages, the early signs appear promising.
<h4>Preliminary findings</h4>
The University of Lausanne and the University of Applied Sciences Northwestern Switzerland carried out an analysis of all of the seven trials green lit since the first trial <a href="https://businessofcannabis.com/switzerlands-flourishing-cannabis-pilots-gain-european-spotlight-a-model-for-others/">(Weed Care)</a> was green lit in 2023.
Conducted on behalf of the Federal Office of Public Health (FOPH), the study examines the initial experiences of the projects from 2023 to mid-2024, examining the impact each different sales model has on health and consumption.
Across the various trials situated in Basel-Stadt, Bern, Biel, Lausanne, Lucerne, Vernier, the City of Zurich as well as various municipalities in the canton of Zurich and Basel-Landschaft, around 7000 adults are currently thought to be participating in the studies, though their collective mandate allows for significantly more to take part.
This sample generally has a higher level of education than the general population, with nearly half of participants holding a university degree, and it is made up predominantly (80.07%) of males with a mean age of 36.6 years.
While the report stipulates that due to the ‘short implementation period’ the results are ‘limited and must be considered preliminary’, a few key observations are already coming to light.
<figure aria-describedby="caption-attachment-43334" class="wp-caption aligncenter"><img data-dominant-color="7c8a97" data-has-transparency="false" fetchpriority="high" decoding="async" class="wp-image-43334 size-full not-transparent" src="https://businessofcannabis.com/wp-content/uploads/2025/03/Pilot-Trials.webp" alt="" width="512" height="384" srcset="https://businessofcannabis.com/wp-content/uploads/2025/03/Pilot-Trials.webp 512w, https://businessofcannabis.com/wp-content/uploads/2025/03/Pilot-Trials-300x225.webp 300w" sizes="(max-width: 512px) 100vw, 512px"><figcaption class="wp-caption-text">Image Credit: University of Lausanne</figcaption></figure>Firstly, and perhaps most importantly for the stated goal of harm reduction, the results indicate that while consumers generally stick to their established consumption patterns, if there is a change it ‘is established in the direction of lower-risk consumption’ via methods like vapes.
Meanwhile it noted a ‘destigmatising effect’ for consumers, particularly in trials conducted in pharmacies rather than dedicated dispensaries, and in social clubs. Non-profit associations were found to ‘promote the construction of a community of peers’.
Despite concerns around adverse social impacts on the communities where the trials are taking place, ‘no disturbance of public order’ were observed around the points of sale, and no leakage of the cannabis from the trials into the illicit market was observed.
The police have also shown themselves to be in favor of the trials in all the cases studied, with the idea of being able to prioritise other tasks.
In some of the for-profit trials, such as Grashaus, the study noted that ‘tensions rose’ between the company funding and supplying the project and the scientific team during the recruitment phase, with the company pushing for a broad admission of participants to quickly reach the sample size, and study managers prioritising quality and safety.
Notable differences also arose regarding prevention between the for-profit and non-profit trials, with results suggesting non-profit studies tended to see staff push more proactively for things like smoking cessation intervention, while the for-profit trials placed greater emphasis on individual responsibility.
For-profit trials were also found to advertise much more aggressively. While the promotion of cannabis products is banned across all schemes, the advertising of the pilot itself is allowed, and profit-focused trials were found to be much more present on social media and targeted younger audiences, while non-profit trials offered neutral and factual information.
<h4>Wider impact on politics and further reform</h4>
While the preliminary results are valuable in themselves, the overarching goal of these studies is to determine the best possible framework for wider reform, acting largely as a precursor for potential full legalisation.
As such, the study suggests with the establishment of its network of pilot trials, the ‘Swiss legislator has equipped itself with a tool to gather a rich evidence base to fuel reflections on the cannabis issue’.
It adds that as cannabis is ‘often the subject of lively political debate in the country’, with discussions ‘almost constant’ at the federal level, the studies are likely to provide ‘food for thought not only on the advisability of regulation but also on its exact terms if necessary’.
Political trends can already be observed across the various participating cantons, the report states. The first and most surprising is that the opinions of political parties have ‘only evolved in favour of the tests’ over the last decade.
Media coverage, meanwhile has been ‘neutral and informative’ for the most part, emphasising the technical aspects of each trial, though its noted that coverage was marked by a ‘slightly favourable orientation’ towards the trials.
Even in regions with political resistance, such as Bern, opposition has softened over time, reflecting a broader shift in public and political attitudes toward cannabis regulation.
In cities like Zurich and Basel, the media has highlighted potential economic and social benefits, including reductions in the illegal market and improved public safety.
While some criticism remains, particularly in concerns over the ethical implications of cannabis sales in pharmacies and the possible unintended consequences of regulation, most discussions have framed these issues as challenges to be addressed rather than reasons to reject the trials.
The trials have also been seen as an opportunity to inform future cannabis policies, with political discourse increasingly leaning towards pragmatic and scientific approaches rather than strict prohibition​.
.
The post <a href="https://businessofcannabis.com/switzerlands-7000-recreational-cannabis-pilot-participants-show-tendency-towards-lower-risk-consumption/">Switzerland’s 7000 Recreational Cannabis Pilot Participants Show Tendency Towards ‘Lower-Risk Consumption’</a> appeared first on <a href="https://businessofcannabis.com/">Business of Cannabis</a>.

The preliminary findings from Switzerland’s seven active pilot trials, involving around three per cent of the country’s active cannabis consumers, have been published by a local university. Just days after […]
The post <a href="https://businessofcannabis.com/switzerlands-7000-recreational-cannabis-pilot-participants-show-tendency-towards-lower-risk-consumption/">Switzerland’s 7000 Recreational Cannabis Pilot Participants Show Tendency Towards ‘Lower-Risk Consumption’</a> appeared first on <a href="https://businessofcannabis.com/">Business of Cannabis</a>.

Business of Cannabis

Switzerland’s 7000 Recreational Cannabis Pilot Participants Show Tendency Towards ‘Lower-Risk Consumption’

Germany held a federal election on February 23, 2025, and a new government will be formed now that the election is over. The bad news from the election is that the conservative CDU/CSU party gained the largest percentage of votes (28.52%), and with it the largest number of seats (208). The CDU/CSU party has been historically critical of Germany’s recent cannabis policy modernization changes.



However, the good news is that the CDU/CSU party is well short of having a majority in the new federal government and that a coalition government will have to be formed. CDU/CSU leadership has made it clear that they will not form a coalition with the even more conservative AfD party, and will instead work with federal lawmakers that hold a more favorable view towards German cannabis policies and regulations.



“A coalition of CDU/CSU and SPD seems likely, which means that the SPD will probably continue to play a very important role in the future of the cannabis industry,” the <a href="https://cannabiswirtschaft.de/english/" target="_blank" rel="noreferrer noopener">German Cannabis Business Association (BvCW)</a> stated about the recent election results (translated from German to English). “The CDU/CSU’s demand to reverse cannabis legalization is not a productive strategy, but would lead to the renewed criminalization of patients and consumers.”



The BvCW also stated that “of the cannabis and drug policy spokespersons, Simone Borchardt (CDU), Carmen Wegge (SPD), Kirsten Kappert-Gonther (Greens) and Linda Heitmann (Greens) as well as Ates Gürpinar (Left) were re-elected. Dirk Heidenblut (SPD) did not stand for re-election. The FDP and thus also Kristine Lütke will no longer be represented in the next Bundestag due to the 5% hurdle.”



<h4 class="wp-block-heading">
Legal Cannabis Thriving in Germany
</h4>



Germany’s election came at an important time for the nation’s emerging legal cannabis and hemp industries. Lawmakers in Germany adopted a national adult-use cannabis legalization measure in 2024, with the initial provisions of the policy change taking effect on April 1, 2024. As of that date, adults in Germany can legally cultivate up to three plants in their private residences, possess a personal amount of cannabis, and consume cannabis in private settings.



Additionally, cannabis was removed from Germany’s Narcotics List, which has had a significant impact on the nation’s legal medical cannabis industry. The removal of cannabis from the Narcotics List has boosted domestic production, made medical cannabis research easier, and helped streamline the process by which suffering people can register as patients. According to a <a href="https://internationalcbc.com/report-german-medical-cannabis-prescriptions-increased-1000-in-9-months/" target="_blank" rel="noreferrer noopener">recent report</a> by the Bloomwell Group, prescriptions for medical cannabis in Germany increased by roughly 1,000% between March 2024 and December 2024.



Medical cannabis imports <a href="https://krautinvest.de/cannabis-importe-2024-im-vierten-quartal-fast-viermal-hoeher-als-im-ersten/" target="_blank" rel="noreferrer noopener">increased significantly in Germany in 2024</a> to help meet the growing demand for medical cannabis products. In the fourth quarter of 2024, roughly 31.7 tons of medical cannabis products were imported to Germany, which is nearly four times as much as in the first quarter (8.1 tons) of 2024. Overall, medical cannabis imports amounted to 71.1 tons in Germany in 2024, which is more than twice as much compared to what was imported in 2023 (32.5 tons).



Germany’s legal cannabis industry is booming by every measure right now, including the growth of the nation’s cultivation association sector. Cultivation associations became legal in Germany starting on July 1st, 2024, providing adult-use consumers a way to legally source recreational products.



<h4 class="wp-block-heading">Cannabis Policies Here to Stay</h4>



Cannabis advocates and industry members in Germany were concerned that the 2025 election would yield a government that was hostile towards the nation’s new cannabis policies and industry. However, it appears that a reversal of the new CanG law is unlikely under the eventual coalition government, and that most, if not all, of what is currently in place in Germany is here to stay.



Arguably, the least clear component of Germany’s previously approved legalization model is regional adult-use cannabis commerce pilot trials, often referred to as ‘Pillar 2.’ Pilot trials, which are currently successfully operating in the Netherlands and Switzerland, permit limited recreational cannabis commerce at a local level for research purposes to help lawmakers and regulators gather data to be better informed when crafting national policies and regulations.



Pillar 2 was originally expected to launch in Germany near the end of 2024, but that timeframe has obviously passed. Cannabis advocates and industry members are hopeful that the incoming coalition government will permit trials to launch in 2025, but it is unclear at this time if that will happen. <a href="https://internationalcbc.com/27-german-jurisdictions-express-interest-in-cannabis-model-projects/" target="_blank" rel="noreferrer noopener">Over two dozen jurisdictions in Germany</a> have expressed a desire to launch regional adult-use cannabis commerce pilot trials.



<h4 class="wp-block-heading">German Cannabis Business Week</h4>



In the meantime, Germany will remain the most exciting cannabis market in Europe, and that is why the upcoming German Cannabis Business Week is so timely. The German Cannabis Business Week will bring together leaders from across the global cannabis industry to Berlin, Germany, beginning on April 28th, 2025. The week will commence with <a href="https://thetalmangroup.com/talman-events/talman-berlin-2025/" target="_blank" rel="noreferrer noopener">The Talman House’s exclusive investor gathering</a>, held at the prestigious Hotel Adlon Kempinski, an internationally renowned venue recognized for its historic significance and unmatched hospitality.



Following the Talman House event in Berlin, Europe’s largest and longest-running cannabis B2B event—the International Cannabis Business Conference (ICBC)—will once again bring its <a href="https://internationalcbc.com/berlin/" target="_blank" rel="noreferrer noopener">flagship two-day conference</a> to the iconic Estrel Berlin Hotel on April 29-30.
The post <a href="https://cannabisnow.com/how-will-germanys-recent-election-impact-cannabis-policy/">How Will Germany’s Recent Election Impact Cannabis Policy?</a> appeared first on <a href="https://cannabisnow.com/">Cannabis Now</a>.

After a federal election last week, Germany's conservative party, who has been vocally critical of recent cannabis policy, received the most votes. 
The post <a href="https://cannabisnow.com/how-will-germanys-recent-election-impact-cannabis-policy/">How Will Germany’s Recent Election Impact Cannabis Policy?</a> appeared first on <a href="https://cannabisnow.com/">Cannabis Now</a>.

How Will Germany’s Recent Election Impact Cannabis Policy?

New proposed amendments to Manitoba’s regulations would limit cannabis sales to age-restricted stores in urban areas of the province. 
The post <a href="https://stratcann.com/news/manitoba-bill-seeks-to-end-controlled-access-licences-in-urban-areas/">Manitoba bill seeks to end controlled-access licences in urban areas</a> appeared first on <a href="https://stratcann.com/">StratCann</a>.

Manitoba bill seeks to end controlled-access licences in urban areas

While most provinces—excluding PEI and Newfoundland and Labrador—have agreed to allow interprovincial alcohol sales directly to consumers, the cannabis industry was left out of the...
The post <a href="https://stratcann.com/news/cannabis-continues-to-be-excluded-from-interprovincial-trade-discussions/">Cannabis continues to be excluded from interprovincial trade discussions</a> appeared first on <a href="https://stratcann.com/">StratCann</a>.

Cannabis continues to be excluded from interprovincial trade discussions

A Missouri lawsuit challenging double taxation by local and county municipalities on marijuana sales will be heard by the state Supreme Court.
<a href="https://mjbizdaily.com/marijuana-sales-tax-challenge-heads-to-missouri-supreme-court/">Marijuana sales-tax challenge heads to Missouri Supreme Court</a> is a post from: <a href="https://mjbizdaily.com/">MJBizDaily: Financial, Legal &amp; Cannabusiness news for cannabis entrepreneurs</a>

Marijuana sales-tax challenge heads to Missouri Supreme Court

Canadian cannabis producer Organigram Holdings closed on the final of three tranches of an overall investment of 124.6 million Canadian dollars (roughly $87 million) from a wholly owned subsidiary of British American Tobacco.
<a href="https://mjbizdaily.com/cannabis-producer-organigram-closes-final-tranche-of-ca124m-funding/">Cannabis producer Organigram closes final tranche of CA$124.6M funding</a> is a post from: <a href="https://mjbizdaily.com/">MJBizDaily: Financial, Legal &amp; Cannabusiness news for cannabis entrepreneurs</a>

Cannabis producer Organigram closes final tranche of CA$124.6M funding

A Texas lawmaker wants to end the state’s nation-leading, $3 billion hemp-derived THC market while also expanding its notoriously restrictive medical marijuana program that bans all but extremely low THC products.
<a href="https://mjbizdaily.com/texas-senator-pitches-medical-marijuana-program-expansion-hemp-thc-ban/">Texas senator pitches medical marijuana program expansion, hemp THC ban</a> is a post from: <a href="https://mjbizdaily.com/">MJBizDaily: Financial, Legal &amp; Cannabusiness news for cannabis entrepreneurs</a>

Texas senator pitches medical marijuana program expansion, hemp THC ban

Canada is expected to introduce a raft of new cannabis regulations later this month, according to leaked documents.
According to <a href="https://stratcann.com/news/updates-to-cannabis-regulations-expected-march-12/">Stratcann</a>, which has seen the unofficial leaked Orders of Council, new regulations regarding packaging, licencing limits, research and production standards for businesses across the country.
The documents, which have been circulating online since March 05 and are expected to be published in the bi-monthly Gazette II update on March 12, suggest that cannabis products could soon be sold in transparent packaging, enabling customers to view products before purchasing for the first time.
There will also be more flexibility in packaging design, with a broader allowance for multi-packs and additional colours, marking a significant shift from the industry’s previously rigid labelling restrictions.
Additionally, producers can now include multiple barcodes on packaging, and leaflets can be inserted inside containers to provide extra product information.
Elsewhere micro cultivators, processors and nurseries could soon be allowed to expand their production capacities significantly.
Micro cultivators will now be allowed up to 800sq m of canopy space, four times the current limit, while micro processors will also see a jump in production limits, with an annual cap of 2,400 kg, up from 600 kg per year.
Cannabis nurseries, which were previously restricted to 50 square meters of flowering space and 5 kg of dried flower on-site, will now be able to expand to 200 square meters of flowering space and store up to 20 kg of dried flower.
A further update to the rules simplifies cannabis destruction protocols for licensed producers, reducing the requirement to just one witness instead of two.
In another shift, cannabis pollen will officially be recognized under federal regulations, allowing it to be bought and sold for breeding purposes, rather than being limited to internal use by cultivators.
Beyond production changes, regulatory hurdles for non-human and animal cannabis research will be eased, making it simpler for researchers to conduct studies without facing as many compliance restrictions.
Meanwhile, licensed cannabis producers will gain more flexibility in Quality Assurance oversight, allowing them to appoint alternative Quality Assurance Persons when necessary.
The post <a href="https://businessofcannabis.com/canada-expected-to-introduce-raft-of-new-changes-to-cannabis-regulations/">Canada Expected to Introduce Raft of New Changes to Cannabis Regulations</a> appeared first on <a href="https://businessofcannabis.com/">Business of Cannabis</a>.

Canada is expected to introduce a raft of new cannabis regulations later this month, according to leaked documents. 
The post <a href="https://businessofcannabis.com/canada-expected-to-introduce-raft-of-new-changes-to-cannabis-regulations/">Canada Expected to Introduce Raft of New Changes to Cannabis Regulations</a> appeared first on <a href="https://businessofcannabis.com/">Business of Cannabis</a>.

Canada Expected to Introduce Raft of New Changes to Cannabis Regulations

A proposal for federal legalization of cannabis is now expected to be submitted to the White House by the end of the week, driving a bump in US cannabis stocks.
According to <a href="https://www.marijuanamoment.net/trump-white-house-invites-proposal-on-federal-marijuana-legalization-activist-says/">Marijuana Moment,</a> drug policy expert and co-founder of Law Enforcement Action Partnership (LEAP) Howard Wooldridge, a Trump administration representative indicated they would welcome a proposal on cannabis reform.
During a weekly meeting of Americans for Tax Reform, a group of conservative activists last week, Wooldridge said he was given some ‘one-on-one’ time with the representative to discuss his plans to advise the administration to legalize cannabis at the federal level.
Speculation about Trump’s position on cannabis reform has been rife since the presidential campaign, given the forward momentum set in motion by the Biden administration.
As <a href="https://businessofcannabis.com/trumps-position-on-cannabis-reform-remains-mystery-as-he-calls-for-death-penalty-for-drug-dealers-while-appointing-pardons-czar/">Business of Cannabis reported last month,</a> the administration’s rhetoric on cannabis reform has been unclear at best, and at times contradictory.
The staffer, who was kept anonymous, was reportedly ‘open to any and all suggestions’, and Wooldridge suggested that he would submit a proposal by the end of the week.
It comes amid a spike in US cannabis stock prices, which jumped on March 04, a day before the story was published, meaning it is unclear whether these events are connected.
<a href="https://www.newcannabisventures.com/american-cannabis-operator-index/">New Cannabis Ventures’ American Cannabis Stock Index</a>, which tracks the performance of leading US cannabis stocks, rose by over 20% as the markets opened.
The post <a href="https://businessofcannabis.com/federal-cannabis-legalization-proposal-to-be-submitted-by-end-of-the-week-as-us-stocks-rise/">Federal Cannabis Legalization Proposal to Be Submitted by End of the Week as US Stocks Rise</a> appeared first on <a href="https://businessofcannabis.com/">Business of Cannabis</a>.

A proposal for federal legalization of cannabis is now expected to be submitted to the White House by the end of the week, driving a bump in US cannabis stocks. 
The post <a href="https://businessofcannabis.com/federal-cannabis-legalization-proposal-to-be-submitted-by-end-of-the-week-as-us-stocks-rise/">Federal Cannabis Legalization Proposal to Be Submitted by End of the Week as US Stocks Rise</a> appeared first on <a href="https://businessofcannabis.com/">Business of Cannabis</a>.

Federal Cannabis Legalization Proposal to Be Submitted by End of the Week as US Stocks Rise

Cannabis sales in Canada dropped last year, but pre-roll sales continued to rise and are on the verge of becoming the top sales category in the country.
<a href="https://mjbizdaily.com/pre-rolls-close-in-on-top-cannabis-sales-spot-in-canada/">Pre-rolls close in on top cannabis sales spot in Canada</a> is a post from: <a href="https://mjbizdaily.com/">MJBizDaily: Financial, Legal &amp; Cannabusiness news for cannabis entrepreneurs</a>

Pre-rolls close in on top cannabis sales spot in Canada

<h4><img data-dominant-color="3d3d3d" data-has-transparency="false" decoding="async" class="alignnone size-full wp-image-43326 not-transparent" src="https://businessofcannabis.com/wp-content/uploads/2025/03/New-Stocks-Template-2025-03-06T094217.345-png.webp" alt="" width="1300" height="1200" srcset="https://businessofcannabis.com/wp-content/uploads/2025/03/New-Stocks-Template-2025-03-06T094217.345-png.webp 1300w, https://businessofcannabis.com/wp-content/uploads/2025/03/New-Stocks-Template-2025-03-06T094217.345-300x277.webp 300w, https://businessofcannabis.com/wp-content/uploads/2025/03/New-Stocks-Template-2025-03-06T094217.345-1024x945.webp 1024w, https://businessofcannabis.com/wp-content/uploads/2025/03/New-Stocks-Template-2025-03-06T094217.345-768x709.webp 768w, https://businessofcannabis.com/wp-content/uploads/2025/03/New-Stocks-Template-2025-03-06T094217.345-600x554.webp 600w, https://businessofcannabis.com/wp-content/uploads/2025/03/New-Stocks-Template-2025-03-06T094217.345-750x692.webp 750w, https://businessofcannabis.com/wp-content/uploads/2025/03/New-Stocks-Template-2025-03-06T094217.345-1140x1052.webp 1140w" sizes="(max-width: 1300px) 100vw, 1300px"></h4>
<h4>Kanabo</h4>
<stock-market-widget type="chart" template="line" assets="KNB.L" range="1mo" interval="1d" price_field="close" border_width="3" tension="0.5" line_color="#5679FF" range_selector="true" axes="true" cursor="true" api="yahoo-finance"></stock-market-widget> 
London Stock Exchange-listed (LSE) UK medical cannabis operator Kanabo has published its broad financial results for 2024, revealing growing revenue and falling losses.
In an update published this week, the digital health service reported a 44% increase in revenue for the full year to £1.3m, up from £0.9m in 2023.
This increase in revenue appeared to be balanced across the whole year, with the company reporting a 55% increase for H1 of 2024 in September to £694k.
The double-digit growth was attributed to numerous ‘strategic initiatives’ including a raft of AI integration across its operations, alongside its ongoing cultivation project in Spain.
At its flagship digital ‘GP Service’, Kanabo has integrated an AI-driven ‘DocNow’ system which automates and analyses patient information ahead of a consultation, reportedly increasing doctor’s consultation capacity from three to 20 sessions per hour.
It is also in ‘ongoing discussions’ regarding the integration of an ‘AI-powered triage system’, which it says generates 33% gross profit per consultation, and sees less than 10% of AI-triaged cases rejected by clinical professionals.
Another key driver of this revenue growth has been Kanabo’s investment in Spain via its partially owned subsidiary Agritech. In March 2024, <a href="https://businessofcannabis.com/love-hemp-falls-into-administration-for-second-time-akanda-to-issue-new-share-offering-more-from-kanabo/">Business of Cannabis reported</a> that Agritech had received a major investment to consult on the construction of a high-tech cultivation facility in the country.
This consultant venture has reportedly generated £226k in revenue throughout 2024 and promises to not only realise an additional £1m this year, but also sure up Kanabo’s supply chain with reliable access to medical cannabis APIs.
Despite these financial gains, the company is still a loss maker, posting an EBITDA loss of £1.9m in 2024.
While the company is still in the red, this was a significant improvement on 2023’s £2.2m loss, and Kanabo is confident that its cost reduction programme will continue to reduce these losses through 2025.
By the close of this year, Kanabo says it hopes to reduce losses by 20% through further automation of its processes. Already, in January 2025, the company says its general and administrative fixed costs fell by 14%, dropping from £91,449 average monthly costs in 2024 to £78,963.
“These savings stemmed from streamlined administrative processes, improved IT management, and ongoing automation efforts,” it said in an RNS statement.
Looking ahead, Kanabo anticipates further revenue growth, driven by both increasing market demand and increased efficiency. In Q1 of 2025, Kanabo says its clinic’s patient base grew by 51%, aided by ‘new partnerships with patient-focused organisations’.
Meanwhile, its monthly revenue increased by 406% year-on-year in January 2025, up from just £15,192 to £76,842.
<h4>Organigram </h4>
<stock-market-widget type="chart" template="line" assets="OGI" range="1mo" interval="1d" price_field="close" border_width="3" tension="0.5" line_color="#5679FF" range_selector="true" axes="true" cursor="true" api="yahoo-finance"></stock-market-widget> 
Canadian cannabis operator Organigram, which has an increasing presence across various European markets, announced this week that it has received its third and final investment from British American Tobacco (BAT).
<a href="https://businessofcannabis.com/organigram-announces-transformative-c124m-investment-from-tobacco-giant-bat/">In November 2023, the tobacco giant signed a deal</a> to invest a further C$124.6m in Organigram in three separate tranches, seeing BAT retain a 30% of the cannabis company’s common shares.
Since BAT initially invested in Organigram in March 2021, the pair have also been working on a Product Development Collaboration (PDC), with an ‘accelerated focus on innovative cannabis science and R&amp;D outside of combustibles’ with the fresh investment.
This week, BAT acquired the final tranche of Organigram shares as part of this deal, 7.56 million common shares and 5.33 million preferred shares at C$3.2203 per share, generating gross proceeds of C$41.5m
As previously reported, a significant portion of this funding was allocated to Organigram’s investment pool, Jupiter, which focuses on international expansion.
Following previous investments of C$21m in German cannabis company Sanity Group and C$2.7m in US-based Open Book Extracts, Organigram now has approximately C$57.8 million available for further investments.
<a href="https://seekingalpha.com/article/4756999-organigram-holdings-inc-ogi-q1-2025-earnings-call-transcript">It came just weeks after it hosted a Q1, 2025, earnings call</a> in which its CEO, Beena Goldenberg, provided a clear picture of its progress across Europe.
<stock-market-widget type="chart" template="line" assets="BATS.L" range="1mo" interval="1d" price_field="close" border_width="3" tension="0.5" line_color="#5679FF" range_selector="true" axes="true" cursor="true" api="yahoo-finance"></stock-market-widget> 
Organigram’s key focus is Germany, and its flower exports are expected to increase markedly once its Moncton facility receives EU GMP certification, expected in Spring 2025.
It noted that currently, many non-EU GMP producers rely on third-party conversion facilities in countries like Portugal before exporting to Germany, meaning that EU-GMP certification will eliminate this middleman and improve margins.
It is also targeting Germany’s slated pilot projects, though given the current political climate, it’s questionable whether these will go ahead.
The company also suggested that the entirety of this final tranche of funding will be put towards its Jupiter pool, and will be used to fund further international investments.
<h4>Curity Pharma </h4>
Greek medical cannabis cultivator Curity Pharma has officially received its operating license from Greece’s Ministries of Development, Health, and Rural Development.
According to a market update this week, this license will allow the vertically integrated medical cannabis business to launch its operations immediately in the fledgling market.
Curity boasts a 67,000 sq metre facility that ‘operates in compliance with Good Manufacturing Practice (EU GMP) standards with a view to producing medical cannabis products to support the ‘rising demand’ across Europe and in the domestic market.
CEO and co-founder Manos Chatiras said: “This license marks the beginning of a new chapter for Curity Pharma and the medical cannabis industry.
“Greece is becoming an important player in the European medical cannabis sector, driving solutions based on science and advanced technology. Our vision for developing and producing innovative therapies is now coming to life.
“We are ready to implement our strategy to offer the best therapeutic solutions to Greek patients while also executing our export plan to establish Greek medical cannabis as a reference point across Europe.”
The post <a href="https://businessofcannabis.com/organigram-gets-final-investment-from-tobacco-giant-kanabo-sees-double-digit-revenue-increase-more-from-curity-pharma/">Organigram Gets Final Investment From Tobacco Giant, Kanabo Sees Double Digit Revenue Increase, &amp; More From Curity Pharma</a> appeared first on <a href="https://businessofcannabis.com/">Business of Cannabis</a>.

London Stock Exchange-listed (LSE) UK medical cannabis operator Kanabo has published its broad financial results for 2024, revealing growing revenue and falling losses.
The post <a href="https://businessofcannabis.com/organigram-gets-final-investment-from-tobacco-giant-kanabo-sees-double-digit-revenue-increase-more-from-curity-pharma/">Organigram Gets Final Investment From Tobacco Giant, Kanabo Sees Double Digit Revenue Increase, &amp; More From Curity Pharma</a> appeared first on <a href="https://businessofcannabis.com/">Business of Cannabis</a>.

Organigram Gets Final Investment From Tobacco Giant, Kanabo Sees Double Digit Revenue Increase, &amp; More From Curity Pharma

Details on updates to Canada’s cannabis regulations are expected on March 12, 2025, according to recently-published Orders in Council.
The post <a href="https://stratcann.com/news/updates-to-cannabis-regulations-expected-march-12/">Updates to cannabis regulations expected March 12</a> appeared first on <a href="https://stratcann.com/">StratCann</a>.

Updates to cannabis regulations expected March 12

New Jersey Gov. Phil Murphy is proposing a significant tax hike on the state’s $1 billion adult-use marijuana industry and a new, even bigger tariff on intoxicating hemp products.
<a href="https://mjbizdaily.com/new-jersey-governor-proposes-stiff-marijuana-tax-hike-new-hemp-levy/">New Jersey governor proposes stiff marijuana tax hike, new hemp levy</a> is a post from: <a href="https://mjbizdaily.com/">MJBizDaily: Financial, Legal &amp; Cannabusiness news for cannabis entrepreneurs</a>

New Jersey governor proposes stiff marijuana tax hike, new hemp levy

The post <a href="https://azmarijuana.com/marijuana-video/journalist-traces-nycs-weed-supply-to-the-source/">Journalist traces NYC’s weed supply to the source</a> appeared first on <a href="https://azmarijuana.com/">AZ Marijuana</a>.

The post <a href="https://azmarijuana.com/marijuana-video/journalist-traces-nycs-weed-supply-to-the-source/">Journalist traces NYC’s weed supply to the source</a> appeared first on <a href="https://azmarijuana.com/">AZ Marijuana</a>.

AZ Marijuana

Journalist traces NYC’s weed supply to the source

Marijuana industry finance company SHF Holdings, Safe Harbor Financial, has modified its debt with Partner Colorado Credit Union.
<a href="https://mjbizdaily.com/marijuana-finance-company-safe-harbor-modifies-debt-to-increase-cash-flow/">Marijuana finance company Safe Harbor modifies debt to increase cash flow</a> is a post from: <a href="https://mjbizdaily.com/">MJBizDaily: Financial, Legal &amp; Cannabusiness news for cannabis entrepreneurs</a>

Marijuana finance company Safe Harbor modifies debt to increase cash flow

California’s legal cannabis industry is still failing to match the state’s thriving illicit market amid increasing regulatory and competition pressures, according to a new report.
A new study, commissioned by the Department of Cannabis Control (DCC), suggests that the illicit market still accounts for around 60% of total consumption in the state.
The unregulated sector is now estimated to produce between 7m and 16.3m pounds of cannabis annually.
That is despite legal cannabis production growing by double digits in 2024, increasing by 11.8% to 1.4m pounds, the highest since the state legalized adult-use sales in 2018.
Meanwhile, the number of active cannabis licences has also continued to grow, albeit marginally. Between September 2022 to October 2024, licences grew from 1544 to 1584.
Despite the slight growth in operational businesses, revenues have continued to falter, dropping from $5.39bn to $5.18bn in the same period.
This is largely due to continued price compression in the market with wholesale prices dropping 57% from their peak in 2020, with outdoor-grown cannabis experiencing the steepest decline at 74%.
Elsewhere, local taxes and fees remain high, and efforts to ease this pressure have had mixed results for businesses. The suspension of California’s cultivation tax in 2022 provided some relief, but businesses are now bracing for a scheduled excise tax increase in 2025, which could further impact margins.
Additionally, law enforcement is reported to have eradicated an estimated 7.5% to 18.3% of illicit cannabis production last year, showing some progress in cracking down on illegal cultivation, though the scale of unlicensed operations remains substantial and far in excess of the legal market.
These <a href="https://www.gov.ca.gov/2025/03/04/california-seizes-534-million-in-illegal-cannabis-in-2024/">increased enforcement efforts</a> are expected to help stabalize the market this year. Emerging categories such as cannabis-based animal products and intoxicating hemp cannabinoids are expected to provide new revenue opportunities for legal businesses.
The post <a href="https://businessofcannabis.com/californias-legal-cannabis-market-achieves-marginal-growth-in-the-face-of-a-dominant-illicit-market/">California’s Legal Cannabis Market Achieves Marginal Growth in the Face of a Dominant Illicit Market</a> appeared first on <a href="https://businessofcannabis.com/">Business of Cannabis</a>.

California’s legal cannabis industry is still failing to match the state’s thriving illicit market amid increasing regulatory and competition pressures, according to a new report. A new study, commissioned by […]
The post <a href="https://businessofcannabis.com/californias-legal-cannabis-market-achieves-marginal-growth-in-the-face-of-a-dominant-illicit-market/">California’s Legal Cannabis Market Achieves Marginal Growth in the Face of a Dominant Illicit Market</a> appeared first on <a href="https://businessofcannabis.com/">Business of Cannabis</a>.

California’s Legal Cannabis Market Achieves Marginal Growth in the Face of a Dominant Illicit Market

Not unlike chia seeds and ancient grains, matcha is popping up on menus around the country right now. It most frequently appears in baked goods, smoothies, chocolate or as a stand-alone tea, and its lovely pale green color and herbal flavor makes for an intriguing ingredient. Combine matcha with cannabis and you have a showstopper.



Matcha is finely ground green tea powder that is — and has been for centuries — the basis for the Japanese tradition of the tea ceremony. Because the entire tea leaf is ground into a fine powder, the whole plant becomes consumable when added to hot water to make a tea. One can’t help but draw a comparison between this green tea plant and cannabis. Matcha is, in essence, a full-spectrum drink.



Much like cannabis, matcha is also regarded as having important nutritional properties, including lowering cholesterol and regulating blood sugar levels. Matcha is rich in chlorophyll and is a natural detoxifying agent that helps to cleanse the body by removing toxins. Matcha powder also contains considerably more caffeine than standard green tea. However, the amino acid L-theanine, which matcha produces when it is grown in the shade, counteracts the negative results of ingesting too much caffeine like jitters or caffeine crashes.



When it comes to flavor, matcha is strong and earthy with a hint of sweetness, enhanced when <a href="https://cannabisnow.com/recipe-healing-herbal-heat-thats-buzzing-honey/">honey</a> or agave is added to it. Matcha works well as an ingredient in all kinds of recipes, adding a layer of complexity to the flavor, a gorgeous bright green color and many health advantages. Given that cannabis has many of the same flexible qualities, it’s a natural pairing with matcha. Learn to love matcha and it will love you back.



<h4 class="wp-block-heading">Ingredients</h4>



<ul class="wp-block-list">
<li>1 tablespoon matcha powder</li>



<li>½ cup boiling water</li>



<li>1 ½ cups whole milk, or any dairy substitute, heated</li>



<li>2 – 3 teaspoons honey or agave</li>



<li>2 teaspoons (or less) <a href="https://cannabisnow.com/edibles-how-to-make-canna-butter-and-canna-oil/">canna-butter or canna-coconut oil</a>, melted</li>
</ul>
<h4 class="wp-block-heading">Directions</h4>



1.     Place the matcha powder in a heatproof measuring cup or bowl. In a tea kettle or pot, heat the water. Let it come to a boil and then let it sit off the heat for two minutes. Pour the water over the matcha powder and stir, preferably with a bamboo matcha whisk.



2.     Heat up the milk in a small pot and stir to make sure it doesn’t burn or boil.



3.     In order to get the best-tasting, foamiest latte and emulsify your cannabis butter or oil into the latte, a quick spin in the blender is the way to go. Place the matcha and water mixture in the blender and add the rest of the ingredients.



4.     Process in the blender for a minute and then pour into two mugs.



<h4 class="wp-block-heading">Dosage</h4>



Make sure you know the potency of your canna-oil or canna-butter so that you give yourself an amount of <a href="https://cannabisnow.com/what-is-thc/">THC</a> you can tolerate. With edibles, it’s best to go low and slow. If you need to add less than the 2 teaspoons of canna-oil the recipe above calls for, that’s OK.
The post <a href="https://cannabisnow.com/edibles-recipe-marijuana-infused-matcha-latte/">Edibles Recipe: A Marvelous Marijuana-Infused Matcha Latte</a> appeared first on <a href="https://cannabisnow.com/">Cannabis Now</a>.

Take full-spectrum infusion to a whole other level with this cannabis and matcha treat.
The post <a href="https://cannabisnow.com/edibles-recipe-marijuana-infused-matcha-latte/">Edibles Recipe: A Marvelous Marijuana-Infused Matcha Latte</a> appeared first on <a href="https://cannabisnow.com/">Cannabis Now</a>.

Edibles Recipe: A Marvelous Marijuana-Infused Matcha Latte

The UK boasts one of the fastest-growing medical cannabis markets on the planet, and according to Prohibition Partners’ <a href="https://prohibitionpartners.com/reports/the-global-cannabis-report-5th-edition/">Global Cannabis Report: 5th Edition</a>, around  60,000 patients were treated with medical cannabis in the UK throughout 2024.
However, unlike markets such as Germany, where growth has been driven by a major regulatory change, the UK’s growth is driven almost entirely by its operators and their continued commitment to innovation.
One such company,<a href="https://curaleaflaboratories.co.uk/"> Curaleaf Laboratories</a>, has invested significantly in the UK and its state-of-the-art facility in Sunderland, now the country’s largest medical cannabis processing site, employing around 200 staff.
Business of Cannabis was given the opportunity to explore this facility, taking a rare look behind the curtain at the technology, process and ethos of <a href="https://curaleaflaboratories.co.uk/">Curaleaf Laboratories</a>.
<h4>‘Patient Obsession’ </h4>
Its facility, situated near the banks of the River Wear, initially focused on creating bespoke, alternative medicines as a ‘specials’ manufacturer.
Their MHRA-approved and NHS-accredited facility manufactured and supplied a full range of unlicensed medicines across the UK, to over 3,000 NHS and private healthcare providers.
Having been a premium supplier of specials for over a decade, its founding partners, brothers Jonathan and Richard Hodgson, adapted to market changes and began focusing on the medical cannabis industry. The company was acquired by Curaleaf in 2019, before becoming the first manufacturer of full-spectrum medical cannabis in the UK.
Now Curaleaf International’s UK managing director, reflecting on the journey so far, from their humble North East beginnings to having an international, vertically integrated supply chain delivering cannabis-based medicinal products (CBPMs), Jonathan Hodgson said: “Since joining the Curaleaf International group, our journey on becoming the leader in the UK medical cannabis industry has been nothing short of incredible.
<img data-dominant-color="abadb4" data-has-transparency="false" decoding="async" class="size-full wp-image-43284 aligncenter not-transparent" src="https://businessofcannabis.com/wp-content/uploads/2025/03/Curaleaf-1.webp" alt="" width="512" height="341" srcset="https://businessofcannabis.com/wp-content/uploads/2025/03/Curaleaf-1.webp 512w, https://businessofcannabis.com/wp-content/uploads/2025/03/Curaleaf-1-300x200.webp 300w" sizes="(max-width: 512px) 100vw, 512px">
“Our UK operations, as well as our vertical supply chain and NPD function have allowed Curaleaf to widen access in the UK for both healthcare professionals and patients alike. The introduction of innovative dosage formats, brands and 3rd party distribution partnerships has continued to elevate Curaleaf into a leadership position in the UK that focuses on accelerating access.”
It’s clear that Hodgson has succeeded in instilling his passion among his ever-expanding workforce.
As we toured the various manufacturing, processing, packing and distribution areas, we were greeted with a smile by every staff member, all of whom spoke enthusiastically about their role and had a clear understanding of the company’s vision and mission.
“It’s fulfilling to come to work every day knowing that you’re helping to get this medicine to the people who really need it. It’s nice to think what we do here is having a positive impact on their quality of life,” one staff member told us as they oversaw the packing of dried medical cannabis flower into 10-gram pouches.
<img data-dominant-color="503c4b" data-has-transparency="true" loading="lazy" decoding="async" class="aligncenter wp-image-43297 size-large has-transparency" src="https://businessofcannabis.com/wp-content/uploads/2025/03/Curaleaf_Labs_stacked_colour-1-1024x541.webp" alt="" width="1024" height="541" srcset="https://businessofcannabis.com/wp-content/uploads/2025/03/Curaleaf_Labs_stacked_colour-1-1024x541.webp 1024w, https://businessofcannabis.com/wp-content/uploads/2025/03/Curaleaf_Labs_stacked_colour-1-300x159.webp 300w, https://businessofcannabis.com/wp-content/uploads/2025/03/Curaleaf_Labs_stacked_colour-1-768x406.webp 768w, https://businessofcannabis.com/wp-content/uploads/2025/03/Curaleaf_Labs_stacked_colour-1-600x317.webp 600w, https://businessofcannabis.com/wp-content/uploads/2025/03/Curaleaf_Labs_stacked_colour-1-750x396.webp 750w, https://businessofcannabis.com/wp-content/uploads/2025/03/Curaleaf_Labs_stacked_colour-1-1140x603.webp 1140w, https://businessofcannabis.com/wp-content/uploads/2025/03/Curaleaf_Labs_stacked_colour-1-png.webp 1523w" sizes="(max-width: 1024px) 100vw, 1024px">
This mission, we’re told, is primarily to widen patient access in the UK and Europe, not just by providing a diverse range of products that can potentially help patients but also an effective roster enabling prescribing doctors to make the best clinical decisions possible.
As such, while on-site in Sunderland, Curaleaf’s R&amp;D/NPD teams were testing out new formulations and flavours of its market-leading pastilles.
The abundance of test trays of pastilles pointed to a relentless pursuit of excellence, with only the very best making it through development, in what the company described as a ‘patient obsession.’
<h4>Investing in Innovation</h4>
<a href="https://curaleafpharmacy.co.uk/">Curaleaf Pharmacy</a>, also based at the Sunderland site, dispenses more medical cannabis prescriptions than any other pharmacy in the UK, and now serves multiple third-party clinics.
This pursuit of excellence is bolstered by a continued focus on and investment in technology and innovation, embodied by a 4m tall and 11m long automated prescription dispensing system. Effectively a giant robot purpose-built to ensure patients receive their prescriptions as quickly as possible.
Adam Foster, superintendent pharmacist &amp; head of pharmacy operations for <a href="https://curaleafpharmacy.co.uk/">Curaleaf Pharmacy</a>, tells us his team are now dispensing 1000 or more prescriptions every single day for patients across the UK: a number that is set to increase significantly when its automated dispensing machine is fully operational.
<img data-dominant-color="9fa2a7" data-has-transparency="false" loading="lazy" decoding="async" class="size-full wp-image-43288 aligncenter not-transparent" src="https://businessofcannabis.com/wp-content/uploads/2025/03/Curaleaf-3.webp" alt="" width="512" height="341" srcset="https://businessofcannabis.com/wp-content/uploads/2025/03/Curaleaf-3.webp 512w, https://businessofcannabis.com/wp-content/uploads/2025/03/Curaleaf-3-300x200.webp 300w" sizes="(max-width: 512px) 100vw, 512px">
He told Business of Cannabis: “At the heart of all of our operational and technological advancements , we have a patient-centric team that pride themselves on delivering a best-in-class dispensing service.
“The increase in our operational capacity enables us to manage more patients and more prescriptions on a daily basis. As well as this, our diverse product formulary has also resulted in more 3rd party private clinics sending their patients to <a href="https://curaleafpharmacy.co.uk/">Curaleaf Pharmacy</a>, which we are extremely keen to continue improving upon.”
As well as providing its own range of medical cannabis products, <a href="https://curaleaflaboratories.co.uk/">Curaleaf Laboratories</a> works with a number of businesses that share the same vision and benefit from the company’s ability to import bulk raw material and deliver a best-in-class manufacturing and distribution model.
The company’s product portfolio goes beyond traditional offerings, introducing advanced delivery systems with a view to opening the door for as many new patient demographics as possible.
As <a href="https://curaleaflaboratories.co.uk/">Curaleaf Laboratories</a> looks to the future, it plans to continue expanding its technological capabilities, rolling out new products, and further refining its operations, with a driving focus on contributing to accelerated growth of the wider industry and improving patient access.
 
The post <a href="https://businessofcannabis.com/inside-the-uks-largest-medical-cannabis-facility-how-curaleaf-is-transforming-patient-access/">Inside the UK’s Largest Medical Cannabis Facility: How Curaleaf Laboratories is Transforming Patient Access</a> appeared first on <a href="https://businessofcannabis.com/">Business of Cannabis</a>.

Curaleaf Laboratories, has invested significantly in the UK and its state-of-the-art facility in Sunderland, now the country’s largest medical cannabis processing site, employing around 200 staff. 
The post <a href="https://businessofcannabis.com/inside-the-uks-largest-medical-cannabis-facility-how-curaleaf-is-transforming-patient-access/">Inside the UK’s Largest Medical Cannabis Facility: How Curaleaf Laboratories is Transforming Patient Access</a> appeared first on <a href="https://businessofcannabis.com/">Business of Cannabis</a>.

Inside the UK’s Largest Medical Cannabis Facility: How Curaleaf Laboratories is Transforming Patient Access

<a href="https://azmarijuana.com/eblast/030525"><img decoding="async" src="https://azmarijuana.com/wp-content/uploads/2025/03/22Red-AZmarijuana-Stah-n-Cash-3-3.jpg" alt="22red" width="555" class="aligncenter size-full wp-image-1145812" srcset="https://azmarijuana.com/wp-content/uploads/2025/03/22Red-AZmarijuana-Stah-n-Cash-3-3.jpg 600w, https://azmarijuana.com/wp-content/uploads/2025/03/22Red-AZmarijuana-Stah-n-Cash-3-3-249x600.jpg 249w, https://azmarijuana.com/wp-content/uploads/2025/03/22Red-AZmarijuana-Stah-n-Cash-3-3-62x150.jpg 62w" sizes="(max-width: 600px) 100vw, 600px"></a>
The post <a href="https://azmarijuana.com/images/win-500-cash-1-4-pound-from-22red/">Win $500 cash + 1/4 pound from 22Red</a> appeared first on <a href="https://azmarijuana.com/">AZ Marijuana</a>.

The post <a href="https://azmarijuana.com/images/win-500-cash-1-4-pound-from-22red/">Win $500 cash + 1/4 pound from 22Red</a> appeared first on <a href="https://azmarijuana.com/">AZ Marijuana</a>.

Win $500 cash + 1/4 pound from 22Red

Nextleaf Solutions reported gross revenue of $3.85 million in its most recent quarter report for the three months ended December 31, 2025 (Q1 2025), net...
The post <a href="https://stratcann.com/financials/strong-branded-revenue-delivers-nextleafs-first-profitable-quarter-in-a-year/">Strong branded revenue delivers Nextleaf’s first profitable quarter in a year</a> appeared first on <a href="https://stratcann.com/">StratCann</a>.

Strong branded revenue delivers Nextleaf’s first profitable quarter in a year

New York’s fledgling legal cannabis market is set to undergo significant changes which could not only enable the sale of intoxicating hemp products in dispensaries but also open the door for out-of-state operators.
On Monday, March 03, a new bill was introduced in the New York Senate which would repeal emergency regulations restricting the sale of intoxicating hemp products, set to be enforced this July.
As the march of intoxicating hemp continues across the country with little to no regulation under federal law, individual states are continuing to issue their legislation to deal with this new and poorly researched set of substances.
New York’s Office for Cannabis Management (OCM) had pushed through emergency regulations to stem the tide of these products, which include THC variants like Delta 10 and Delta 8, which was scheduled to come into force on July 27, 2025.
Now, S05809 has been submitted to the New York State Senate, aiming to repeal this crackdown, focusing specifically on Delta 9 THC, the primary psychoactive compound in cannabis, potentially allowing for the sale of other THC variants in licenced dispensaries.
Furthermore, beginning January 1, 2026, licensed cannabis retailers would legally be permitted to sell cannabinoid hemp products, provided they meet safety standards set by the OCM.
Meanwhile, <a href="https://www.businessexpress.ny.gov/app/answers/cms/a_id/3833">the OCM has this week introduced a new type of cannabis business licence, the Adult-Use Processor Type 3 Branding License</a>, offering a new avenue for cannabis brands to enter New York’s legal market without operating a physical processing facility or engaging in direct plant-touching activities.
While New York’s cannabis programme was designed to promote local businesses and prevent giant multi-state operators from bulldozing their way into the market, this could effectively remove these guardrails.
The Type 3 Branding License enables a cannabis brand to market its products in New York through white-label agreements with state-licensed processors.
Under this arrangement, a licensed processor handles all cannabis-related activities—including extraction, blending, infusion, packaging, and labelling—while the brand licensee contributes intellectual property (such as logos and product specifications) and non-cannabis materials (like rolling papers, flavouring agents, or vaporizers). The processor must follow specific brand quality standards set by the licensee, ensuring product consistency.
Importantly, this license allows brands to enter the New York market without being classified as a ‘True Party of Interest’ in a processing facility, making it easier for companies to expand without direct financial or operational entanglements with New York-based processors.
However, the New York Office of Cannabis Management (OCM) still requires full disclosure of ownership, management, and financial details to ensure compliance with regulations on ownership limits, control, and undue influence.
The post <a href="https://businessofcannabis.com/new-york-opens-doors-to-out-of-state-cannabis-brands-as-bill-to-legalize-intoxicating-hemp-advances/">New York Opens Doors to Out-of-State Cannabis Brands as Bill to Legalize Intoxicating Hemp Advances</a> appeared first on <a href="https://businessofcannabis.com/">Business of Cannabis</a>.

New York’s fledgling legal cannabis market is set to undergo significant changes which could not only enable the sale of intoxicating hemp products in dispensaries but also open the door […]
The post <a href="https://businessofcannabis.com/new-york-opens-doors-to-out-of-state-cannabis-brands-as-bill-to-legalize-intoxicating-hemp-advances/">New York Opens Doors to Out-of-State Cannabis Brands as Bill to Legalize Intoxicating Hemp Advances</a> appeared first on <a href="https://businessofcannabis.com/">Business of Cannabis</a>.

New York Opens Doors to Out-of-State Cannabis Brands as Bill to Legalize Intoxicating Hemp Advances

It’s a wild, busy world out there. We are loving the convenience that comes with cannabis legalization – but navigating the immense selection of products found on shelves can be overwhelming. If you’re heading to the dispensary, going somewhere with quality-stocked goods backed with a smile is the dream. And this is just why <a href="https://www.lume.com/" target="_blank" rel="noreferrer noopener">Lume Cannabis Co.</a> is standing out in the Michigan marketplace.  



Offering a wide array of premium products across 38 dispensaries conveniently located throughout the state, Lume’s extensive line of edibles, carts, pre-rolls and flower has every type of consumer covered. Whether you’re a first timer or a forever faithful, Lume’s recipe of pairing premium products with the proven power of friendly budtenders has the Great Lakes State rightly buzzing.



<h4 class="wp-block-heading">Origins In Quality</h4>



Founded in 2017, Lume is a vertically integrated company which first established itself as a pioneer in cultivation, redefining the grow process through the pillars of quality, innovation and accessibility. Recognized today as one of the largest cannabis operators in Michigan, the heart of Lume’s grow efforts can be found in the form of two large-scale indoor cultivation centers: a 250,000 square-foot facility in Evart, and another 56,000 square-foot facility in Dimondale. Combined with an outdoor farm operated in Northern Michigan, Lume is presently overseeing more than 7 million square feet of cannabis.



Grown with state-of-the-art techniques, Lume cannabis flower is cultivated from start to finish with consumers’ enjoyment in mind. After perfecting the process of forging the flower that ultimately fuels their beloved products, Lume expanded rapidly, becoming one of Michigan’s largest cannabis brands while also opening numerous dispensaries across the state.



<h4 class="wp-block-heading">Shop With Satisfaction</h4>



Whether you live in Cedar Springs, Big Rapids or Cadillac, you’ll find there’s a Lume nearby, ready to light your way to a sublime cannabis experience.



“When you think of Lume, think bright, modern stores packed with the best products and a team that actually knows their stuff,” says Jeff Verlinden, Lume’s director of retail. “Whether you want to browse, get expert recs, or be in and out in minutes, we make it easy. And with 38 locations across Michigan, there’s probably a Lume right where you need one.”



Once you’ve found your nearest location, the fun part begins. Whether you’re looking to restock your dab bar with mouth-watering live resin concentrates, swing by for smooth burning pre-rolls ahead of a big day out, or treat your aching joints to a THC-infused tincture, there’s something for all to be found on the shelves at Lume. For those seeking more potent products, their menus also include a curated selection of high-THC strains.



At the heart of every Lume product is quality cannabis, which is why they needed to harvest a staggering 150,000 pounds of flower in 2024 alone. Infusing a passion for innovation, sustainability and education into an array of products which consumers now know and love, Lume has also proven its dedication when it comes to innovating the next generation of delights to come.



<h4 class="wp-block-heading">New THC Seltzer Buzzes In</h4>



Most recently, Lume’s continued desire to find the best of what’s next has taken the form of a new social tonic called <a href="https://www.lume.com/buzzn-seltzer">BUZZN</a>, which blends THC seltzer and sparkling botanicals into cans that are big on flavor but 100% hangover-free.



Enjoy flavorful sips full of bubbles and real fruit juice, plus the full benefits of 7.5mg of premium Michigan cannabis included in every can. Swapping BS for a buzz built on nature’s best, BUZZN offers the smooth lift and exceptional taste you deserve when reaching for a THC seltzer.



<figure class="wp-block-image size-full"><a href="https://cannabisnow.com/wp-content/uploads/2025/03/BUZZN-BODY-A71.webp"><img loading="lazy" decoding="async" width="1000" height="600" src="https://cannabisnow.com/wp-content/uploads/2025/03/BUZZN-BODY-A71.webp" alt="" class="wp-image-70451" srcset="https://cannabisnow.com/wp-content/uploads/2025/03/BUZZN-BODY-A71.webp 1000w, https://cannabisnow.com/wp-content/uploads/2025/03/BUZZN-BODY-A71-300x180.webp 300w, https://cannabisnow.com/wp-content/uploads/2025/03/BUZZN-BODY-A71-768x461.webp 768w, https://cannabisnow.com/wp-content/uploads/2025/03/BUZZN-BODY-A71-400x240.webp 400w" sizes="auto, (max-width: 1000px) 100vw, 1000px"></a></figure>“Not only is BUZZN THC Seltzer crafted with 7.5mg real THC, it’s made with real fruit juice, natural flavors and no artificial sweeteners,” says Jimmy Sezwick, VP of Product. “It takes clean ingredients to thoughtfully raise the bar in cannabis consumption, and BUZZN doesn’t have any ingredients you can’t pronounce. It’s big on flavor but low on calories and 100% hangover-free.” 



BUZZN is the latest example of Lume’s commitment to thoughtfully raising the bar when it comes to creating quality, Michigan-made cannabis products. And best of all, you can now grab the full line of BUZZN flavors—including Watermelon, Cherry and Strawberry—at a tantalizingly affordable price. Try a trio of cans for only $9, swoop a six-pack for $16, or commit to the cause with an 18-pack for just $45.



<h4 class="wp-block-heading">Moving Michigan Forward</h4>



The arrival of adult-use cannabis in Michigan in 2019 not only gave those of legal age access to the wonderful properties of weed—it also brought new professional opportunities to the state.



With over 1,000 employees currently on their payroll, Lume Cannabis Co. is proud to be one of the leading cannabis industry employers in Michigan, where they continue to focus on building talent within and providing upwards career trajectories for everyone within the company. By providing a safe and secure environment reinforced by a culture focused on customer needs, Lume’s employees can develop an unparalleled excellence in cannabis knowledge. That expertise is then passed on to every customer who enters their stores.



Committed to providing high-quality products—and safe, affordable, welcoming access to every flavor of customer—Lume’s commitment to being a leader in Michigan’s legal cannabis scene is only growing brighter.
The post <a href="https://cannabisnow.com/lume-dispensaries-illuminate-best-of-legal-cannabis-in-michigan/">Lume Dispensaries Illuminate Best of Legal Cannabis in Michigan</a> appeared first on <a href="https://cannabisnow.com/">Cannabis Now</a>.

With 38 locations operating across the state, Lume Cannabis Co. boasts high marks thanks to its consistently friendly service and deep menus packed with local, quality products.
The post <a href="https://cannabisnow.com/lume-dispensaries-illuminate-best-of-legal-cannabis-in-michigan/">Lume Dispensaries Illuminate Best of Legal Cannabis in Michigan</a> appeared first on <a href="https://cannabisnow.com/">Cannabis Now</a>.

Lume Dispensaries Illuminate Best of Legal Cannabis in Michigan

The UK’s long and troubled CBD novel foods approval process seems to be gaining some momentum, as numerous major companies have announced their progression to the final risk assessment stage.
Since the start of the year, five new applications have passed the Food Standards Agency’s (FSA) safety assessment phase, nearly twice the amount approved in the entirety of 2024.
As some companies move forward in the process, others have been removed from it altogether, with the FSA removing 102 products from the public list.
While the FSA has stated that the companies affected have been notified, it is understood that the reasons behind their removal remain opaque.
<h4>What happened </h4>
Five new safety assessments for CBD novel food applications have been published by the FSA and FSS (Food Standard Scotland) since the start of 2025.
These follow <a href="https://businessofcannabis.com/progress-for-uk-cbd-industry-fsa-issues-first-positive-safety-assessments-in-novel-food-process/">three approvals in 2024,</a> seeing Chanelle McCoy’s subsidiary, Pureis, and Cannaray become the first two dossiers to received safety approval in April.
Months later, the first consortium application was approved, with the European Industrial Hemp Association’s RP
Cannaray similarly received the first ever positive risk assessment for its isolated CBD application, meaning both can now move on to the next stage of authorisation, risk management.
In January, 2025, UK-based cannabinoid Active Pharmaceutical Ingredients (API) manufacturer, Brains Bioceutical, confirmed that it had received safety approval from the FSA for its CBD isolate.
On the same day, Mile High Labs, one of the largest importers of cannabinoid ingredients and finished products to the UK, also received a positive safety assessment for its dossier.
A month later, and a further three companies safety assessments were also published and approved by the FSA, US retailer cbdMD, UK supplier TTS Pharma, and the UK’s Bridge Farm Group.
<ul>
<li aria-level="1">April 30, 2024</li>
</ul>
<ul>
<li>
<ul>
<li>
<ul>
<li aria-level="2">Chanelle McCoy / Pureis</li>
<li aria-level="2"><a href="https://science.food.gov.uk/article/126748">RP07</a></li>
</ul>
</li>
</ul>
</li>
</ul>
<ul>
<li aria-level="1">April 30, 2024</li>
</ul>
<ul>
<li>
<ul>
<li>
<ul>
<li aria-level="2">Cannaray</li>
<li aria-level="2"><a href="https://science.food.gov.uk/article/126747">RP350</a></li>
</ul>
</li>
</ul>
</li>
</ul>
<ul>
<li aria-level="1">August 15, 2024</li>
</ul>
<ul>
<li>
<ul>
<li>
<ul>
<li aria-level="2">EIHA Consortium</li>
<li aria-level="2"><a href="https://science.food.gov.uk/article/121803">RP427</a></li>
</ul>
</li>
</ul>
</li>
</ul>
<ul>
<li aria-level="1">Janaury 31, 2025</li>
</ul>
<ul>
<li>
<ul>
<li>
<ul>
<li aria-level="2">Mile High Labs</li>
<li aria-level="2"><a href="https://science.food.gov.uk/article/128215">RP349 </a></li>
</ul>
</li>
</ul>
</li>
</ul>
<ul>
<li aria-level="1">January 31, 2025</li>
</ul>
<ul>
<li>
<ul>
<li>
<ul>
<li aria-level="2">Brains Bioceutical</li>
<li aria-level="2"><a href="https://science.food.gov.uk/article/128192">RP11</a></li>
</ul>
</li>
</ul>
</li>
</ul>
<ul>
<li aria-level="1">February 28, 2025</li>
</ul>
<ul>
<li>
<ul>
<li>
<ul>
<li aria-level="2">CBD MD</li>
<li aria-level="2"><a href="https://science.food.gov.uk/article/129715">RP793</a></li>
</ul>
</li>
</ul>
</li>
</ul>
<ul>
<li aria-level="1">February 28, 2025</li>
</ul>
<ul>
<li>
<ul>
<li>
<ul>
<li aria-level="2">TTS Pharma (Jevalex, HERBL)</li>
<li aria-level="2"><a href="https://science.food.gov.uk/article/129216">RP521</a></li>
</ul>
</li>
</ul>
</li>
</ul>
<ul>
<li aria-level="1">February 28, 2025</li>
</ul>
<ul>
<li>
<ul>
<li>
<ul>
<li aria-level="2">Bridge Farm Group</li>
<li aria-level="2"><a href="https://science.food.gov.uk/article/129890">RP354</a></li>
</ul>
</li>
</ul>
</li>
</ul>
Notably, all of the newly approved applications adhere to the controversial acceptable daily intake (ADI) of 10mg, despite a number of applications initially proposing and even calling for a higher ADI.
Three applications (RP11, RP349, RP793) initially requested a higher ADI (35 mg/day, 35 mg/day, and 24 mg/day, respectively), but cbdMD was the only case where an ADI of 24 mg/day was formally rejected.
Since the shock change of ADI from 70mg to 10mg in October 2023, the industry has criticised the cap for being far too restrictive, arguing that the threshold is to low for any benefits of CBD to be felt.
Given that all the applications to pass the safety assessment so far have adhered to this ADI, it appears that the FSA is enforcing this as a hard limit.
<a href="https://www.cannabistrades.org/stories/risk-for-risks-sake">The Cannabis Trades Association (CTA)</a> has criticised the FSA for their rigid enforcement of this ADI, arguing that the limit is being misapplied as a legal cap rather than advisory guidance.
Furthermore, they argue that regulators are applying a blanket ADI to all CBD products, despite toxicology data showing clear differences between isolates, distillates, and full-spectrum extracts.
<h4>Public list updates</h4>
Meanwhile, the ‘public list’ of CBD products which are allowed to remain on the market before receiving full validation from the FSA has seen a major cull.
A total of 102 products were removed from the list, meaning they are no longer in the process for approval and should be removed from sale.
While some products were removed voluntarily, others are understood to have been removed without a full explanation from the FSA.
A full breakdown of the updates to the public list, <a href="https://content.govdelivery.com/accounts/UKFSAG/bulletins/3d11c85">according to an update from the FSA,</a> is below.
<ul>
<li aria-level="1">Excite for life: 20 product names changed from ‘4’ to ‘for’</li>
<li aria-level="1">Charlotte’s Web; Dushey Med: 4 products removed</li>
<li aria-level="1">Charlotte’s Web; Savage Cabbage (RP230, RP231): 54 products removed</li>
<li aria-level="1">CROP England: 26 products changed from RP427 to RP438</li>
<li aria-level="1">Infinity CBD:  All 35 chocolate products altered name</li>
<li aria-level="1">Naturecan: 1 product reinstated</li>
<li aria-level="1">Pure Life Naturals: 6 products removed</li>
<li aria-level="1">RP70: 16 products removed</li>
<li aria-level="1">RP85: 9 products removed</li>
<li aria-level="1">RP126/127/91: 7 products reinstated</li>
<li aria-level="1">RP242: 13 products removed</li>
<li aria-level="1">RP225 and RP238: Incorrectly joint RP number with RP427 – removed from 11 product listings</li>
<li aria-level="1">RP346: 134 products’ status change to validated</li>
</ul>
 
The post <a href="https://businessofcannabis.com/five-more-companies-have-passed-novel-foods-cbd-safety-assessment-since-start-of-the-year/">Five More Companies Have Passed Novel Foods CBD Safety Assessment Since Start of the Year</a> appeared first on <a href="https://businessofcannabis.com/">Business of Cannabis</a>.

The UK’s long and troubled CBD novel foods approval process seems to be gaining some momentum, as numerous major companies have announced their progression to the final risk assessment stage. 
The post <a href="https://businessofcannabis.com/five-more-companies-have-passed-novel-foods-cbd-safety-assessment-since-start-of-the-year/">Five More Companies Have Passed Novel Foods CBD Safety Assessment Since Start of the Year</a> appeared first on <a href="https://businessofcannabis.com/">Business of Cannabis</a>.

Five More Companies Have Passed Novel Foods CBD Safety Assessment Since Start of the Year

Super-strength cannabis edibles have a small but passionate legion of defenders. In certain cases, for instance, there is a wholly valid medical justification for a 1000-milligram brownie — but the truth is, marijuana-laced goodies are not for everyone and low-dose edibles seem to reign for those who partake.



And this is particularly true at high doses.



Whenever “extreme adverse effects” result from cannabis, it seems an edible (or a plateful of them) is involved. This is why most states with legalized adult-use cannabis have passed laws limiting the amount of <a href="https://cannabisnow.com/what-is-thc/">THC</a> in edibles, and why these limits haven’t been overturned.



It turns out preferring a mild buzz to a days-long, edible-triggered, near-psychedelic odyssey may be wired into our brains. Because as researchers at Indiana University and Purdue University recently found, this preference appears to be absolutely wired into the brains of mice.



In a study, results of which were <a href="https://www.ncbi.nlm.nih.gov/pubmed/31029878" target="_blank" rel="noreferrer noopener" aria-label=" (opens in a new tab)">published</a> in the journal Drug and Alcohol Dependence, researchers at the Department of Psychology and Indiana Alcohol Research Center, Indiana University – Purdue University in Indianapolis fed a cohort of mice dough infused with THC, in variable amounts. 



<h4 class="wp-block-heading">Know Thy Limits</h4>



Doses in the dough ranged from 1 milligram of THC per kilogram of bodyweight to up to 10 milligrams of THC per kilogram. The mice also had access to “normal” food and water, which suggests they were not attacking the dough out of hunger. (For comparison’s sake: a 180-pound man would be eating an edible with roughly 800 milligrams of THC were he to match the mightiest mouse dough.)



The mice ate the dough — as lab mice are wont to do — but the more powerful the dough, the less the mice ate, researchers found. When the dough was at 5 mg/kg or 10 mg/kg, some of the mice ate “significantly less” than 100%, suggesting there was something in that dough that disagreed with the mice.



“The simple fact that mice self-administered THC dough could be seen as evidence that it is rewarding,” the researchers wrote. “However, inspection of consumption patterns indicates that THC might have been aversive at higher dose.”



But not every mouse shied away from the highest-strength dough. Some mice ate it all, no matter how strong. After eating the dough, effects included less movement and a decrease in body temperature — you know, typical stoned mice things. Interestingly, the impact was most pronounced in the male mice, the researchers found.



The study “demonstrated what appears to be THC-induced conditioned taste aversion,” the researchers wrote, adding that the mice did not appear to be stressed and were otherwise perfectly fine, if very blazed.



The study is notable for a few reasons. There is limited scientific data on self-administration of THC, even among animals. And since there are still legal and “ethical” barriers to performing such experiments on humans, as the researchers noted, mice — who, like rats, provide <a rel="noreferrer noopener" aria-label=" (opens in a new tab)" href="https://www.sciencedaily.com/releases/2014/11/141119132707.htm" target="_blank">something of a yardstick</a> for understanding biology and functions like the immune system in humans — are the next-best option. And this study is one of few where an animal subject had access to self-administered THC at all, meaning it’s one of the few where desire for THC could be gauged. 



It’s neither accurate nor fair to say that edibles are a liability. But among the problems that have arisen during the cannabis legalization era, powerful edibles — and eating too much of them — has absolutely been one of the marijuana movement’s biggest challenges.



The good news is that edibles are relatively easy to manage, because this is what labeling is for. And if you are a human who prefers a <a href="https://cannabisnow.com/tag/microdosing/">microdose</a> to a heroic macro-brownie, just know that you are not alone in the animal kingdom.




The post <a href="https://cannabisnow.com/study-everyone-prefers-low-dose-cannabis-edibles-even-mice/">Study: Everyone Prefers Low-Dose Cannabis Edibles — Even Mice</a> appeared first on <a href="https://cannabisnow.com/">Cannabis Now</a>.

Researchers conducting a study on THC and desire found that mice shied away from the maximum-strength edibles.
The post <a href="https://cannabisnow.com/study-everyone-prefers-low-dose-cannabis-edibles-even-mice/">Study: Everyone Prefers Low-Dose Cannabis Edibles — Even Mice</a> appeared first on <a href="https://cannabisnow.com/">Cannabis Now</a>.

Study: Everyone Prefers Low-Dose Cannabis Edibles — Even Mice

Authorities in the US capitol have closed over two dozen unlicensed cannabis retails over the last six months to crack down on the grey market.
It came as the state, which officially legalized adult-use cannabis in 2017, failed to advance a bill that would legalize home cannabis cultivation for the ninth consecutive year.
Washington DC’s unique status as a ‘federal district’, meaning it is directly governed by the federal government rather than having its own independent legislature, continues to cause havoc for the state’s legitimate cannabis operators and cannabis consumers alike.
Despite being one of the first states to legalize adult-use cannabis, because it remains federally illegal Congress has largely blocked the implementation of its cannabis programme.
This has driven a booming grey market in which businesses exploit a provision allowing the gifting of up to two ounces to a friend without payment.
<a href="https://businessofcannabis.com/as-crime-surges-d-c-legal-cannabis-operators-struggle-against-unchecked-illegal-market/">Over time, this loophole has been stretched</a>, with entire brick-and-mortar stores now operating under the guise of gifting and legitimate businesses struggling to compete.
As previously reported, legitimate businesses have long been calling for immediate reform, and for enforcement to crack down on these grey market operators, who make it very difficult to compete legally and are often associated with high levels of crime.
Now, it seems that the authorities are starting to take action, with intensified enforcement efforts seeing the closure of 25 unlicensed stores over the last six months.
According to a statement from the office of DC Attorney General Brian Schwalb, who led the operation in partnership with the Metropolitan Police Department (MPD) and the District Alcoholic Beverage and Cannabis Administration (ABCA),  these store have ‘been illegally selling unregulated, untested products that put District residents’ safety at risk’ for too long.
Since July 2024, ABCA and MPD have issued cease-and-desist orders, conducted undercover purchases, and executed search warrants at non-compliant locations.
Authorities have seized large quantities of cannabis, along with weapons, cash, and other illegal drugs. Some shop owners have been arrested, including one individual found with a semi-automatic firearm.
One store, after being forcibly closed, had its owners break back in and change the locks, leading to further legal action. Another establishment’s shutdown resulted in the seizure of:
<ul>
<li aria-level="1">35 pounds of cannabis flower</li>
<li aria-level="1">22 pounds of THC edibles</li>
<li aria-level="1">6 pounds of psilocybin mushrooms and edibles</li>
<li aria-level="1">2 pounds of cocaine</li>
<li aria-level="1">2 pounds of methamphetamine</li>
<li aria-level="1">Over $6,800 in cash</li>
<li aria-level="1">A semi-automatic handgun</li>
<li aria-level="1">Ten dogs kept on the premises</li>
</ul>
Meanwhile, according to <a href="https://www.marijuanamoment.net/washington-lawmakers-once-again-abandon-effort-to-allow-adults-to-grow-marijuana-at-home/">Marijuana Moment</a>, lawmakers have once again failed to pass a bill that would legalize home cannabis cultivation, keeping personal growing a felony.
House Bill 1449, sponsored by Rep. Shelley Kloba, aimed to allow adults to grow up to six plants at home. Despite less opposition from regulators and approval from one committee, the bill was not acted upon before a key deadline, effectively killing it for 2025. 
The post <a href="https://businessofcannabis.com/washington-authorities-close-25-unlicensed-stores-as-home-grow-bill-fails-again/">Washington Authorities Close 25 Unlicensed Stores as Home Grow Bill Fails Again</a> appeared first on <a href="https://businessofcannabis.com/">Business of Cannabis</a>.

Authorities in the US capitol have closed over two dozen unlicensed cannabis retails over the last six months to crack down on the grey market. It came as the state, […]
The post <a href="https://businessofcannabis.com/washington-authorities-close-25-unlicensed-stores-as-home-grow-bill-fails-again/">Washington Authorities Close 25 Unlicensed Stores as Home Grow Bill Fails Again</a> appeared first on <a href="https://businessofcannabis.com/">Business of Cannabis</a>.

Washington Authorities Close 25 Unlicensed Stores as Home Grow Bill Fails Again

As the number of medicinal cannabis patients continues to rise here in Britain and internationally, a new charity, CannCare, has launched to uphold and champion the rights of those facing discrimination for consuming their prescribed medication.
Manchester-based CannCare provides help, support, and information to CBPM (cannabis-based products for medicinal use) patients when they encounter issues with public bodies – such as housing associations, local councils, and law enforcement – and private enterprises, like employers.
“Many people still aren’t aware that medicinal cannabis has been legal here in the UK for six and a half years,” said CannCare CEO and founder, Callum Jones. “As a result, it’s increasingly common for patients to experience discrimination from those who believe that they’re breaking the law.
“We’ve seen this happen firsthand. It can be an incredibly stressful experience for patients. We want to see a future where all CBPM patients in the UK can confidently take their prescription medication without fear of harassment, prosecution, or persecution.”
Already the CannCare team has successfully resolved a landmark case involving a patient from West Sussex who was threatened with eviction from her rental property for consuming medicinal cannabis.
“We won’t shy away from taking affirmative action when a patient we’re working with is being unfairly stigmatised for consuming medicinal cannabis,” said Jones.
<h4>Councillor Andrew Walters Appointed Trustee  </h4>
As well as championing the rights of medicinal cannabis patients in the UK, CannCare aims to broaden public awareness of medicinal cannabis’ availability; outlining its efficacy, legal status, and positive impact.
As part of these efforts, and to bolster the CannCare team, five trustees have been appointed to the board – including Salford councillor and medicinal cannabis advocate, Cllr Andrew Walters.
“We aim to bring patients, healthcare professionals, and the public together to promote awareness and understanding of medicinal cannabis,” said Cllr Walters. “Plant-based medicines, like CBPMs, can make a massive difference to a patient’s overall quality of life. The only thing getting in the way is stigma. This is why education and information will remain key.”
CannCare is also a member of the UK’s Cannabis Industry Council and plans a number of patient outreach initiatives across the UK in coming months.
The charity is also committed to creating a community for UK medicinal cannabis patients; both on and offline; through a digital community platform and in-person events.
<a href="https://canncare.uk/membership/">CBPM patients, carers, and supporters can join CannCare for free</a> or can choose to pay a voluntary donation fee.
The post <a href="https://businessofcannabis.com/prescription-not-prosecution-medicinal-cannabis-charity-canncare-primed-to-fight-for-patients-rights/">Prescription Not Prosecution: Medicinal Cannabis Charity, CannCare, Primed To Fight For Patients’ Rights </a> appeared first on <a href="https://businessofcannabis.com/">Business of Cannabis</a>.

As the number of medicinal cannabis patients continues to rise here in Britain and internationally, a new charity, CannCare, has launched to uphold and champion the rights of those facing discrimination for consuming their prescribed medication.  
The post <a href="https://businessofcannabis.com/prescription-not-prosecution-medicinal-cannabis-charity-canncare-primed-to-fight-for-patients-rights/">Prescription Not Prosecution: Medicinal Cannabis Charity, CannCare, Primed To Fight For Patients’ Rights </a> appeared first on <a href="https://businessofcannabis.com/">Business of Cannabis</a>.

Prescription Not Prosecution: Medicinal Cannabis Charity, CannCare, Primed To Fight For Patients’ Rights 

<img loading="lazy" decoding="async" class="aligncenter size-full wp-image-1145787" src="https://azmarijuana.com/wp-content/uploads/2025/02/Sedona.png" alt="Sedona" width="1068" height="622" srcset="https://azmarijuana.com/wp-content/uploads/2025/02/Sedona.png 1068w, https://azmarijuana.com/wp-content/uploads/2025/02/Sedona-600x349.png 600w, https://azmarijuana.com/wp-content/uploads/2025/02/Sedona-715x416.png 715w, https://azmarijuana.com/wp-content/uploads/2025/02/Sedona-150x87.png 150w, https://azmarijuana.com/wp-content/uploads/2025/02/Sedona-768x447.png 768w, https://azmarijuana.com/wp-content/uploads/2025/02/Sedona-610x355.png 610w" sizes="auto, (max-width: 1068px) 100vw, 1068px">
*Update: Due to unexpected weather conditions in Sedona, Curaleaf has rescheduled the grand opening from March 7th and 8th to March 14th. The ribbon-cutting ceremony will now take place at 10:00 AM MST on March 14th, followed by vendor promotions and exclusive deals.
Curaleaf has announced the relocation of its Sedona, Arizona dispensary to 1610 State Road 89A.  The new location opened February 27th, and will celebrate its grand opening on March 7th and 8th with a ribbon-cutting ceremony, vendor promotions, and exclusive deals. Vendors will be present on site both days from 10:00 am to 6:00 pm
Curaleaf Sedona’s new location will be open from 9:00 am to 8:00 pm MST seven days a week, accommodating both recreational and medical marijuana. Customers can explore Curaleaf’s premium suite of products, including its wide variety of trusted brands such as Select, Grassroots, JAMS, Find and Curaleaf. Products range across flower, concentrates, vapes, infused pre-rolls and more, and feature Select Zero Proof Hemp Seltzer, Select vapes with a new strain offering across Stiq, Cliq and Briq hardware, as well as Find flower (half ounce and ounce), and Grassroots (1/8ths, concentrates and infused pre-rolls). With over 150 vendors represented and a continually growing roster, Curaleaf Sedona offers a rich variety of cannabis products to meet the needs of all customers and will introduce even more innovative product offerings in the weeks to come.
“Since 2018, Arizona has been an exciting state for us to grow and evolve our retail and product offering. Now one of the 16 Curaleaf dispensaries operating in the state, the new Curaleaf Sedona offers customers a more accessible and convenient shopping experience, right off Highway 89A,” said Luke Flood, Regional Senior Vice President at Curaleaf. “The new Sedona dispensary allows us to better serve both medical and adult use customers with improved visibility, and an expanded product selection, all within a welcoming environment that reflects our longstanding commitment to the community.”
For more information on Curaleaf’s 16 local dispensaries, delivery program, and products in Arizona, please visit: <a href="https://curaleaf.com/dispensary/arizona">curaleaf.com/dispensary/arizona</a>
 
The post <a href="https://azmarijuana.com/arizona-medical-marijuana-news/arizona-dispensary-relocates-and-grand-opening-is-march-7th-8th/">Arizona Dispensary Relocates and Grand Opening Is March 14th</a> appeared first on <a href="https://azmarijuana.com/">AZ Marijuana</a>.

*Update: Due to unexpected weather conditions in Sedona, Curaleaf has rescheduled the grand opening from March 7th and 8th to March 14th. The ribbon-cutting ceremony will now take place at 10:00 AM MST on March 14th, followed by vendor promotions and exclusive deals. Curaleaf has announced the relocation of its Sedona, Arizona dispensary to 1610 ...
The post <a href="https://azmarijuana.com/arizona-medical-marijuana-news/arizona-dispensary-relocates-and-grand-opening-is-march-7th-8th/">Arizona Dispensary Relocates and Grand Opening Is March 14th</a> appeared first on <a href="https://azmarijuana.com/">AZ Marijuana</a>.

Arizona Dispensary Relocates and Grand Opening Is March 14th

Industry Blazers spotlights Arizona’s talented cannabis industry professionals who influence and grow the industry. Brought to you by a collaboration between Proven Media and AZmarijuana.com. Do you know someone that is an Industry Blazer in Arizona? Email us their name and contact info. Name: Bri Hicks Company: Giving Tree Dispensary Title: Cultivation Manager Website: GivingTreeDispensary.com Instagram: ...
The post <a href="https://azmarijuana.com/arizona-medical-marijuana-news/arizona-industry-blazers-celebrates-womens-history-month/">Arizona Industry Blazers Celebrates Women’s History Month</a> appeared first on <a href="https://azmarijuana.com/">AZ Marijuana</a>.

Arizona Industry Blazers Celebrates Women’s History Month

Did you know that you spend approximately <a href="https://pubmed.ncbi.nlm.nih.gov/21056174/#:~:text=to%20do%20so-,We%20spend%20about%20one-third%20of%20our%20life%20either%20sleeping,Handb%20Clin%20Neurol." target="_blank" rel="noreferrer noopener">one-third</a> of your life sleeping? March is National Sleep Month, so now is the perfect time to reflect on your sleep health. Sleep is one of the <a href="https://www.hopkinsmedicine.org/-/media/migration/all-childrens-hospital/documents/healthy-weight-toolkit/4-pillars.pdf" target="_blank" rel="noreferrer noopener">four pillars</a> of health and is essential for brain function, emotional well-being and physical health. If you don’t get enough sleep, you run the risk of developing chronic conditions like heart disease, obesity and cognitive decline.



If you struggle to get enough sleep, you’re not alone. About 50 to 70 million Americans have sleep disorders. 1 in 3 adults (<a href="https://www.gallup.com/analytics/390536/sleep-in-america-2022.aspx" target="_blank" rel="noreferrer noopener">about 84 million people</a>) don’t regularly get the <a href="https://www.nhlbi.nih.gov/health/sleep-deprivation/how-much-sleep" target="_blank" rel="noreferrer noopener">recommended amount</a> of uninterrupted sleep needed to protect their health. According to a <a href="https://www.gallup.com/analytics/390536/sleep-in-america-2022.aspx" target="_blank" rel="noreferrer noopener">2022 Gallup survey</a>, only 32% of Americans said they got “excellent” or “very good” sleep; 35% described their sleep as “good,” and 33% said their sleep was “fair” or “poor.”



<h4 class="wp-block-heading">Cannabis and Sleep</h4>



Cannabis is regarded by many to be a beneficial sleep aid. It may <a href="https://www.healthline.com/health/medical-marijuana/cannabis-for-sleeping#takeaway" target="_blank" rel="noreferrer noopener">reportedly</a> “help you fall asleep faster, sleep more soundly, or otherwise improve the overall quality of your sleep.”



The cannabinoids found in cannabis, like THC and CBD, interact with the body’s <a href="https://cannabisnow.com/mind-body-health-cannabis-the-endocannabinoid-system/">endocannabinoid system (ECS)</a>. This complex set of receptors regulates sleep, mood and relaxation. When cannabinoids bind to CB1 receptors in the brain, they send messages to increase levels of sleep-promoting adenosine and suppress the brain’s arousal system. Together, these effects may help cannabis users feel sedated or sleepy. Many people already use cannabis as a sleep aid; a <a href="https://www.sleepfoundation.org/sleep-aids/cannabis-and-sleep" target="_blank" rel="noreferrer noopener">Sleep Foundation survey</a> found that around 70% of young adults regularly use cannabis to help them fall asleep. Plus, as many as 85% say it improves their sleep quality.



Another cannabinoid is gaining in popularity to help improve sleep. Cannabinol (<a href="https://cannabisnow.com/cbn-inside-cannabinoid-relieves-insomnia/" target="_blank" rel="noreferrer noopener">CBN</a>) is gaining a reputation for being the “sleepy cannabinoid.” It’s a non-psychoactive minor cannabinoid that forms as THC degrades from oxidation. <a href="https://www.sleepfoundation.org/sleep-aids/cbn-for-sleep" target="_blank" rel="noreferrer noopener">Research</a> shows that CBN is effective when combined with the two main cannabinoids in either full-spectrum or broad-spectrum formulations. Companies that are ahead of the game are including CBN in their CBD-based sleep products.



<h4 class="wp-block-heading">National Sleep Month’s Top 10 Hemp-Derived Sleep Aids</h4>



Whether you’re dealing with occasional sleeplessness or chronic insomnia, these natural, hemp-derived sleep aids might be the missing piece in your sleep puzzle. And because they’re all derived from the hemp plant, they’re federally legal so you can order from anywhere in the US.







<figure class="wp-block-image size-full"><a href="https://cannabisnow.com/wp-content/uploads/2025/02/Kanha.png"><img loading="lazy" decoding="async" width="1000" height="600" src="https://cannabisnow.com/wp-content/uploads/2025/02/Kanha.png" alt="" class="wp-image-70395" srcset="https://cannabisnow.com/wp-content/uploads/2025/02/Kanha.png 1000w, https://cannabisnow.com/wp-content/uploads/2025/02/Kanha-300x180.png 300w, https://cannabisnow.com/wp-content/uploads/2025/02/Kanha-768x461.png 768w, https://cannabisnow.com/wp-content/uploads/2025/02/Kanha-400x240.png 400w" sizes="auto, (max-width: 1000px) 100vw, 1000px"></a></figure><h4 class="wp-block-heading">Kanha FX Sleep Marionberry Plum Gummies</h4>



Kanha’s <a href="https://kanhalife.com/product/sleep-marionberry-plum-gummies/" target="_blank" rel="noreferrer noopener">Marionberry Plum Gummies</a> feature a 3:2:1 blend of CBD, CBN and THC. These are specially formulated to gently relax you and melt away stress for a deep, restorative slumber. Each gummy contains 30mg CBD, 20mg CBN and 10mg THC to help you sleep soundly. These fast-acting NANO technology powered gummies have a rapid onset of that are often felt in a matter of minutes.











<figure class="wp-block-image size-full"><a href="https://www.opalandjoy.com/products/restorative-sleep-system"><img loading="lazy" decoding="async" width="1000" height="600" src="https://cannabisnow.com/wp-content/uploads/2025/02/Opal-and-Joy.png" alt="" class="wp-image-70386" srcset="https://cannabisnow.com/wp-content/uploads/2025/02/Opal-and-Joy.png 1000w, https://cannabisnow.com/wp-content/uploads/2025/02/Opal-and-Joy-300x180.png 300w, https://cannabisnow.com/wp-content/uploads/2025/02/Opal-and-Joy-768x461.png 768w, https://cannabisnow.com/wp-content/uploads/2025/02/Opal-and-Joy-400x240.png 400w" sizes="auto, (max-width: 1000px) 100vw, 1000px"></a></figure><h4 class="wp-block-heading">Opal &amp; Joy Restorative Sleep System</h4>



Opal &amp; Joy’s <a href="https://www.opalandjoy.com/products/restorative-sleep-system" target="_blank" rel="noreferrer noopener">Restorative Sleep System </a>is a unique, dual-product system that’s specifically designed for women experiencing perimenopause sleep issues. It’s made up of two products: Rest, which supports the endocannabinoid system and contains full-spectrum CBD, CBN and linalool; and Relax, which supports the endocrine system and contains powerful adaptogens including reishi and ashwagandha. This ground-breaking, clinically formulated approach provides wrap-around support for women to help tackle the source of perimenopause sleep issues, like hormone regulation, anxiety, insomnia, night sweats, joint pain and more.



<figure class="wp-block-image size-full"><a href="https://medterracbd.com/products/sound-asleep-gummies?variant=43844966088896"><img loading="lazy" decoding="async" width="1000" height="600" src="https://cannabisnow.com/wp-content/uploads/2025/02/Medterra.png" alt="" class="wp-image-70387" srcset="https://cannabisnow.com/wp-content/uploads/2025/02/Medterra.png 1000w, https://cannabisnow.com/wp-content/uploads/2025/02/Medterra-300x180.png 300w, https://cannabisnow.com/wp-content/uploads/2025/02/Medterra-768x461.png 768w, https://cannabisnow.com/wp-content/uploads/2025/02/Medterra-400x240.png 400w" sizes="auto, (max-width: 1000px) 100vw, 1000px"></a></figure><h4 class="wp-block-heading">Medtarra Sound Asleep CBD Gummies</h4>



Medtarra’s <a href="https://medterracbd.com/products/sound-asleep-gummies?variant=43844966088896" target="_blank" rel="noreferrer noopener">Sound Asleep CBD gummies</a> are a high-potency blend of THC, melatonin, L-theanine and CBD. Scientifically crafted to promote a healthy sleep cycle and ensure you awake refreshed, each gummy contains 50mg CBD and 5mg THC.



<h4 class="wp-block-heading"></h4>



<figure class="wp-block-image size-full"><a href="https://viiahemp.com/products/zen-sleep-cbn-gummies-thc-free?variant=40741973622897"><img loading="lazy" decoding="async" width="1000" height="600" src="https://cannabisnow.com/wp-content/uploads/2025/02/Viia.png" alt="" class="wp-image-70388" srcset="https://cannabisnow.com/wp-content/uploads/2025/02/Viia.png 1000w, https://cannabisnow.com/wp-content/uploads/2025/02/Viia-300x180.png 300w, https://cannabisnow.com/wp-content/uploads/2025/02/Viia-768x461.png 768w, https://cannabisnow.com/wp-content/uploads/2025/02/Viia-400x240.png 400w" sizes="auto, (max-width: 1000px) 100vw, 1000px"></a></figure><h4 class="wp-block-heading">Viia Hemp Zen Sleep CBN Gummies</h4>



For those seeking the benefits of cannabinoids without THC, Viia Hemp’s <a href="https://viiahemp.com/products/zen-sleep-cbn-gummies-thc-free?variant=40741973622897" target="_blank" rel="noreferrer noopener">Zen Sleep gummies</a> combine CBN with other sleep-promoting ingredients, including L-Theanine, which is an amino acid in tea leaves that may promote relaxation and relief.



<figure class="wp-block-image size-full"><a href="https://urb.shop/collections/rest/products/mile-high-skybites?_pos=4&amp;_fid=6dbe1cfcf&amp;_ss=c&amp;variant=49810976506135"><img loading="lazy" decoding="async" width="1000" height="600" src="https://cannabisnow.com/wp-content/uploads/2025/02/Mile-High.png" alt="" class="wp-image-70389" srcset="https://cannabisnow.com/wp-content/uploads/2025/02/Mile-High.png 1000w, https://cannabisnow.com/wp-content/uploads/2025/02/Mile-High-300x180.png 300w, https://cannabisnow.com/wp-content/uploads/2025/02/Mile-High-768x461.png 768w, https://cannabisnow.com/wp-content/uploads/2025/02/Mile-High-400x240.png 400w" sizes="auto, (max-width: 1000px) 100vw, 1000px"></a></figure><h4 class="wp-block-heading">URB Mile High Skybites</h4>



For those with a higher tolerance, the <a href="https://urb.shop/collections/rest/products/mile-high-skybites?_pos=4&amp;_fid=6dbe1cfcf&amp;_ss=c&amp;variant=49810976506135" target="_blank" rel="noreferrer noopener">Mile High Skybites</a> from URB might be the ticket to deep sleep. Formulated using Tetrahydrocannabiphorol (THCP) and nano D9, URB claims these to be the strongest gummies it’s ever produced. Choose from various mouth-watering flavors, including Passion Fruit, Watermelon Juice and Guava Smoothie.



<figure class="wp-block-image size-full"><a href="https://sleepybeargummies.com/products/sleepy-bear-cbd-cbn-melatonin-sleep-support?variant=48560968040731"><img loading="lazy" decoding="async" width="1000" height="600" src="https://cannabisnow.com/wp-content/uploads/2025/02/Sleep-Bear.png" alt="" class="wp-image-70390" srcset="https://cannabisnow.com/wp-content/uploads/2025/02/Sleep-Bear.png 1000w, https://cannabisnow.com/wp-content/uploads/2025/02/Sleep-Bear-300x180.png 300w, https://cannabisnow.com/wp-content/uploads/2025/02/Sleep-Bear-768x461.png 768w, https://cannabisnow.com/wp-content/uploads/2025/02/Sleep-Bear-400x240.png 400w" sizes="auto, (max-width: 1000px) 100vw, 1000px"></a></figure><h4 class="wp-block-heading">Sleepy Bear Premium Sleep Support</h4>



<a href="https://sleepybeargummies.com/products/sleepy-bear-cbd-cbn-melatonin-sleep-support?variant=48560968040731" target="_blank" rel="noreferrer noopener">Sleepy Bear</a> also taps into the power of CBN and Melatonin. Its proprietary 5/3/2 Formula combines specific amounts of CBD, CBN and melatonin to help restore your natural sleep cycle and improve long-term sleep quality. Each gummy contains 15mg CBD, 9mg CBN and 2mg melatonin. The top-selling CBD sleep brand also has a CBD/CBN-only version, as well as a CBN/THC version, giving you lots of options to choose from.



<figure class="wp-block-image size-full"><a href="https://www.charlottesweb.com/products/sleep-cbd-gummies-melatonin"><img loading="lazy" decoding="async" width="1000" height="600" src="https://cannabisnow.com/wp-content/uploads/2025/02/CW.png" alt="" class="wp-image-70391" srcset="https://cannabisnow.com/wp-content/uploads/2025/02/CW.png 1000w, https://cannabisnow.com/wp-content/uploads/2025/02/CW-300x180.png 300w, https://cannabisnow.com/wp-content/uploads/2025/02/CW-768x461.png 768w, https://cannabisnow.com/wp-content/uploads/2025/02/CW-400x240.png 400w" sizes="auto, (max-width: 1000px) 100vw, 1000px"></a></figure><h4 class="wp-block-heading">Charlotte’s Web Sleep Gummy</h4>



Formulated with melatonin and its famous CBD oil, <a href="https://www.charlottesweb.com/products/sleep-cbd-gummies-melatonin" target="_blank" rel="noreferrer noopener">Sleep Gummy</a> by Charlotte’s Web supports sound sleep and balanced sleep cycles. Each gummy contains 10mg CBD and 3mg melatonin and are in a natural raspberry flavor.



<figure class="wp-block-image size-full"><a href="https://plainjane.com/cbd-/-cbn-sleep-gummies/"><img loading="lazy" decoding="async" width="1000" height="600" src="https://cannabisnow.com/wp-content/uploads/2025/02/Plain-Jane.png" alt="" class="wp-image-70392" srcset="https://cannabisnow.com/wp-content/uploads/2025/02/Plain-Jane.png 1000w, https://cannabisnow.com/wp-content/uploads/2025/02/Plain-Jane-300x180.png 300w, https://cannabisnow.com/wp-content/uploads/2025/02/Plain-Jane-768x461.png 768w, https://cannabisnow.com/wp-content/uploads/2025/02/Plain-Jane-400x240.png 400w" sizes="auto, (max-width: 1000px) 100vw, 1000px"></a></figure><h4 class="wp-block-heading">Plain Jane Sleep Gummies</h4>



Plain Jane’s <a href="https://plainjane.com/cbd-/-cbn-sleep-gummies/" target="_blank" rel="noreferrer noopener">Sleep Gummies</a> offer a delicious and beginner-friendly way to experience the benefits of CBD, CBN and melatonin. Each blueberry-flavored gummy contains approximately 9.40mg of full-spectrum CBD, 4.18mg of CBN and 2.5mg of melatonin.



<figure class="wp-block-image size-full"><a href="https://wyldcanna.com/products/boysenberry/"><img loading="lazy" decoding="async" width="1000" height="600" src="https://cannabisnow.com/wp-content/uploads/2025/02/Wyld.png" alt="" class="wp-image-70393" srcset="https://cannabisnow.com/wp-content/uploads/2025/02/Wyld.png 1000w, https://cannabisnow.com/wp-content/uploads/2025/02/Wyld-300x180.png 300w, https://cannabisnow.com/wp-content/uploads/2025/02/Wyld-768x461.png 768w, https://cannabisnow.com/wp-content/uploads/2025/02/Wyld-400x240.png 400w" sizes="auto, (max-width: 1000px) 100vw, 1000px"></a></figure><h4 class="wp-block-heading">Wyld Boysenberry Gummies</h4>



Wyld’s <a href="https://wyldcanna.com/products/boysenberry/" target="_blank" rel="noreferrer noopener">Boysenberry Gummies</a> use a 1:1:1 blend of THC, CBD and CBN that work together to soothe body and mind. Each delicious fruit gummy contains 10mg THC, 10mg CBD and 10mg CBN, making this a great choice for those seeking deeper sleep.



<figure class="wp-block-image size-full"><a href="https://dadgrass.com/collections/thcgummies/products/dad-grass-deluxe-nighttime-thc-gummies-with-cbd-cbn?variant=41898024337494"><img loading="lazy" decoding="async" width="1000" height="600" src="https://cannabisnow.com/wp-content/uploads/2025/02/Dad-Grass.png" alt="" class="wp-image-70394" srcset="https://cannabisnow.com/wp-content/uploads/2025/02/Dad-Grass.png 1000w, https://cannabisnow.com/wp-content/uploads/2025/02/Dad-Grass-300x180.png 300w, https://cannabisnow.com/wp-content/uploads/2025/02/Dad-Grass-768x461.png 768w, https://cannabisnow.com/wp-content/uploads/2025/02/Dad-Grass-400x240.png 400w" sizes="auto, (max-width: 1000px) 100vw, 1000px"></a></figure><h4 class="wp-block-heading">Dad Grass Deluxe Nighttime THC Gummies with CBD &amp; CBN</h4>



Designed to help you fall asleep faster, stay asleep longer and wake up refreshed, each <a href="https://dadgrass.com/collections/thcgummies/products/dad-grass-deluxe-nighttime-thc-gummies-with-cbd-cbn?variant=41898024337494" target="_blank" rel="noreferrer noopener">Deluxe Nighttime Gummy</a> delivers 2mg THC, 18mg CBD and 2mg CBN, offering extra strength support for deeper, more restful sleep. These full-spectrum, fast-acting gummies are precisely dosed for consistent results. Infused with a delicious Midnight Berry flavor, they offer a soothing and enjoyable way to unwind before bed.



<h4 class="wp-block-heading">Practice Good Sleep Hygiene</h4>



While these hemp-derived sleep aids can help you fall asleep, you must do the work to ensure you have “good sleep hygiene.” This refers to healthy habits and practices that promote quality sleep. By consistently practicing good sleep hygiene, you can improve sleep quality. Better sleep makes you feel more refreshed and energized throughout the day.



Here are key elements of good sleep hygiene:



<ol class="wp-block-list">
<li>
Maintain a Consistent Schedule: Go to bed and wake up at the same time every day, even on weekends, to regulate your body’s internal clock.</li>
</ol>
<ul class="wp-block-list">
<li>
Create a Relaxing Bedtime Routine: Wind down with calming activities like reading, meditation or a warm bath to signal to your body that it’s time to sleep.</li>
</ul>
<ul class="wp-block-list">
<li>
Optimize Your Sleep Environment: Keep your bedroom cool, dark and quiet. Use blackout curtains, white noise machines, or essential oils such as lavender for relaxation.</li>
</ul>
<ul class="wp-block-list">
<li>
Limit Screen Time: Avoid electronic devices (phones, tablets, TVs) at least an hour before bed, as blue light can interfere with melatonin production.</li>
</ul>
<ul class="wp-block-list">
<li>
Be Mindful of Food &amp; Drink: Avoid heavy meals, caffeine and alcohol close to bedtime, as they can disrupt sleep quality.</li>
</ul>
<ul class="wp-block-list">
<li>
Get Regular Exercise: Engage in physical activity during the day, but avoid intense workouts right before bedtime.</li>
</ul>
<ul class="wp-block-list">
<li>
Manage Stress and Anxiety: Practice relaxation techniques like deep breathing, journaling or gentle stretching to calm the mind.</li>
</ul>
<ul class="wp-block-list">
<li>
Limit Naps: Keep daytime naps short (20–30 minutes) and earlier in the day to avoid interfering with nighttime sleep.</li>
</ul>
Good sleep is not a luxury — it’s a necessity for optimal health and well-being. Are you ready to prioritize your sleep health and consider the potential benefits of premium hemp-derived sleep aids?
The post <a href="https://cannabisnow.com/10-hemp-derived-sleep-aids/">Top 10 THC and CBD Products to Improve Sleep Quality</a> appeared first on <a href="https://cannabisnow.com/">Cannabis Now</a>.

If you’re struggling to get the sleep you need, these premium products might help you get back on track.
The post <a href="https://cannabisnow.com/10-hemp-derived-sleep-aids/">Top 10 THC and CBD Products to Improve Sleep Quality</a> appeared first on <a href="https://cannabisnow.com/">Cannabis Now</a>.

Top 10 THC and CBD Products to Improve Sleep Quality

<a href="https://azmarijuana.com/eblast/030125"><img decoding="async" src="https://azmarijuana.com/wp-content/uploads/2025/02/unnamed.jpg" alt="Pondy" width="600" class="aligncenter size-full wp-image-1145808"></a>
The post <a href="https://azmarijuana.com/images/this-weekend-leafers-diamond-infused-joints-ponderosa-dispensary-specials/">This Weekend! Leafers Diamond-Infused Joints &amp; Ponderosa Dispensary Specials!</a> appeared first on <a href="https://azmarijuana.com/">AZ Marijuana</a>.

The post <a href="https://azmarijuana.com/images/this-weekend-leafers-diamond-infused-joints-ponderosa-dispensary-specials/">This Weekend! Leafers Diamond-Infused Joints &amp; Ponderosa Dispensary Specials!</a> appeared first on <a href="https://azmarijuana.com/">AZ Marijuana</a>.

This Weekend! Leafers Diamond-Infused Joints &amp; Ponderosa Dispensary Specials!

<a href="https://azmarijuana.com/eblast/022825"><img decoding="async" src="https://azmarijuana.com/wp-content/uploads/2025/02/asdf.jpg" alt="Good" width="550" class="aligncenter size-full wp-image-1145791"></a>
The post <a href="https://azmarijuana.com/images/puff-puff-pass-dont-miss-out-on-these-crazy-deals/">Puff Puff Pass – Don’t Miss Out On These CRAZY Deals</a> appeared first on <a href="https://azmarijuana.com/">AZ Marijuana</a>.

The post <a href="https://azmarijuana.com/images/puff-puff-pass-dont-miss-out-on-these-crazy-deals/">Puff Puff Pass – Don’t Miss Out On These CRAZY Deals</a> appeared first on <a href="https://azmarijuana.com/">AZ Marijuana</a>.

Puff Puff Pass – Don’t Miss Out On These CRAZY Deals

As cannabis continues to be socially accepted and flourish in the legal market, the new industry must come to terms with the discriminatory and damaging past of the failed War on Drugs. For decades, thousands of citizens have been—and continue to be—<a href="https://cannabisnow.com/?s=war+on+drugs">unjustly convicted and incarcerated</a> and now live with the many societal disadvantages of a criminal cannabis conviction. To combat these many disadvantages for a once crime that’s now legal in some form in much more than half the US, progressive states are implementing policies to include individuals from areas that were devastated by the draconian policies of the decades-long failure of the drug war. Known as social equity, these programs could provide opportunities for lucrative business ownership in communities that are often overlooked for economic opportunities.



A new cannabis brand out of Chicago has made social equity a cornerstone of its corporate ethos while also combining and respecting the urban American subcultures that pushed weed culture into the mainstream. <a href="https://www.umidispensary.com/">Ümi Farms</a> is a parent company for cannabis brands specifically geared toward social equity causes, including ÜMI retail dispensaries and the ÜMI Farms craft cannabis cultivation facility. It was founded by CEO Akele Parnell, an attorney and cannabis activist who’s deeply committed and entrenched in those very topics on multiple fronts.



Parnell has served a number of legal and advocacy roles for various cannabis companies and organizations. A graduate of Washington University in St. Louis’ Law School, Parnell previously held the position of in-house counsel for Green Thumb Industries and staff attorney for the Chicago Lawyers’​ Committee for Civil Rights. In advocacy, Parnell has been involved with Chicago<a href="https://cannabisnow.com/tag/norml/"> NORML</a> for half a decade and been a board member since 2020.



“Pretty much immediately after joining the industry, I wondered where all the people from communities were that have been devastated by the War on Drugs,” Parnell says. So, I set out on a mission to bring more folks like me into the industry.”



Illinois became the 11th state to legalize medical and adult-use cannabis on January 1, 2020, when the Cannabis Regulation and Tax Act came into effect. The state opened applications for new cannabis licenses later that year, a historic measure that received more than 600 social equity applications. Unlike other states’ flawed implementation of social equity, Parnell describes Illinois’ approach as “robust” despite initial challenges. “We were successful in getting licenses into the hands of hundreds of social equity and Black and Latino-owned businesses,” he says. “A lot is still left to be desired when achieving the process of social equity. Hopefully, in the relatively near future, we can get to a good spot where we can feel that we’ve accomplished the things we set out to.”


<div class="wp-block-image">
<figure class="aligncenter size-large"><a href="https://cannabisnow.com/wp-content/uploads/2025/02/Akele_Parnell_Umi-scaled.jpg"><img loading="lazy" decoding="async" width="683" height="1024" src="https://cannabisnow.com/wp-content/uploads/2025/02/Akele_Parnell_Umi-683x1024.jpg" alt="" class="wp-image-70408" srcset="https://cannabisnow.com/wp-content/uploads/2025/02/Akele_Parnell_Umi-683x1024.jpg 683w, https://cannabisnow.com/wp-content/uploads/2025/02/Akele_Parnell_Umi-200x300.jpg 200w, https://cannabisnow.com/wp-content/uploads/2025/02/Akele_Parnell_Umi-768x1152.jpg 768w, https://cannabisnow.com/wp-content/uploads/2025/02/Akele_Parnell_Umi-1024x1536.jpg 1024w, https://cannabisnow.com/wp-content/uploads/2025/02/Akele_Parnell_Umi-1365x2048.jpg 1365w, https://cannabisnow.com/wp-content/uploads/2025/02/Akele_Parnell_Umi-scaled.jpg 1707w" sizes="auto, (max-width: 683px) 100vw, 683px"></a><figcaption class="wp-element-caption">CEO Akele Parnel</figcaption></figure>
</div>


Ümi Farms recognizes cannabis’ decorated legacy and the socially restorative future that the plant could have. The name Ümi is quite interesting from a language standpoint, as it translates into different words in different languages, while the meanings all represent life. In Japanese, “Ümi” means “ocean;” in Arabic, “Ümi” means “mother,” “foundation” and “source.” In the language of the Mambwe people from Zambia and Tanzania, “Ümi” translates to “life.” In his 1999 debut album, Black on Both Sides, Mos Def included a song called “Ümi Says.”  According to Parnell, the name “has an important meeting to the cannabis ecosystem we’re building.”



<a href="https://www.instagram.com/getlab11/" target="_blank" rel="noreferrer noopener">Lab 11</a> is the first brand launched under Ümi Farms. Parnell describes it as their “ultimate brainchild.” “A minority and veteran-owned social equity brand, Lab 11 is as diverse, dynamic and determined as the communities we aim to uplift through the transformative power of the plant,” he says. 



Inspired by the creativity of contemporary urban subcultures and a nostalgia for the golden era of the industry, Lab 11 celebrates the legacy of cannabis culture—progressive, free, countercultural and provocative—all while exploring it’s impacts throughout time. “It’s our answer to a legal cannabis market full of brands that don’t really speak our language,” Parnell says. “There hasn’t been an opportunity for a brand to be brought by folks that are immersed in these progressive, free and countercultural ecosystems and environments in Chicago. It includes a lot of activists, a lot of creatives, a lot of chefs, a lot of cultural workers and ultimately, that’s what Lab 11 is about.”



The majority of Lab 11’s owners and operators were raised in communities deeply impacted by previous drug policies, such as the Woodlawn neighborhood in Chicago. “We’ve been doing advocacy for social equity across the country pretty much the entire time we’ve been in the industry,” Parnell says. “As the brand grows, we’ll continue to give opportunities to people from communities that have been disproportionately impacted and we’ll find ways to give back.”



Parnell says that Ümi Farms and Lab 11 will continue to partner with brands and individuals who hold similarly advanced views on social equity and further reforms from horribly damaging drug laws outside of cannabis. The brand will also be creating a sort of mentorship program in the Illinois industry, where those who are aspiring to work in cannabis will be paired up with employees to receive on-the-job training.



“We’ll continue to build that ecosystem and that community and create a safe place for people to come and enjoy the plant,” Parnell says. “We’ll continue to find ways to build and increase social equity in Illinois.”




The post <a href="https://cannabisnow.com/umi-farms-is-serious-about-social-equity/">Ümi Farms Is Serious About Social Equity</a> appeared first on <a href="https://cannabisnow.com/">Cannabis Now</a>.

Illinois attorney-turned-activist Akele Parnell is making good on the devastating damages caused by the War on Drugs.
The post <a href="https://cannabisnow.com/umi-farms-is-serious-about-social-equity/">Ümi Farms Is Serious About Social Equity</a> appeared first on <a href="https://cannabisnow.com/">Cannabis Now</a>.

Ümi Farms Is Serious About Social Equity

<a href="https://azmarijuana.com/eblast/022725"><img loading="lazy" decoding="async" class="aligncenter size-full wp-image-1145770" src="https://azmarijuana.com/wp-content/uploads/2025/02/unnamed.gif" alt="Tumble" width="600" height="2500"></a>
Introducing the Holy Trinity by Tumble. Lic: 20772514
The post <a href="https://azmarijuana.com/images/tumble-by-timeless-has-united-three-legendary-strains/">Tumble by Timeless Has United Three Legendary Strains…</a> appeared first on <a href="https://azmarijuana.com/">AZ Marijuana</a>.

Introducing the Holy Trinity by Tumble. Lic: 20772514
The post <a href="https://azmarijuana.com/images/tumble-by-timeless-has-united-three-legendary-strains/">Tumble by Timeless Has United Three Legendary Strains…</a> appeared first on <a href="https://azmarijuana.com/">AZ Marijuana</a>.

Tumble by Timeless Has United Three Legendary Strains…

<a href="https://azmarijuana.com/eblast/022625"><img decoding="async" src="https://azmarijuana.com/wp-content/uploads/2025/02/Slugger.jpg" alt="Slugger" width="556" class="aligncenter size-full wp-image-1145782" srcset="https://azmarijuana.com/wp-content/uploads/2025/02/Slugger.jpg 650w, https://azmarijuana.com/wp-content/uploads/2025/02/Slugger-346x600.jpg 346w, https://azmarijuana.com/wp-content/uploads/2025/02/Slugger-87x150.jpg 87w, https://azmarijuana.com/wp-content/uploads/2025/02/Slugger-610x1057.jpg 610w" sizes="(max-width: 650px) 100vw, 650px"></a>
The post <a href="https://azmarijuana.com/images/sluggers-launches-friday-exclusively-at-curaleaf/">Sluggers launches Friday EXCLUSIVELY at Curaleaf</a> appeared first on <a href="https://azmarijuana.com/">AZ Marijuana</a>.

The post <a href="https://azmarijuana.com/images/sluggers-launches-friday-exclusively-at-curaleaf/">Sluggers launches Friday EXCLUSIVELY at Curaleaf</a> appeared first on <a href="https://azmarijuana.com/">AZ Marijuana</a>.

Sluggers launches Friday EXCLUSIVELY at Curaleaf

<img loading="lazy" decoding="async" src="https://azmarijuana.com/wp-content/uploads/2025/02/Slugger.png" alt="Slugger Cannabis" width="715" height="400" class="aligncenter size-full wp-image-1145780" srcset="https://azmarijuana.com/wp-content/uploads/2025/02/Slugger.png 715w, https://azmarijuana.com/wp-content/uploads/2025/02/Slugger-600x336.png 600w, https://azmarijuana.com/wp-content/uploads/2025/02/Slugger-150x84.png 150w, https://azmarijuana.com/wp-content/uploads/2025/02/Slugger-610x341.png 610w" sizes="auto, (max-width: 715px) 100vw, 715px"> IF YOU GROW IT, THEY WILL COME. 
SLUGGERS BRINGS CALIFORNIA LEGACY TO ARIZONA WITH CURALEAF LAUNCH ON FEBRUARY 28TH
Arizona, get ready to step up to the plate—Sluggers is officially launching at Curaleaf on February 28th! Known for its high-quality cannabis and collector-worthy products, Sluggers is bringing its winning legacy from California to the desert, introducing fans to an undeniably top-tier experience.
<h3>A WINNING LEGACY OF FUN &amp; NOSTALGIA</h3>
Sluggers is more than just cannabis—it’s a celebration of culture, craftsmanship, and the joy of the game. Rooted in a legacy of excellence, Sluggers channels the spirit of competition and the thrill of victory into every product. Whether you’re a seasoned connoisseur or a newcomer looking for a high-quality hit, Sluggers delivers an unforgettable experience with every puff.
Born from the dedication of cannabis pioneers, Sluggers isn’t here just to play the game—we’re here to win it. That means pushing the boundaries of cannabis innovation while keeping our roots firmly planted in the traditions that made us great. From expert cultivation to cutting-edge production techniques, Sluggers is redefining what it means to be a heavyweight in the industry.
<h3>A LEAGUE OF OUR OWN</h3>
As one of the fastest-growing cannabis brands of 2025, we’re proud to bring our signature quality, consistency, and passion to Arizona. With state-of-the-art cultivation and production facilities, a focus on premium extracts, and a dedication to crafting an enhanced retail experience, we’re giving Arizona cannabis enthusiasts something to cheer about.
<ul>
<li aria-level="1">
Home Field Advantage: Grown and produced in state-of-the-art facilities.
</li>
<li aria-level="1">
Quality Assurance: Only the best from cultivation, extraction, and manufacturing.
</li>
<li aria-level="1">
Enhanced Shopping Experience: Eye-catching displays, promotions, and gift-with-purchase offerings.
</li>
<li aria-level="1">
Exceptional Value: Premium products at competitive prices.
</li>
<li aria-level="1">
Made by OG’s: Developed by cannabis pioneers with decades of experience.
</li>
<li aria-level="1">
Collectible Cannabis: Every Sluggers product tells a story and comes with a special collectible.
</li>
</ul>
<h3>THE COLLECTIBLE EXPERIENCE</h3>
Cannabis meets culture with Sluggers’ unique collector’s items. Each Sluggers product is more than just high-quality cannabis—it’s a piece of history. With every 5-pack of Juiced infused pre-rolls, consumers will receive a strain-specific baseball card, adding an extra layer of excitement to their purchase. 
<h3>EXCLUSIVE ARIZONA STRAINS: ROAD RUNNER &amp; CACTUS BREATH</h3>
To mark our grand entrance into Arizona, Sluggers is bringing two exclusive Juiced 5pk strains: Road Runner and Cactus Breath. Crafted to capture the bold essence of the Southwest, these strains are set to become instant classics.
<ul>
<li aria-level="1">
Triple Infused: Each joint is packed with THCA diamonds, high-terpene extract (HTE), premium hash, and kief for an ultra-potent, flavorful experience.
</li>
<li aria-level="1">
Unbeatable Value: At 3.5g per pack, Sluggers offers premium infused pre-rolls at a price point that beats leading competitors.
</li>
</ul>
<h3>JOIN THE SLUGGERS MOVEMENT</h3>
Sluggers is more than just a brand—it’s a lifestyle. With high-quality products, exclusive strains, and a legacy of excellence, we’re here to bring Arizona cannabis consumers a game-changing experience. Whether you’re in it for the nostalgia, the high potency, or the collector’s thrill, Sluggers is set to be a heavy hitter in the Arizona market.
Get ready, Arizona—Sluggers is stepping up to the plate, and every hit is a home run.
<h3>WHERE TO FIND US</h3>
<ul>
<li aria-level="1">Shop Sluggers at Curaleaf starting February 28th!</li>
<li aria-level="1">
Follow us on Instagram: <a href="https://www.instagram.com/sluggers.arizona/">@sluggers.arizona</a>
</li>
<li aria-level="1">
Grab official Sluggers gear:<a href="https://shop.sluggers.com/"> shop.sluggers.com</a>
</li>
</ul>
Don’t miss out—step up, take a swing, and experience the Sluggers difference for yourself!
The post <a href="https://azmarijuana.com/arizona-medical-marijuana-news/sluggers-brings-california-legacy-to-arizona-with-curaleaf-launch-on-feb-28/">Sluggers Brings California Legacy to Arizona with Curaleaf Launch on Feb 28</a> appeared first on <a href="https://azmarijuana.com/">AZ Marijuana</a>.

IF YOU GROW IT, THEY WILL COME.  SLUGGERS BRINGS CALIFORNIA LEGACY TO ARIZONA WITH CURALEAF LAUNCH ON FEBRUARY 28TH Arizona, get ready to step up to the plate—Sluggers is officially launching at Curaleaf on February 28th! Known for its high-quality cannabis and collector-worthy products, Sluggers is bringing its winning legacy from California to the desert, ...
The post <a href="https://azmarijuana.com/arizona-medical-marijuana-news/sluggers-brings-california-legacy-to-arizona-with-curaleaf-launch-on-feb-28/">Sluggers Brings California Legacy to Arizona with Curaleaf Launch on Feb 28</a> appeared first on <a href="https://azmarijuana.com/">AZ Marijuana</a>.

Sluggers Brings California Legacy to Arizona with Curaleaf Launch on Feb 28

The bong is so much more than just an object that looks cool and gets you high. The bong helps us create rituals in our lives. Just look around today—it seems as if Americans are lost. Cannabis culture can fill that void and inspire change in the world. The bong specifically can be a vehicle to that change. As a glass artist and co-founder of Jerome Baker Designs (JBD), it’s safe to say I’ve come to know the bong very well. 



The life of a bong goes a little something like this: It gets purchased from a head shop and you name it, hide it from your parents, and bring it along in friends’ cars. That goes on for a certain amount of time until one day it gets broken or confiscated by the police. It’s a horrible feeling. A bong represents a person’s style. This applies across cultures, from hillbillies to hip-hop culture.



<h4 class="wp-block-heading">How Jerome Baker Designs Got Its Start</h4>



Today, <a href="https://jeromebaker.com/" target="_blank" rel="noreferrer noopener">Jerome Baker</a> is considered the leader in American-made glass art. But before I became CEO of JBD, I was a college art student. During that time, I met an old man who lived down the street named <a href="https://www.instagram.com/bobsnodgrass1946/?hl=en" target="_blank" rel="noreferrer noopener">Bob Snodgrass</a>. He just so happened to be a world-renowned glass pipe innovator. His pipes were the first to change color the more you used them. I got connected with him, and he was always surrounded by some of the most interesting people in Oregon. I started learning to blow glass with that crew.



In the early days of JBD, my glassblowing partner Jordan Shefter and I would go door to door to frat houses banging on the doors during parties with a bag full of bongs for $125 wholesale and try to sell them. We grew the business from there. Nowadays, there are collector’s groups on Facebook where we connect with individuals. In some cases, JBD pieces have gone up twenty times in value over the years.



JBD quickly became a million-dollar business in the early nineties, and by 1999 it was a $4 million dollar business with 70 employees in Eugene, Oregon, which is a big city for outdoor recreation and the arts. We were making bongs that people recognized as art while staying true to what Jordan and I started in that college dorm room together. 



<blockquote class="wp-block-quote is-layout-flow wp-block-quote-is-layout-flow">
<blockquote class="wp-block-quote is-layout-flow wp-block-quote-is-layout-flow">
We were making bongs that people recognized as art while staying true to what Jordan and I started in that college dorm room together. 
</blockquote>
</blockquote>



<figure class="wp-block-image size-full"><a href="https://cannabisnow.com/wp-content/uploads/2024/02/Jerome-Baker-Dream-Factory.jpg"><img loading="lazy" decoding="async" width="1000" height="600" src="https://cannabisnow.com/wp-content/uploads/2024/02/Jerome-Baker-Dream-Factory.jpg" alt="Jerome Baker Designs" class="wp-image-68037" srcset="https://cannabisnow.com/wp-content/uploads/2024/02/Jerome-Baker-Dream-Factory.jpg 1000w, https://cannabisnow.com/wp-content/uploads/2024/02/Jerome-Baker-Dream-Factory-300x180.jpg 300w, https://cannabisnow.com/wp-content/uploads/2024/02/Jerome-Baker-Dream-Factory-768x461.jpg 768w, https://cannabisnow.com/wp-content/uploads/2024/02/Jerome-Baker-Dream-Factory-400x240.jpg 400w" sizes="auto, (max-width: 1000px) 100vw, 1000px"></a><figcaption class="wp-element-caption">Jerome Baker Dream Factory. PHOTO Dabsel Adams</figcaption></figure><h4 class="wp-block-heading">JBD Gets Raided in Operation Pipe Dreams</h4>



On February 23, 2003, I got arrested in <a href="https://www.sfgate.com/opinion/openforum/article/On-the-Role-of-Government-Wasted-on-pipe-dreams-2665766.php" target="_blank" rel="noreferrer noopener">Operation Pipe Dreams</a> alongside 55 other people, one of whom was Tommy Chong. There were many red flags before his arrest—people digging through garbage cans for evidence and the like. Eventually, JBD headquarters got raided. JBD staff was hogtied while the feds, state police, postal service police and more tore the place apart.



The police took everything. Our <a href="https://web.archive.org/web/20240112215439/https:/jeromebaker.com/">archived old website</a> at the time was also confiscated. All our computers and the digital photos on them were taken, too. And then everything in the shop got confiscated, including glass. I had nothing left other than a camera with a disc in it. The photos on that camera are the only pre-raid photos that survived. In 2000, the feds auctioned off my old domain and I bought it back.



I was shocked. One day, Jerome Baker Designs had 70 employees, and the next day it was just a memory. The accused were arraigned in Pittsburgh, Pennsylvania to face federal charges. Tommy Chong ended up doing an entire year in federal prison. His cellmate was Jordan Belfort, the former stockbroker played by Leonardo DiCaprio in the movie “The Wolf of Wall Street.”



The Bush Administration, which was in charge at the time, ultimately used Tommy Chong and the justice system to make a political statement. The times have changed, but the law is still the exact same at the federal level: The cannabis industry is still illegal federally.



<figure class="wp-block-image size-full"><a href="https://cannabisnow.com/wp-content/uploads/2024/02/Jerome-Baker-Designs-Grateful-Dead-Bong.jpg"><img loading="lazy" decoding="async" width="1000" height="1000" src="https://cannabisnow.com/wp-content/uploads/2024/02/Jerome-Baker-Designs-Grateful-Dead-Bong.jpg" alt="Jerome Baker Designs Grateful Dead Bong" class="wp-image-68035" srcset="https://cannabisnow.com/wp-content/uploads/2024/02/Jerome-Baker-Designs-Grateful-Dead-Bong.jpg 1000w, https://cannabisnow.com/wp-content/uploads/2024/02/Jerome-Baker-Designs-Grateful-Dead-Bong-300x300.jpg 300w, https://cannabisnow.com/wp-content/uploads/2024/02/Jerome-Baker-Designs-Grateful-Dead-Bong-150x150.jpg 150w, https://cannabisnow.com/wp-content/uploads/2024/02/Jerome-Baker-Designs-Grateful-Dead-Bong-768x768.jpg 768w, https://cannabisnow.com/wp-content/uploads/2024/02/Jerome-Baker-Designs-Grateful-Dead-Bong-100x100.jpg 100w" sizes="auto, (max-width: 1000px) 100vw, 1000px"></a><figcaption class="wp-element-caption">A piece from the Jerome Baker and the Grateful Dead glass collab.</figcaption></figure><h4 class="wp-block-heading">Building JBD Back Up</h4>



By the time <a href="https://cannabisnow.com/legal-sales-in-colorado-its-time-for-the-federal-government-to-allow-the-free-market-to-control-cannabis/">Colorado legalized in 2012</a>, JBD was back in action. Ever since the beginning, I knew that once this industry started going legal, that would be our chance to make a big push. We were smoking weed at the 2012 Cannabis Cup in Denver and realized that the time had come.



We had kept the brand alive in the skateboard sector. Anticipating Las Vegas would be a good place to do business, we set up shop in the Arts District, where we still make our pieces by hand to this day. Inside our studio, called the <a href="https://www.instagram.com/lvdreamfactory/?hl=en" target="_blank" rel="noreferrer noopener">Las Vegas Dream Factory</a>, we have a retail shop akin to Harry Potter’s wand shop—you can cruise in and see which piece speaks to you.



Since the beginning, Jerome Baker Designs has come a long way. In the early days, I was following American rock n’ roll legends Grateful Dead on tour with friends, blowing glass in the parking lots. When guitarist Jerry Garcia died, we decided to finally form a company and name it after him. Jerome is a nod to Jerry. Baker refers to getting baked. This was <a href="https://jeromebaker.com/collections/grateful-dead" target="_blank" rel="noreferrer noopener">the Grateful Dead’s first venture into the premium cannabis glass space.</a> This partnership is something JBD and the Grateful Dead had been talking about for a long time. The band and our brand go way back—they inspired it all. With cannabis legalization picking up steam nationwide, it seemed like a good time. 



All these years later—after all those shows—it’s such a trip to be working with the Grateful Dead on high-quality glass cannabis products. Through this partnership, <a href="https://jeromebaker.com/collections/grateful-dead">all Grateful Dead artwork</a> featured on JBD bongs is officially licensed—it’s the real deal.  These glass pipes and bongs are geared towards the everyday kind of a stoner, where people use the plant in an everyday fashion. It’s a cool take on what’s hot in the world of stoners and cannabis. From soccer moms to recording artists, everybody who’s using the plant daily should be able to access and use the glass smoking products we’ve created with the Grateful Dead. They’ve got the same old Jerome Baker Designs quality; we’re using the same designs we were using 30 years ago. They’ve stood the test of time. We still innovate, but we knew what we were doing back then, too.



<figure class="wp-block-image size-full"><a href="https://cannabisnow.com/wp-content/uploads/2024/02/Jerome-Baker-Glass-Blower.jpg"><img loading="lazy" decoding="async" width="1000" height="975" src="https://cannabisnow.com/wp-content/uploads/2024/02/Jerome-Baker-Glass-Blower.jpg" alt="Jerome Baker Designs" class="wp-image-68036" srcset="https://cannabisnow.com/wp-content/uploads/2024/02/Jerome-Baker-Glass-Blower.jpg 1000w, https://cannabisnow.com/wp-content/uploads/2024/02/Jerome-Baker-Glass-Blower-300x293.jpg 300w, https://cannabisnow.com/wp-content/uploads/2024/02/Jerome-Baker-Glass-Blower-768x749.jpg 768w" sizes="auto, (max-width: 1000px) 100vw, 1000px"></a><figcaption class="wp-element-caption">Jason Harris of Jerome Baker at work.</figcaption></figure><h4 class="wp-block-heading">The Big Picture</h4>



Cannabis is a massive play. Ancillary products in cannabis represented a $10 million industry last year. My vision centers around humanizing cannabis and making it part of everyday consciousness and conversation. Our glass pieces, after all, are conversation pieces at a time when more conversations are definitely needed. They prove thoughts and bring the sacred to life. We don’t talk about bongs as if they are paraphernalia. To us, they are pieces of art.
The post <a href="https://cannabisnow.com/the-story-behind-jerome-baker-glass-art/">The Story of Jerome Baker Glass Art</a> appeared first on <a href="https://cannabisnow.com/">Cannabis Now</a>.

Jerome Baker Designs (JBD) first made its marks in the nineties. What worked then is working now, too. Co-founder Jason Harris takes us on a trip down memory lane and shares his vision for cannabis—and humanity.
The post <a href="https://cannabisnow.com/the-story-behind-jerome-baker-glass-art/">The Story of Jerome Baker Glass Art</a> appeared first on <a href="https://cannabisnow.com/">Cannabis Now</a>.

The Story of Jerome Baker Glass Art

I have a thing about most documentaries; it’s not unlike the thing I have about Brussels sprouts: I never want to watch/eat them, then I’m always glad I did. Happens. Every. Time. And the idea that I had to sit through a documentary that’s already nearly three years old, well, let’s just say my enthusiasm meter wasn’t exactly jumping with mind-blowing excitement.



Grass Is Greener ostensibly follows hip-hop icon Fab Five Freddy on his often-disturbing trek to uncover the truth about the history of cannabis prohibition in the US. Commencing in the 1920s New Orleans jazz clubs where Louis Armstrong, Billie Holiday and Duke Ellington were forced to perpetually fend off being arrested due to overtly racist policies, the documentary concludes by interviewing rap legends Snoop Dogg and B-Real of Cypress Hill as they expertly discuss the current state of cannabis.



The film, streaming on Netflix, also provides perspectives from relevant lawyers, cannabis advocates and activists. By far the most harrowing are examples of families torn apart by America’s pervasive and unjustified obsession with convicting people of color for minor marijuana infractions. It’s a lot to take in.



The riveting examination provides us with a villain early on, the cartoonishly bigoted first director of the Bureau of Narcotics, Harry Anslinger. The political appointee enforced fabricated policies while ignoring definitive scientific studies specifically targeting two groups still grappling (and demanding) social justice in this nation: African Americans and Mexican immigrants. In fact, the very name “cannabis” was purposedly changed to “marijuana” to further connect the supposedly dangerous narcotic more directly with the feared Mexicans crossing the border. It’s all as infuriating as it is outrageous, but given the current societal climate in the US, not at all surprising. C’mon now, is Harry Anslinger all that different from, say, Jeff Sessions, the enforcer of the draconian child separation policy at the US border during the previous administration? Here’s a hint: He’s not.



<figure class="wp-block-image size-large is-resized"><a href="https://cannabisnow.com/wp-content/uploads/2023/01/Grass-Is-Greener-Netflix.jpg"><img loading="lazy" decoding="async" width="691" height="1024" src="https://cannabisnow.com/wp-content/uploads/2023/01/Grass-Is-Greener-Netflix-691x1024.jpg" alt="Grass Is Greener" class="wp-image-63874" srcset="https://cannabisnow.com/wp-content/uploads/2023/01/Grass-Is-Greener-Netflix-691x1024.jpg 691w, https://cannabisnow.com/wp-content/uploads/2023/01/Grass-Is-Greener-Netflix-203x300.jpg 203w, https://cannabisnow.com/wp-content/uploads/2023/01/Grass-Is-Greener-Netflix-768x1137.jpg 768w, https://cannabisnow.com/wp-content/uploads/2023/01/Grass-Is-Greener-Netflix.jpg 1000w" sizes="auto, (max-width: 691px) 100vw, 691px"></a><figcaption class="wp-element-caption">Grass Is Greener features commentary from music legends Snoop Dogg, B-Real and Damian Marley. </figcaption></figure>But wait! There are good guys, too. Most surprising, perhaps, was former New York City Mayor Fiorello LaGuardia, who commissioned a report on cannabis that refuted all of Anslinger’s preposterous claims. “Instead of science, the government knowingly and willingly chose propaganda, chose racism over and over again,” said one astute subject of the documentary about the irrefutable evidence found in LaGuardia’s report. But the direct line from Anslinger, to Richard Nixon’s War On Drugs, to Ronald (and Nancy) Reagan’s “Just Say No” campaign and to Bill Clinton’s odious Crime Bill all relegated cannabis to be perceived as nothing short of premeditated evil. And it was all a lie.



I was amped up for action by the time Grass Is Greener gets to Jack Herer’s revelatory The Emperor Wears No Clothes, the truth bomb of a book that blew the lid off the perpetuated untruths about weed the US government had been spewing for a century. And by the end of the doc, I’m left with not only a crystal-clear understanding of the history of cannabis, but an even better understanding about American jurisprudence and how acutely unjust it has always been. Always.



Grass Is Greener should be required viewing for cannabis lovers, yes, but also for lovers of our country and democracy and justice. I’m so glad I saw this remarkably important documentary. Not surprisingly, I’m now craving a heaping serving of Brussels sprouts. I got the do-something munchies for sure.



This story was originally published in the <a href="https://cannabisnow.com/subscribe">print edition</a> of Cannabis Now.
The post <a href="https://cannabisnow.com/grass-is-greener-review/">Film Review: ‘Grass Is Greener’ Documentary Nails It</a> appeared first on <a href="https://cannabisnow.com/">Cannabis Now</a>.

This stellar Netflix documentary tracks the disturbing history of cannabis prohibition in the US.
The post <a href="https://cannabisnow.com/grass-is-greener-review/">Film Review: ‘Grass Is Greener’ Documentary Nails It</a> appeared first on <a href="https://cannabisnow.com/">Cannabis Now</a>.

Film Review: ‘Grass Is Greener’ Documentary Nails It

<img loading="lazy" decoding="async" src="https://azmarijuana.com/wp-content/uploads/2021/11/Memes.jpg" alt="Memes" width="1024" height="1009" class="aligncenter size-full wp-image-1139746" srcset="https://azmarijuana.com/wp-content/uploads/2021/11/Memes.jpg 1024w, https://azmarijuana.com/wp-content/uploads/2021/11/Memes-600x591.jpg 600w, https://azmarijuana.com/wp-content/uploads/2021/11/Memes-715x705.jpg 715w, https://azmarijuana.com/wp-content/uploads/2021/11/Memes-150x148.jpg 150w, https://azmarijuana.com/wp-content/uploads/2021/11/Memes-768x757.jpg 768w, https://azmarijuana.com/wp-content/uploads/2021/11/Memes-610x601.jpg 610w" sizes="auto, (max-width: 1024px) 100vw, 1024px">

<center>View hilarious marijuana memes <a href="https://azmarijuana.com/category/marijuana-memes/">here</a>.</center>
The post <a href="https://azmarijuana.com/marijuana-memes/marijuana-meme-of-the-day-21/">Marijuana Meme of the Day</a> appeared first on <a href="https://azmarijuana.com/">AZ Marijuana</a>.

View hilarious marijuana memes here.
The post <a href="https://azmarijuana.com/marijuana-memes/marijuana-meme-of-the-day-21/">Marijuana Meme of the Day</a> appeared first on <a href="https://azmarijuana.com/">AZ Marijuana</a>.

Marijuana Meme of the Day

Calgary city council is being asked to allow the sale of cannabis products at events where attendees are at least 18 years old.

: Cannabis

Calgary city council to be asked to approve cannabis sales at adult-only events

Aphria Inc. has agreed to pay $30 million to settle a class-action lawsuit by shareholders alleging the company made misrepresentations to capital markets in 2018.

Cannabis company Aphria reaches 30M agreement to settle shareholder class-action lawsuit

Eric Dejaeger, who last year was sentenced for historical sex crimes against children in Alberta, pleaded guilty to similar assaults committed as a priest in Igloolik, Nunavut.

‘Sick monster’: Defrocked priest pleads guilty to sex assaults of children in Nunavut

Four weeks into the Canada Post strike, labour experts say it becomes 'critically important' to maintain public support. Here's why that might be getting tougher.

Canada Post strike tests public support heading into holidays: experts

After years of delays, researchers are set to move forward on a landmark clinical trial meant to evaluate the efficacy of smoked medical marijuana in treating post-traumatic stress disorder (PTSD) in military veterans. The study is being funded with tax revenue from legal cannabis sales in<a href="https://weedmaps.com/learn/laws-and-regulations/michigan"> Michigan</a>.



The<a href="https://maps.org/"> Multidisciplinary Association for Psychedelic Studies</a>, or MAPS, announced this week that the U.S. Food and Drug Administration (FDA) gave approval for Phase 2 of the research, which MAPS described in a press release as “a randomized, placebo-controlled study of 320 Veterans suffering from moderate to severe PTSD who have previously used cannabis.”



The group said the study “is designed to investigate the inhalation of high THC dried cannabis flower, versus placebo cannabis, with the daily dose being self-titrated by participants.” It's meant to reflect consumption patterns already happening across the country and study “the 'real-world' use of inhaled cannabis to understand its potential benefits and risks in treating PTSD.”



MAPS said the project is years in the making, noting that it faced several challenges in clearing the research with the FDA that were only recently resolved.



“After three years of negotiations with the FDA, this decision opens the door to future research into cannabis as a medical treatment, offering hope to millions,” the organization said.



“These data are critical to inform patients, medical providers, and adult-use consumers when considering cannabis in treatment plans for the management of PTSD, pain, and other serious health conditions,” the group's press release said, “yet regulatory obstacles have historically made it difficult or impossible to conduct meaningful research on the safety and effectiveness of cannabis products typically consumed in regulated markets.”



MAPS said that over the years, it responded to five partial clinical hold letters from the FDA that halted the study's progress.



“On August 23, 2024, MAPS responded to the FDA's fifth clinical hold letter by <a href="https://maps.org/2024/08/23/maps-submits-formal-dispute-resolution-request-against-fdas-clinical-hold-on-phase-2-study-of-cannabis-for-veterans-with-ptsd-mjp2/">submitting</a> a Formal Dispute Resolution Request (FDRR) to resolve the continued scientific and regulatory disagreement with the Division on four key issues,” according to the organization: “1) the proposed THC dose of the cannabis flower product, 2) smoking as a delivery method, 3) vaping as a delivery method, and 4) the enrollment of cannabis naïve participants.”



<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"><div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="550" data-dnt="true">
After more than three years of tireless effort and five rounds of pushback from FDA, MAPS has won a Formal Dispute Resolution Request (FDRR) with the FDA’s Division of Psychiatry — the same Division that rejected Lykos’ New Drug Application for MDMA-assisted therapy for PTSD.… <a href="https://t.co/sUiTjAIV9F">pic.twitter.com/sUiTjAIV9F</a>— MAPS (@MAPS) <a href="https://twitter.com/MAPS/status/1859305560434237771?ref_src=twsrc%5Etfw">November 20, 2024</a>
</blockquote>
</div></figure>Sue Sisley, a psychiatrist and the principal investigator for the study, said the trial will help shed more light on the scientific legitimacy of using smoked marijuana to treat PTSD. Despite the growing use of cannabis among patients with PTSD and the condition's inclusion in many state medical marijuana programs, she said there's a lack of rigorous data evaluating the treatment's efficacy.



“Within the United States, millions of Americans are smoking or vaporizing cannabis to manage or treat their symptoms,” Sisley said in a statement. “In the absence of high-quality data related to cannabis, much of the information available to patients and regulators is rooted in prohibition and focused only on potential risks, without consideration of potential benefits.”



“In my own practice, Veteran patients have shared how smoking cannabis helped them manage their PTSD symptoms more than traditional pharmaceuticals,” she continued. “Suicide among Veterans is an urgent public health crisis, but it's solvable if we invest in researching new treatments for life-threatening health conditions like PTSD.”



Phase 2 of the research, Sisley said, “will generate data that doctors, like myself, can use to develop treatment plans to help people manage their PTSD symptoms.”



Allison Coker, director of cannabis research at MAPS, said the resolution with the FDA came when the agency said it would <a href="https://maps.org/2024/11/07/maps-cleared-to-proceed-by-fda-on-phase-2-study-of-smoked-cannabis-for-veterans-with-ptsd-mjp2/">allow Phase 2 to proceed with smoked cannabis</a> at commercially available THC levels. Vaporization remains on hold, however, until the FDA can assess the safety of any particular delivery device.



In response to the FDA's <a href="https://maps.org/2024/09/19/maps-achieves-agreement-on-three-key-points-despite-appeal-denied-letter-received-from-fda-on-phase-2-study-of-cannabis-for-veterans-with-ptsd-mjp2/">separate concern</a> around enrolling cannabis-naive participants in the study, MAPS <a href="https://maps.org/2024/10/10/maps-submits-sixth-clinical-hold-response-to-fda-on-phase-2-study-of-cannabis-for-veterans-with-ptsd-mjp2/">updated</a> the protocol to require that participants must have “prior experience inhaling (smoking or vaporizing) cannabis.”



FDA had also taken issue with the study's design of allowing self-titration — meaning participants can consume as much cannabis as they choose, up to a certain amount — but MAPS refused to relent on that point.



An FDA spokesperson told the <a href="https://www.nytimes.com/2024/11/20/us/marijuana-ptsd-cannabis-science-fda-study.html?fbclid=IwZXh0bgNhZW0CMTEAAR1uChXEbvIb6a3owwEtDvviz7QDntdpJ0EXYv8vDUR9gwxVWCp3cd2nPU0_aem_igSMOaWhm6whfS7Fj_s2iw">New York Times</a>, which first reported the Phase 2 approval, that she was unable to provide details about what led to the decision but said that the agency “recognizes that there is great need for additional treatment options for mental health conditions such as PTSD.”



The study is being funded by <a href="https://www.marijuanamoment.net/michigan-spends-20m-in-marijuana-revenue-to-study-medical-cannabis-for-veterans-with-ptsd/">Michigan's Veteran Marijuana Research Grant Program</a>, which uses state revenue from legal cannabis taxes to fund FDA-approved, nonprofit-sponsored clinical trials “researching the efficacy of marijuana in treating the medical conditions of United States armed services veterans and preventing veteran suicide.”



State officials announced $13 million in funding for the research back in 2021, part of a total $20 million grant funding round. Another $7 million that year went to Wayne State University's Bureau of Community Action and Economic Opportunity, which partnered with researchers to study how cannabis might treat a variety of mental health disorders, including PTSD, anxiety, sleep disorders, depression, and suicidality.



In 2022, meanwhile, the Michigan Cannabis Regulatory Agency recommended that year's $20 million go toward two universities: the University of Michigan, where researchers proposed looking at the use of CBD in pain management, and Wayne State University, which was awarded grants for two separate studies: one that billed itself as the “first randomized, controlled, large-scale clinical trial” to examine whether the use of cannabinoids could improve outcomes for veterans with PTSD who are undergoing prolonged exposure (PE) therapy and another into the effects of marijuana on “neuroinflammation and neurobiological underpinnings of suicide ideation in veterans with PTSD.”



The founder and president of MAPS, Rick Doblin, said in the group's <a href="https://www.globenewswire.com/news-release/2024/11/20/2984688/0/en/MAPS-Successfully-Clears-Path-for-Cannabis-Research-through-FDA-Formal-Dispute.html?fbclid=IwZXh0bgNhZW0CMTEAAR0uh26TmWEmyGWfhxOW9hVa6wT39qi5etyNPDk7-veDARPM-JwVSKQgrvg_aem_2PvGSWUtiFh0Nv3sHdtY3Q">announcement</a> of the newly FDA-approved trial that veterans “are in dire need of treatments that can ease their challenging symptoms of PTSD.”



“MAPS takes pride in leading the way to open new research pathways by challenging the FDA to think differently,” he said. “Our cannabis work challenges FDA's typical approach to scheduled dosing and administration of drugs. MAPS refused to compromise the study design in order to fit into the standard box of FDA thinking in order to ensure that cannabis research reflects cannabis use.”



MAPS's past research has included not just cannabis but also, as the group's name suggests, psychedelics. It created a spinoff drug development company, Lykos Therapeutics (formerly MAPS Public Benefit Corporation), <a href="https://www.marijuanamoment.net/fda-grants-priority-review-of-mdma-assisted-therapy-for-ptsd-psychedelics-drug-development-company-says/">that sought FDA approval earlier this year of MDMA to treat PTSD</a>.



But in August, the FDA declined to approve the MDMA-assisted therapy. Separate research, published in the Journal of Psychedelic Studies, found that <a href="https://www.marijuanamoment.net/results-on-mdma-therapy-for-ptsd-are-encouraging-but-its-not-yet-ready-for-widespread-adoption-study-says/">while results of clinical trials have been “encouraging,” more robust research is needed</a> before MDMA-assisted therapy (MDMA-AT) sees widespread adoption over currently available forms of treatment



Some health officials said afterward that the effort <a href="https://www.marijuanamoment.net/federal-officials-say-psychedelic-assisted-therapy-shows-promise-for-ptsd-but-more-research-is-needed/">nevertheless reflected progress at the federal level</a>.



“We all feel some type of way about the decision that came out some time ago, and that's OK,” said Leith J. States, chief medical officer at the Office of the Assistant Secretary for Health. “It's indicative of a fact that we're moving forward…and we're doing things in a way that marches us forward in an incremental way.”



Separately this month, a Drug Enforcement Administration (DEA) judge <a href="https://www.marijuanamoment.net/dea-judge-rejects-veterans-groups-petition-to-participate-in-marijuana-rescheduling-hearing/">rejected a veterans group's petition to participate in an upcoming hearing on the Biden administration's marijuana rescheduling proposal</a>, which the organization, the Veterans Action Council (VAC), called a “travesty of justice” that excludes key voices that would be affected by the potential policy change.



While DEA “devised a reasonably inclusive stakeholder assortment” of witnesses, VAC said it still “failed” to fulfill its mandate to allow testimony from interested parties. And the veterans organization said that's evidenced by the fact that Mulrooney has <a href="https://www.marijuanamoment.net/dea-marijuana-rescheduling-hearing-delayed-until-2025-agency-judge-rules/">since delayed the formal hearing proceedings until early 2025</a> because DEA provided insufficient information about their selected witnesses' position on rescheduling or why they should be considered interested parties.



Meanwhile, in Congress, a new U.S. Senate bill introduced this month aims to ensure benefits for veterans exposed to <a href="https://www.marijuanamoment.net/senate-bill-would-restore-benefits-for-u-s-army-veterans-subjected-to-psychedelic-experiments-by-former-nazis-during-secret-program/">potentially hazardous chemicals during the Cold War era — including psychedelics like LSD, nerve agents and mustard gas</a>. The secret testing program, which ran from 1948 to 1975 at an Army base in Maryland, involved former Nazi scientists administering the substances to American military members.



More recently, the U.S. military has also invested millions in an effort to develop <a href="https://www.marijuanamoment.net/military-invests-27m-to-develop-new-class-of-psychedelics-inspired-drugs/">a new class of drugs that offers the same fast-acting mental health benefits as traditional psychedelics but without a psychedelic trip</a>.



Veterans have taken a lead role in both medical marijuana legalization and the psychedelics reform movement currently unfolding at the state and federal levels. Earlier this year, for example, veterans service organizations (VSOs) pressed members of Congress to urgently <a href="https://www.marijuanamoment.net/veterans-groups-push-congress-to-take-action-on-psychedelic-therapy-and-medical-marijuana/">pursue the potential benefits of psychedelic-assisted therapy and medical marijuana</a>.



The requests from groups like the Iraq and Afghanistan Veterans of America, Veterans of Foreign Wars of the United States, Disabled American Veterans, and the Wounded Warrior Project came on the heels of organizations at last year's set of annual VSO hearings <a href="https://www.marijuanamoment.net/veterans-advocates-criticize-va-for-stalling-medical-marijuana-research-at-joint-congressional-hearings/">criticizing the Department of Veterans Affairs (VA) for “dragging their feet” on medical marijuana research</a>.



Led <a href="https://www.marijuanamoment.net/federal-psychedelics-reform-is-more-supported-by-republicans-former-texas-governor-claims/">largely by Republican politicians</a>, efforts at reform have included a <a href="https://www.marijuanamoment.net/congressional-committee-approves-gop-led-psychedelics-bill-focused-on-military-veterans-therapeutic-access/">GOP-sponsored psychedelics bill in Congress that focused on veterans' access</a>, various state-level changes, and a bevy of hearings on expanded access.



Rep. Derrick Van Orden (R-WI), who filed one congressional psychedelics bill that advanced through a committee, is also a co-sponsor of a bipartisan measure to provide funding to the Department of Defense (DOD) to conduct clinical trials into the therapeutic potential of certain psychedelics for active duty military members. That reform was <a href="https://www.marijuanamoment.net/biden-signs-defense-bill-requiring-psychedelics-studies-involving-active-duty-military-service-members/">signed into law by President Joe Biden under an amendment attached to the 2024 National Defense Authorization Act (NDAA)</a>.



In March, congressional appropriations leaders also unveiled a spending package that <a href="https://www.marijuanamoment.net/congressional-leaders-again-seek-to-block-d-c-marijuana-sales-while-funding-psychedelic-studies-in-new-spending-bill/">contains language providing $10 million to facilitate the psychedelics studies</a>.



In January, the VA separately issued a request for applications to conduct in-depth research on <a href="https://www.marijuanamoment.net/va-is-funding-new-research-on-psychedelics-benefits-for-veterans-with-ptsd-and-depression/">the use of psychedelics to treat PTSD and depression</a>. And last October, the department launched a new podcast about the future of veteran health care, with <a href="https://www.marijuanamoment.net/first-episode-of-new-federal-veterans-affairs-podcast-focuses-on-psychedelics-healing-potential/">the first episode of the series focused on the healing potential of psychedelics</a>.



At the state level, the governor of Massachusetts in August signed a <a href="https://www.marijuanamoment.net/massachusetts-governor-signs-bill-to-create-psychedelics-working-group-for-veterans-therapy/">military veterans-focused bill that includes provisions to create a psychedelics working group</a> to study and make recommendations about the potential therapeutic benefits of substances like psilocybin and MDMA.



Meanwhile, in California, lawmakers in June pulled from consideration a bipartisan bill that would have authorized a <a href="https://www.marijuanamoment.net/california-lawmakers-withdraw-bill-to-authorize-psilocybin-therapy-pilot-program-for-veterans-and-former-first-responders/">pilot program to provide psilocybin treatment to military veterans and former first responders</a>.



Correction: As the result of an editing error, an earlier version of this story attributed quotes to incorrect members of the MAPS team. Those attributions have been corrected.



<hr class="wp-block-separator has-alpha-channel-opacity">
Written by <a href="https://www.marijuanamoment.net/author/benadlin/">Ben Adlin</a> for Marijuana Moment | Featured image by Anthony Brown/Weedmaps
The post <a href="https://weedmaps.com/news/2024/12/fda-approves-marijuana-clinical-trial-ptsd-veterans/">Treating PTSD with Cannabis: Long-Awaited Study Gets FDA Green Light</a> appeared first on <a href="https://weedmaps.com/news">Weedmaps News</a>.

After years of delays, researchers are set to move forward on a landmark clinical trial meant to evaluate the efficacy of smoked medical marijuana in treating post-traumatic stress disorder (PTSD)…
The post <a href="https://weedmaps.com/news/2024/12/fda-approves-marijuana-clinical-trial-ptsd-veterans/">Treating PTSD with Cannabis: Long-Awaited Study Gets FDA Green Light</a> appeared first on <a href="https://weedmaps.com/news">Weedmaps News</a>.

Weedmaps News

Treating PTSD with Cannabis: Long-Awaited Study Gets FDA Green Light

The proportion of Canadians who smoke cannabis has decreased since legalization, though a recent survey shows it remains the most common method of consumption.

How cannabis use in Canada is changing: less smoke, more sweets

Eight companies will open a dozen stores, with two each in City Centre, Newton, South Surrey, Guildford, Fleetwood and Cloverdale

The Vancouver Sun - RSS Feed

Green light: Surrey council approves 12 new pot stores across the city

The stores must operate under a framework council approved last spring, which bans them from within 200 metres of schools, community centres and other cannabis businesses.

Surrey greenlights 8 companies to open 12 cannabis stores

The Manitoba government is extending, by more than a year, a temporary moratorium on some new cannabis outlets.

Manitoba government says it needs more time to review some cannabis licences

When we think of getting high, we think of smoking cannabis. It’s traditional, and the method used for over a millennia, it’s also the social aspect of sharing a joint that makes it so appealing. However now we have modern and more safe methods for the inhalation of cannabis. It’s time to reconsider lighting your cannabis on fire and baking it instead, using a dry herb vaporizer.



Dry herb vaporizing is using a device that bakes the cannabis, releasing vapor instead of smoke that you inhale. Dry herb vaporizing never goes over the point of combustion which is 450F/232C so you’re never inhaling smoke. The other method of vaporizing is for concentrates, think <a href="https://weedmama.ca/2022/03/06/an-introduction-to-vape-pens/">vape pens</a> however in this article I’m only going to be discussing <a href="https://weedmama.ca/cannabis-basics/vaping/">dry herb vaporizing</a>.



There’s good reasons why it’s superior to smoking cannabis, let’s look at the top 5 reasons why you need to switch from smoking cannabis to dry herb vaporizing:



<figure class="wp-block-image is-style-rounded"><a href="https://youtu.be/3nFCOjlU_3c?si=JUsHYPFgwPb7GuoX"><img fetchpriority="high" decoding="async" width="1024" height="576" src="https://weedmama.ca/wp-content/uploads/2024/10/watch-cannabis-dry-herb-vaporizing-video-1024x576.jpg" alt="" class="wp-image-7201" srcset="https://weedmama.ca/wp-content/uploads/2024/10/watch-cannabis-dry-herb-vaporizing-video-1024x576.jpg 1024w, https://weedmama.ca/wp-content/uploads/2024/10/watch-cannabis-dry-herb-vaporizing-video-300x169.jpg 300w, https://weedmama.ca/wp-content/uploads/2024/10/watch-cannabis-dry-herb-vaporizing-video-768x432.jpg 768w, https://weedmama.ca/wp-content/uploads/2024/10/watch-cannabis-dry-herb-vaporizing-video-100x56.jpg 100w, https://weedmama.ca/wp-content/uploads/2024/10/watch-cannabis-dry-herb-vaporizing-video-922x519.jpg 922w, https://weedmama.ca/wp-content/uploads/2024/10/watch-cannabis-dry-herb-vaporizing-video.jpg 1280w" sizes="(max-width: 1024px) 100vw, 1024px"></a><figcaption class="wp-element-caption">Watch the video for why you need to switch from smoking cannabis to dry herb vaporizing</figcaption></figure><h2 class="wp-block-heading has-large-font-size">1- Dry herb vaporizing is less toxic</h2>



Because dry herb vaporizers never go over 450F/232C (the point of combustion), you aren’t getting as many carcinogens as smoking. Inhaling smoke is bad for your lungs and overall health. It contains harmful carcinogens, these carcinogens are drastically reduced when using a dry herb vaporizer.



<blockquote class="wp-block-quote is-style-default is-layout-flow wp-block-quote-is-layout-flow">
Cannabis vaporizer use can reduce the emission of carbon monoxide, chronic respiratory symptoms, and exposure to several toxins while producing similar subjective effects and blood THC concentration compared with smoking cannabis, holding potential for harm reduction among habitual cannabis smokers. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975973/#:~:text=Cannabis%20vaporizer%20use%20can%20reduce,reduction%20among%20habitual%20cannabis%20smokers." target="_blank" rel="noreferrer noopener">PubMed</a>
</blockquote>



While smoking cannabis is not linked to cancer, smoking cannabis can put you at higher risk of heart attack and stroke as you’re inhaling smoke. It also can put you at higher risk for intense coughing, chronic bronchitis and increases the risk of lung infections.



We don’t know the long term effects of dry herb vaporizing however doctors tend to recommend dry herb vaporizing over smoking for medical patients, as there’s far less toxins when vaporizing.



<h2 class="wp-block-heading has-large-font-size">2- Vaporizing has greater bioavailability</h2>



When you light your cannabis on fire, your burning off some of the cannabinoids and terpenes, therefore reducing the overall bioavailability. When you’re looking at <a href="https://weedmama.ca/cannabis-basics/cannabis-chemistry/">whole plant therapy</a> (where none of the plant properties are removed), dry herb vaporizing is superior as it maintains more cannabinoids and terpenes over smoking.



The bioavailability of cannabinoids is the highest with all inhalation methods at around 10 to 35% overall with vaporizing being the highest, as less cannabinoids are burned off. For comparison, ingested cannabis is approximately 5 to 12%.



<blockquote class="wp-block-quote is-layout-flow wp-block-quote-is-layout-flow">
Vaporized cannabis resulted in qualitatively stronger drug effects for most pharmacodynamic outcomes and higher peak concentrations of THC in blood, compared with equal doses of smoked cannabis (25-mg dose: smoked, 10.2 ng/mL; vaporized, 14.4 ng/mL). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324384/" target="_blank" rel="noreferrer noopener">National Library of Medicine</a>
</blockquote>



This can also make vaporizing feel stronger than smoking for some people. However this also depends on what temperature you’re using, and the strength of the THC in the cannabis flower. Using a 10% THC cultivar will feel lighter than 25%, especially when vaporized at a lower temperature.



Related article: <a href="https://weedmama.ca/2019/02/22/customizing-your-high-with-vaporizing-cannabis/">Customize your high with dry herb vaporizing</a>



Dry herb vaporizing releases various cannabinoids and terpenes, depending on what temperature you’re using. For example the boiling point of CBD is 180C/350F and the boiling point of CBN 185C/365F. You can essentially customize your high with dry herb vaporing. You don’t have that level of control when smoking cannabis.


<div class="wp-block-image">
<figure class="aligncenter size-full is-resized"><a href="https://weedmama.ca/cannabis-basics/vaping/"><img decoding="async" width="348" height="195" src="https://weedmama.ca/wp-content/uploads/2024/03/dryherb-vaporizing.jpg" alt="the basics of dry herb vaporizing" class="wp-image-6953" srcset="https://weedmama.ca/wp-content/uploads/2024/03/dryherb-vaporizing.jpg 348w, https://weedmama.ca/wp-content/uploads/2024/03/dryherb-vaporizing-300x168.jpg 300w, https://weedmama.ca/wp-content/uploads/2024/03/dryherb-vaporizing-100x56.jpg 100w" sizes="(max-width: 348px) 100vw, 348px"></a><figcaption class="wp-element-caption">Learn the basics of dry herb vaporizing</figcaption></figure>
</div>


<h2 class="wp-block-heading has-large-font-size">3- Better flavour</h2>



Because you’re preserving more of the terpenes using a dry herb vaporizer, you also get the true flavour of the terpenes. Terpenes have a boiling point, they’re delicate and combusting your flower destroys many of the terpenes.



Dry herb vaporizers allow you to reduce the temperature, and lower temperatures gives you greater flavour. If you really want to experience the true taste of the terpenes, turn your dry herb vaporizer down to about 180c/356f to experience all of the notes from the cultivar in your vaporizer.



Related article: <a href="https://weedmama.ca/2021/10/07/tips-and-tricks-for-getting-the-best-flavour-from-your-dry-herb-vaporizer/">Tips &amp; tricks for getting the best flavour from your dry herb vaporizer</a>



<h2 class="wp-block-heading has-large-font-size">4- Dry herb vaporizing saves you money </h2>



While the upfront cost of a dry herb vaporizer can run you hundreds of dollars, long term you save money as you use less cannabis overall. Not only do you use less cannabis in a vaporizer, you can reheat the bowl several times, getting up to three or more sessions from one packed bowl.



After vaped bud (AVB)



You can stretch a small amount of cannabis a long way including after you finish with it. You can use the AVB in some milk or with tea and create a cannabis hot toddy of sorts. As it will be higher in CBN, a cannabinoid that can make you feel sleepy, some people like to use AVB tea in the evening to help them sleep. With Dry herb vaporizing you get more use from your cannabis, even turning it into an edible when you’re done. You simply can’t do that when you light cannabis on fire.



<h2 class="wp-block-heading has-large-font-size">5- Reduced smell and more discrete</h2>



The odor from cannabis that’s been smoked can be smelled from quite a distance however vapor dissipates in the air, making it far more discreet. You can still smell cannabis from a dry herb vaporizer but it’s much less than smoke.



Smoke can also seep into fabrics like your clothes and furniture, making it stink. That doesn’t happen with vapor. When you vaporize outside it dissipates quickly making it difficult for anyone to know what you’re doing. 



Overall vaporizing cannabis has far less smell and it’s more discreet than smoking cannabis.



<h2 class="wp-block-heading has-large-font-size">Advice for making the switch from smoking cannabis to dry herb vaporizing</h2>



Vaporizing can feel like you’re inhaling air, it’s quite different than smoking. You can also feel a little light headed at first until you get used to it. The high is different as well, so when you’re making the switch, use a higher setting on your vaporizer. Over 400F/204C will feel closer to smoking, 420F is a great temperature for smokers!



I recommend you lower the temperature as well, so you can get the great flavour from the terpenes. Once you get to higher temperatures, you lose some of the flavour. 



<h2 class="wp-block-heading has-large-font-size">Dry Herb Vaporizers I recommend:</h2>



I written a couple of thorough articles on vaporizers I recommend and why, I’ve also written a detailed article on how to shop for a dry herb vaporizer to suite your lifestyle needs. Visit the articles below for my top picks!



<a href="https://weedmama.ca/2023/12/01/top-5-dry-herb-vaporizers-of-2023-budget-friendly-to-high-end/">Top 5 Dry Herb Vaporizers of 2023: Budget Friendly to High End</a>



<figure class="wp-block-image size-large is-resized"><a href="https://weedmama.ca/2023/12/01/top-5-dry-herb-vaporizers-of-2023-budget-friendly-to-high-end/"><img decoding="async" width="1024" height="640" src="https://weedmama.ca/wp-content/uploads/2023/12/TOP-5-DRY-HERB-VAPORIZERS-2023-1024x640.jpg" alt="" class="wp-image-6774" srcset="https://weedmama.ca/wp-content/uploads/2023/12/TOP-5-DRY-HERB-VAPORIZERS-2023-1024x640.jpg 1024w, https://weedmama.ca/wp-content/uploads/2023/12/TOP-5-DRY-HERB-VAPORIZERS-2023-300x188.jpg 300w, https://weedmama.ca/wp-content/uploads/2023/12/TOP-5-DRY-HERB-VAPORIZERS-2023-768x480.jpg 768w, https://weedmama.ca/wp-content/uploads/2023/12/TOP-5-DRY-HERB-VAPORIZERS-2023-100x63.jpg 100w, https://weedmama.ca/wp-content/uploads/2023/12/TOP-5-DRY-HERB-VAPORIZERS-2023-922x576.jpg 922w, https://weedmama.ca/wp-content/uploads/2023/12/TOP-5-DRY-HERB-VAPORIZERS-2023.jpg 1280w" sizes="(max-width: 1024px) 100vw, 1024px"></a></figure><a href="https://weedmama.ca/2021/08/21/how-to-buy-the-best-dry-herb-vaporizer-for-your-lifestyle-and-my-top-picks/">How to buy the best dry herb vaporizer for your lifestyle needs</a>



<figure class="wp-block-image size-full is-resized"><a href="https://weedmama.ca/2021/08/21/how-to-buy-the-best-dry-herb-vaporizer-for-your-lifestyle-and-my-top-picks/"><img decoding="async" width="957" height="800" src="https://weedmama.ca/wp-content/uploads/2021/08/dryherbvaporizing.jpg" alt="" class="wp-image-4930" srcset="https://weedmama.ca/wp-content/uploads/2021/08/dryherbvaporizing.jpg 957w, https://weedmama.ca/wp-content/uploads/2021/08/dryherbvaporizing-300x251.jpg 300w, https://weedmama.ca/wp-content/uploads/2021/08/dryherbvaporizing-768x642.jpg 768w, https://weedmama.ca/wp-content/uploads/2021/08/dryherbvaporizing-100x84.jpg 100w, https://weedmama.ca/wp-content/uploads/2021/08/dryherbvaporizing-922x771.jpg 922w, https://weedmama.ca/wp-content/uploads/2021/08/dryherbvaporizing-600x502.jpg 600w" sizes="(max-width: 957px) 100vw, 957px"></a></figure><h2 class="wp-block-heading has-large-font-size">FAQ:</h2>



Can I use any type of cannabis in a vaporizer? Dry herb vaporizers are designed for cannabis flower. However, You can buy some models that allow you to use concentrates or oils.



Will I get the same effects as smoking? Vaporizing actually enhances the effects of cannabis because of it’s greater bioavailability. You get more absorption of the cannabinoids in your body because you’re not burning the plant material.



How long does a vaporizing session last compared to smoking? Vaporizing cannabis may last longer than smoking because the cannabis heats gradually, and you can take multiple draws from a single session. You can also reheat the cannabis multiple times in a vaporizer.



Can vaporizing reduce coughing? Yes, while it doesn’t eliminate coughing all together, it does reduce coughing as you’re inhaling steam and not smoke.



Is a vaporizer easy to clean? If you clean the vaporizer regularly by giving it a quick wipe with some rubbing alcohol, it will reduce how often you have to deep clean the vaporizer. Mostly you’re cleaning inside the bowl, vapor path and the mouthpiece with a dry herb vaporizer. They often come with brushes, wipes and other tools to help maintain the unit.



Does vaporizing affect tolerance differently than smoking? Since vaporizing has better bioavailability, you may find your tolerance doesn’t increase as quickly as smoking it does. However this can vary depending on many factors like how much you’re using and how often.



<hr class="wp-block-separator has-text-color has-light-green-cyan-color has-alpha-channel-opacity has-light-green-cyan-background-color has-background is-style-wide">
<h2 class="has-text-align-center wp-block-heading">Elevate your inbox, subscribe to Weed Mama</h2>


<div class="tco-section"><div class="tco-container"><div class="tco-column tco-sm tco-1-1">


 
 <fieldset></fieldset>
<fieldset></fieldset>

</div></div></div>

When we think of getting high, we think of smoking cannabis. It’s traditional, and the method used for over a millennia, it’s also the social aspect of sharing a joint ...

Weed Mama

5 reasons why you need to switch from smoking cannabis to dry herb vaporizing

Wastewater tested in Halifax in 2023 contained almost twice the amount of cannabis metabolites compared with samples taken from other big cities in Canada.

Higher in Halifax: Elevated levels of cannabis metabolites in city’s wastewater

The annual Police and Peace Officers' Memorial Day held at the Alberta Legislature Sunday honoured the 106 police and peace officers who have died in the line of duty since 1876.

Ceremony honours fallen Alberta police and peace officers

'It has become quite an issue that we've witnessed in the past year or so,' Swan River mayor Lance Jacobson said.

Manitoba communities crack down on needle distribution, drug use

Humboldt County, located in Northern California's famed Emerald Triangle, has long been a mecca for cannabis cultivation. Its rich soil and ideal climate produce some of the finest cannabis in…
The post <a href="https://weedmaps.com/news/2024/09/humboldt-county-cannabis-tourist-guide/">High city tourist guide to Humboldt County</a> appeared first on <a href="https://weedmaps.com/news">Weedmaps News</a>.

State of Herb

Loading...